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Abstract 
Carbon based materials have attracted tremendous attention owing to their captivating 
electronic, mechanical and thermal properties. These materials are also being introduced in 
biological systems, considering the fact that life on earth is carbon based.  However, limited 
information is available concerning the potential effects of different structures of these 
carbon materials on biological systems. In the present study, carbon reinforced (i.e. carbon 
nanotubes (CNTs-1D), graphene nanoplatelets (GNPs-2D) and activated carbon (AC-3D)) 
polymer-ceramic (nano-hydroxyapatite (nHA)) composite scaffolds have been developed. 
Poly(vinyl alcohol) (PVA) and poly(lactic-co-glycolic acid) (PLGA) have been used as 
polymer matrix. Initially, four different reinforcements i.e. nHA, CNTs, GNPs and AC 
were reinforced in PVA matrix by varying their concentrations and characterized for their 
physicochemical, mechanical and biological properties to find an optimum concentration. 
The proper dispersion of reinforcement materials up to threshold concentration enhanced 
the mechanical properties of the composites and provided the most favorable 
microenvironment for cell attachment and growth. The threshold (optimum) concentrations 
of different reinforcements were found to be 3% w/v for nHA, 1 wt% for CNTs, 1 wt% for 
GNPs and 2.5 wt% for AC, respectively, above which the agglomeration of reinforcements 
had reduced effect on the scaffold properties. 
The optimum concentrations of each carbon were then reinforced into PVA along with 3% 
w/v of nHA to develop 3 component composite systems (PVA-nHA-carbon). Further, the 
optimum concentrations of each carbon reinforcement were also added to PLGA matrix 
without (PLGA-carbon) and with hydroxyapatite (PLGA-nHA-carbon). These composites 
containing threshold concentration of reinforcements were then characterized for their 
physicochemical, mechanical and biological properties. Along with the hemocompatible 
nature, the composites also exhibited good swelling ratio, degradation percentage and in-
vitro bioactivity. The effective stress transfer between the homogenously dispersed 
  
 
reinforcement materials and polymer matrix increased the tensile strength, Young’s 
modulus and energy at break for the composites many folds. A significant enhancement in 
cell attachment, viability and differentiation was observed in all the composites. The 
suitable surface properties i.e. wettability, surface roughness and surface charge stimulated 
the protein adsorption on the carbonaceous composites making them suitable for MG-63 
cell attachment, proliferation and differentiation.  The augmented collagen secretion, ALP 
activity and matrix mineralization confirmed the improved bone forming ability of the 
cells. Owing to their nanostructure, both CNTs and GNPs exhibited better results in 
comparison to the AC.  
Amongst all composites, GNPs along with nHA showed the strongest effect on the 
properties of PVA and PLGA based composites due to the sheet like 2D structure of GNPs. 
More functional groups and larger area exposed in case of GNPs lead to highest protein 
adsorption and hence, improved its cellular responses. The larger interface directed 
effective load transfer between polymer matrix and GNPs. These results demonstrate the 
potential of carbonaceous composites of polymer-nHA for accelerating bone tissue 
regeneration. 
Keywords: poly(vinyl alcohol); poly(lactic-co-glycolic acid); carbon nanotubes; 
graphene; bone tissue engineering; tensile properties; osteoblast   cells.  
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Chapter 1 
Introduction 
This chapter gives an introduction to bone tissue engineering by providing an overview of 
basic requirements of the tissue engineering. The chapter begins with a summary of 
structure, functions and properties of bone. The current techniques of bone repair, their 
limitations and the need for bone tissue engineering will be discussed. Various types of 
biomaterials (polymers, ceramics, metals and carbon) and techniques for scaffold 
fabrication will also be discussed.  
1.1. Bone 
Bone is an organ of skeletal system with a highly complex and a well-organized structure 
[1]. Its main functions are to provide mechanical support to the body, to protect internal 
organs and to serve as a mineral reservoir. It also maintains calcium and phosphate 
homeostasis, helps in blood production and blood pH regulation [2]. It consists of a mineral 
phase, an organic phase and water [3]. In most of the bones, the mineral content ranges 
from 60-70% of its dry weight and is mainly composed of hydroxyapatite. The organic 
phase contains type 1 collagen (~90%), noncollagenous proteins (~5%) and lipids (~2%). 
The hydroxyapatite crystals are arranged parallel to the collagen fibrils of the organic phase 
[3]. The adult human skeleton is composed of 20% trabecular bone (cancellous and spongy) 
and 80% cortical bone (compact and dense). Bone development occurs by two processes: 
intramembranous or endochondral ossification. In intramembranous ossification, the 
mesenchymal stem cells directly differentiate into osteoblast cells and form bone. In 
contrast, endochondral ossification involves the formation of a cartilage template which 
converts to bone after calcification and invasion of blood vessels. 
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Bone has a unique ability to grow, model and remodel itself continuously throughout the 
lifetime [4]. In response to the physiological conditions or applied stress, bone keeps 
changing its shape and this process is known as bone modeling. To maintain bone strength 
and homeostasis bone remodeling occurs. In the bone remodeling process, old bone is 
resorbed and new bone is formed by osteoclast and osteoblast cells. This process starts 
before birth and continues till death. In most of the cases, after trauma or any disease, bone 
expresses excellent intrinsic capacity to repair and regenerate without the formation of any 
scar tissue. Studies have shown that the natural mechanism of bone repair closely resembles 
to the normal bone formation process [5]. However, the natural bone repair process has 
many disadvantages as it is limited to bone defects that have adequate vascular supply and 
it takes long time for proper healing of bone. Also it is inadequate to repair the large bone 
defects, as observed after nonunion fractures, bone tumor resections and endoprosthetic 
loosening. Therefore, bone grafts such as autografts and allografts are used to enhance bone 
repair and regeneration in such cases.  
Currently, autografts, which involve harvesting bone from the patient’s iliac crest and 
transplanting to the injured site, are the gold standard for bone grafts. Autografts are non-
immunogenic and histocompatible, that possess the essential components of bone 
regeneration like osteoprogenitor cells, osteoinductive growth factors (i.e. bone 
morphogenetic protein (BMPs)) and bone supporting matrix. However, autografts have 
limitations including expensive procedures, donor site morbidity, scarring and many 
surgical risks. The second most common bone grafting technique is known as allografting 
that uses bone from human cadaver. Allografts have risk of immunoreactions and 
infections. Additionally, the supply of bone grafts is much less than the demand. Any 
untreated injury or defect in bone structure can intensely alter patient’s body equilibrium 
and quality of life. Hence, there is a need for new bone defect repair strategies. Engineered 
bone tissues are considered to be a potential alternative to the conventional bone repair 
methods.    
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1.2. Bone tissue engineering 
Tissue engineering is a promising strategy to develop new tissue structures by using a 
combination of cells and matrix scaffolds. It is defined as an interdisciplinary field applying 
the principles of life science and engineering for the development of biological substitutes 
that repair, maintain and improve tissue functions [6]. In terms of its application to engineer 
a bone, the aim is to guide and enhance the osteogenic differentiation of cells cultured on 
three-dimensional matrix. The field of bone tissue engineering was initiated almost 30 
years ago, and it has developed rapidly since then. The key objective of bone tissue 
engineering is to repair or regenerate bone in such a way that the new bone formed is 
integrated structurally with the surrounding bones. Different bone tissue engineering 
strategies are available to develop bone constructs. In the most promising strategy, cells 
with osteogenic potential are isolated and seeded on a scaffold to produce extracellular 
matrix (ECM) which is implanted to the bone defect site (Fig. 1.1). Other methods include 
direct implantation of scaffold with or without cells immediately to the defected site [2, 7]. 
Along with the cells and ECM, intercellular communication, cell-matrix interaction and 
growth factors also play an important role in bone tissue engineering.   
 
Fig. 1.1 Schematic representation of bone tissue engineering process using cellular 
scaffold. 
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1.3. Cells for bone tissue repair and regeneration     
One of the major requirements for bone tissue engineering is the cells that are capable of 
producing bone. These cells are isolated from many sites and expanded into high numbers 
to produce a clinically sized engineered bone tissue. An ideal cell source should be non-
immunogenic, expandable to a large number of cells and possesses osteogenic potential. 
Osteoblasts and mesenchymal stem cells are potential cell sources and also have been found 
to produce biomimetic bone tissue [8]. Primary osteoblast cells are advisable to use as they 
can be taken from patient itself (autologous) and would produce bone matrix immediately 
after implantation. These cells increase the extent of bone regeneration and produce bone 
specific proteins and enzymes (e.g. osteocalcin, alkaline phosphatase and collagen). Using 
enzymatic extraction, the osteoblast cells are extracted from bone and expanded by 
culturing them in-vitro. However, primary pre-differentiated osteoblast cells present some 
limitation such as low expansion rate and less number of cells. Therefore, stem cells are 
considered to be a promising alternative for primary osteoblast cells. Stem cells are 
undifferentiated cells which have the ability of self-renewal and can differentiate into many 
different cell lineages. Various types of stem cells have been utilized for bone regeneration 
such as mesenchymal stem cells, embryonic stem cells, adipose derived stem cells and 
induced pluripotent stem cells [9]. Amongst all, mesenchymal stem cells (MSCs) have 
attracted special interest in bone tissue engineering due to their role in the natural bone 
formation process. MSCs have advantages like easy expansion, high proliferation potential, 
and can be cryo-preserved and differentiated into muscle, bone and cartilage tissue lineages 
[10]. Other than bone marrow, MSCs have also been isolated from umbilical cord blood, 
peripheral blood, amniotic fluid, adipose tissue, kidneys, brain, liver, heart and skin [11-
16]. These cells have shown their potential in the repair of the femur and cranial bone 
defects [17]. The tissue engineered bones using MSCs exhibited mechanical strength 
similar to that of natural bone. The embryonic and induced pluripotent stem cells also have 
tissue regeneration capability. With limited literature available on tissue engineered bones 
from MSCs, extensive research is needed to evaluate their potential for bone regeneration 
and repair. 
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1.4. Scaffolds for bone tissue engineering     
A scaffold is a three-dimensional (3D) structure that provides temporary mechanical 
support during bone regeneration and starts degrading as the tissue grows [18]. It also 
provides a suitable tissue specific environment for cells to proliferate, differentiate and 
form new bone. It functions as a reservoir of nutrients and growth factors. A scaffold should 
possess the following properties to meet the requirements for bone tissue engineering. 
 Biocompatibility: The scaffold should support cellular activity without eliciting 
any local or systematic toxic effects to the host. It should also facilitate molecular 
signaling and generate beneficial tissue specific responses. The biocompatibility of 
a scaffold depends on factors like its structure, chemistry, morphology and material 
processing [19]. Different physical and chemical treatments are available to 
augment the biocompatibility of the scaffold material. Further, several 
biocompatible synthetic polymers have also been developed for bone tissue 
engineering such as poly(vinyl alcohol) (PVA), poly(lactic acid) (PLA), 
poly(glycolic acid) (PGA), polycaprolactone (PCL), and poly(lactic-co-glycolic 
acid) (PLGA), etc. [20].  
 Porosity: The scaffold should possess a 3D interconnected porous structure with 
high surface area to volume ratio such that it allows cells to distribute and grow 
throughout the scaffolds. Porosity is required for diffusion of nutrients and gases to 
the cells inside scaffolds and to remove metabolic waste. Along with porosity, the 
pore size also plays an important role for cells to penetrate inside the scaffold. 
Different tissue regenerations have different pore size requirements according to 
the size of respective cells. Previous studies have reported the optimum pore size 
of 5 µm for neovascularization and fibroblasts, 20 µm for hepatocytes and 20-125 
µm for adult mammalian skin cells [19].  The minimum required pore size for 
osteoblast cells has been reported as 100 µm [21]. Other important factors are pore 
volume, pore size distribution, pore shape and pore wall roughness. 
 Mechanical properties: An ideal scaffold should have sufficient mechanical 
properties to endure the hydrostatic pressure and maintain spaces required for cells 
to grow inside the scaffold [22]. It should have mechanical strength matching to 
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that of host bone. Designing an ideal scaffold for bone regeneration is a challenging 
task owing to the geometry and wide variations in mechanical properties of the 
natural bone. Mechanical properties of cortical bone (Young’s modulus: 15-20 
GPa) and cancellous bone (Young’s modulus: 0.1-2 GPa) vary widely [18]. Hence, 
it becomes difficult to develop scaffolds mimicking the bone tissue. 
 Biodegradability: After repair and regeneration of bone tissue there is no need of 
implant anymore. Therefore, additional surgery is required to remove the implant 
leading to increased complications and cost. To avoid these complications, 
biodegradable scaffolds are being developed. After implantation, these scaffolds 
degrade itself with time and create space for the new bone to grow. The scaffolds 
should degrade at a controlled rate so that the injured bone is repaired completely 
before the scaffold is totally degraded.  
 Surface properties: Surface properties of a scaffold have a strong influence on its 
cellular response. An ideal scaffold should have suitable surface properties to 
encourage cells attachment, proliferation and differentiation. Surface chemistry and 
topological features of a scaffold mediate the cell responses and direct the 
immunological responses. After implantation, the migration of osteogenic cells to 
the scaffold depends on its topographical properties. Further, the surface chemistry 
of scaffold material control the cell adhesion on scaffold surface via cell-protein-
material interactions. Hence, surface properties are an imperative aspect in directing 
cell-material interactions. 
1.5. Scaffold fabrication techniques 
Several techniques have been used for fabrication of scaffolds for bone tissue engineering. 
The developed three dimensional (3D) scaffolds should encourage the cell distribution and 
proliferation. For fabrication of such scaffolds, general processing techniques include 
solvent casting, salt leaching, gas foaming, electrospinning, freeze drying and phase 
separation [23]. Other advanced techniques also exist based on the application of fabricated 
scaffold like self-assembly, rapid prototyping, fiber mesh, fiber bonding, melt molding, 
membrane lamination, etc. [24]. Each technique has its advantages and disadvantages. 
Most widely used techniques have been discussed below. 
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Solvent casting: It is the most widely used, easy and inexpensive technique for the 
preparation of scaffolds [24]. It is based on the evaporation of solvent from polymer (or 
polymer composite) solution when poured into a mold. However, the retention of toxic 
solvent in scaffolds may cause problems after implantation. Hence, to avoid this, the 
prepared scaffolds are dried under vacuum to remove solvent properly. 
Particulate leaching: This method consists of a high density of particulates (porogens) 
dispersed in the polymer solution. The porogen is taken in a mold, and a polymer solution 
is poured into it. The polymer moves into the voids and settles there. After evaporation of 
solvent, the polymer gets hardened, and the porogen is leached out using water or alcohol. 
The leaching of porogen leads to the formation of a porous scaffold. Various porogens 
including salt, sugars, wax, and polymers have been successfully used to fabricate porous 
scaffolds. In this method, the pore size and pore volume can be controlled by using 
appropriate size and density of porogen [24]. However, the pore shape and pore 
interconnectivity cannot be controlled. 
Gas foaming: High temperature and organic solvents used for the preparation of scaffolds 
may cause problems during in-vitro and in-vivo cell culture studies. To avoid such 
circumstances gas has been used as a porogen in gas foaming technique for development 
of porous scaffolds. Polymer discs prepared by compression molding are exposed to carbon 
dioxide at high pressure (800 psi) [25]. The porosity of the scaffold depends on the amount 
of gas porogen. At saturation level, the gas becomes unstable and form clusters which act 
as a porogen. The benefit of gas foaming techniques is that it provides interconnected pores; 
however, the pore size cannot be controlled. 
Phase separation: This method involves the separation of the polymer solution into two 
phases: polymer lean phase (low polymer concentration) and polymer rich phase (high 
polymer concentration). In this technique, the polymer is dissolved, frozen to separate the 
liquid-liquid phase and then quenched forming a two-phase solid. Later, the solvent is 
removed from the system by evaporation, extraction, and sublimation resulting in a porous 
scaffold. The pores obtained by this method are relatively smaller in size and are not well 
distributed [26]. Hence, this technique has been combined with other scaffold fabrication 
methods to control the pore size, structure, and volume. 
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Freeze drying: Freeze drying, also known as lyophilization is based on the principle of 
sublimation. It involves freezing of polymer solution at (~ -70°C) and then removal of 
frozen solvent under high vacuum by sublimation. This method results in scaffolds with 
highly interconnected porous structure. The pore size of the scaffold depends on the 
freezing temperature, freezing rate and pH of the solution. The freeze drying method has 
already been explored to fabricate porous scaffolds using different polymers like PVA, 
PLGA, PLA, PGA, chitosan and their composites [27, 28]. The main advantages of this 
method are the elimination of organic solvent, high temperature, and leaching of the 
porogen.  
Electrospinning: Electrospinning is widely used for fabrication of polymeric fibers with 
the diameter ranging from nanoscale (<1000 nm) to microscale (>1 µm) [29]. It uses high 
voltage electric field created between two electrodes, one placed in a polymer solution and 
another in a collecting target. The polymer solution is ejected from a needle forming a 
droplet. The generated electric field around the droplet overcomes its surface tension, and 
the fibers are formed as the polymer jet travels towards collecting target. The diameter of 
the fibers depends on the properties of polymer solution (viscosity, surface tension, 
conductivity, etc.), flow rate, strength of electric field and distance between the needle and 
collecting target. A wide range of polymers has been used to form nano fibrous scaffolds 
favorable for better cellular growth. However, the main disadvantage of his method is the 
use of organic solvents which can be toxic to cells. 
1.6. Biomaterials used for bone scaffold 
preparation 
Various natural and synthetic biomaterials have been investigated for better repair and 
replacement of the injured bone tissues [30]. An ideal biomaterial should be biocompatible, 
biodegradable, bioactive, porous, and mechanically compatible with the natural bone [31]. 
Biomaterials used for bone tissue engineering are broadly divided into the following 
categories: polymers, ceramics, metals, and carbon based materials.  
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1.6.1. Polymers  
Both, natural and synthetic polymers have been extensively used to develop scaffolds for 
bone tissue engineering. Natural polymers such as collagen, chitosan, starch, silk, and 
hyaluronic acid have shown their potential for tissue engineering applications. These 
natural polymers exhibit bioactivity, low immunogenic potential and receptor-binding 
ligands for cells to attach. The drawbacks of natural polymers are that they have pathogenic 
impurities, weak mechanical strength, less supply, and high cost [32]. On the other hand, 
synthetic polymers (i.e. PVA, PGA, PLA, PLGA, etc.) represent the largest group of 
biomaterials used in tissue engineering. Synthetic polymers have already proven their 
potential in drug delivery, resorbable sutures and orthopedic fixation devices [33]. These 
polymers are biodegradable and have shown reasonable biocompatibility [34]. Their 
degradation products are non-toxic and can be eliminated from the body by normal 
metabolic pathways. The main advantage of synthetic polymers is their tunable properties 
which can be tailored according to the requirements. Also, the risk of toxicity and 
immunogenicity is low due to their known structures and they can be easily molded into 
differently designed shapes for different applications.  
Poly(vinyl alcohol): Among various synthetic polymers, poly(vinyl alcohol) (PVA) has 
received intensive attention in tissue engineering, wound dressing and drug delivery owing 
to its suitable physicochemical properties [35]. PVA (Fig. 1.2) is a biodegradable, 
hydrophilic and biocompatible polymer, produced by partial or full hydrolysis of polyvinyl 
acetate. It dissolves in water at a temperature of 100°C with a holding time of 30 min. and 
its physical and chemical properties depend on the extent of hydrolysis. Moreover, semi-
permeable nature of PVA allows the transportation of oxygen and other nutrients into the 
scaffold for cell survival and removal of wastes from the scaffold [36]. Owing to its good 
flexibility and mechanical properties, it has been used in both implantable and non-
implantable devices. However, its poor cell adhesion, bioinert nature, and insufficient 
mechanical properties hinder its applications as a bone implant.  
Poly(glycolic acid): Among polyesters, PGA is the only hydrophilic biodegradable 
thermoplastic polymer having hydroxyl and carboxyl groups on its two ends [34, 37]. This 
structure leads to the high crystallinity, elevated melting point and low solubility of PGA 
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in organic solvents. The properties such as biodegradability, hydrophilicity, suitable 
mechanical properties, non-toxicity, and formability attracted the attention of researchers 
towards the use of PGA for scaffold preparation by common fabrication methods. Owing 
to its suitable properties, PGA has been widely used to develop degradable synthetic suture 
[38].  The degradation of PGA is a two-step process: the first step includes random 
hydrolytic chain scission of the ester linkage in the amorphous phase after diffusion of 
water, followed by hydrolysis of the crystalline region in the second step [39]. The 
crystallinity of the polymer increases in the first stage and then decreases during the second 
stage. This degradation of PGA results into a natural metabolite, glycolic acid which is 
resorbable when present at high concentration. The rapid degradation of PGA in aqueous 
solution or in-vivo reduces its mechanical stability. Another limitation of PGA is the lack 
of specific cell recognition signals which decreases the cell attachment on its surface [40]. 
Thus, the regulation of degradation rate and the improvement of biological properties are 
required for the extensive biological applications of PGA. 
Poly(lactic acid): The PLA is a polyester widely studied as a scaffold material owing to its 
biocompatibility, biodegradability and fascinating physical properties [41]. It can be 
synthesized into three isomeric forms: D-, L- and DL- isomers. The stereochemical 
structure of PLA influences its physiochemical properties as by varying the ratio of D- or 
L-isomer, the amorphous or crystalline nature of the polymer can be regulated. The 
degradation of PLA by hydrolysis results in lactic acid which is removed from the body by 
tricarboxylic acid cycle in the form of water and carbon dioxide. The presence of methyl 
group in the PLA structure makes it more hydrophobic and amorphous in comparison to 
the PGA. This decreased affinity toward water reduces the degradation rate of the polymer 
and maintains its mechanical integrity for months, both, in-vitro and in-vivo [38]. The L-
isomer of PLA i.e. poly(L-lactic acid) (PLLA) is well known for its excellent mechanical 
properties due to the slower degradation rate when compared to DL-isomer i.e. poly(D, L-
lactic acid) (PDLLA). However, PLA has to suffer from few drawbacks such as poor cell 
adhesion and stimulation of inflammatory responses in-vivo [42].    
Poly(lactic-co-glycolic acid): The PLGA, a copolymer of PLA and PGA, is one of the 
most commonly used biodegradable polymer (Fig. 1.3) [43]. Its degradation (hydrolysis of 
ester bond) leads to the formation of lactic acid and glycolic acid which can be easily 
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removed from the body by metabolic pathways [44].  The PGA is hydrophilic in nature 
whereas PLA is comparatively hydrophobic due to the presence of methyl group. Hence, 
the degradation rate of PLGA can be controlled by varying the ratio of its monomers. Other 
properties like swelling degree, rate of hydrolysis and mechanical strength depend upon 
the crystallinity of PLGA which is again subjected to the ratio of its monomers. Owing to 
its highly biocompatible and biodegradable nature, PLGA has been widely used in bone 
tissue engineering. It has shown good results in controlled drug delivery and can also be 
fabricated in different forms and shapes. However, hydrophobicity, suboptimal mechanical 
strength and poor bioactivity of PLGA are the main disadvantages that often limit its 
applications [45].  
 
 
Fig. 1.2 Molecular structure of poly(vinyl alcohol). 
 
 
Fig. 1.3 Molecular structure of poly(lactic-co-glycolic acid). 
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1.6.2. Ceramics 
Both, natural and synthetic ceramics have been used for the repair of bones. These are 
mainly used for filling bone defects, replacement of defected bone and fracture repair [46]. 
Ceramics are biocompatible, corrosion resistant and highly bioactive. Brittleness, low 
fracture toughness, and high stiffness are the main limitations of ceramics which restrain 
their applications. Natural ceramics such as corals are biocompatible and have 
interconnected porous structure with decent mechanical properties. They have shown their 
potential in the repair of bones such as distal phalanx of the thumb [7]. However, the high 
dissolution rate of these ceramics has restricted their clinical applications. Therefore, 
synthetic ceramics such hydroxyapatite (HA), tri-calcium phosphate (TCP), biphasic 
calcium phosphate (BCP), brushite, and monetite have been developed and evaluated for 
bone repair applications. Calcium phosphate based ceramics have similar mineral phase as 
that of bone. Due to their osteoconductivity (support osteoblast adhesion and proliferation) 
and osteoinductivity (stimulate bone formation), they have been considered for bone tissue 
engineering applications. These ceramics are highly bioactive and biodegradable also. 
Researchers have reported them as a carrier for osteogenic cells and osteoconductive 
growth factors [47]. TCP is a bioactive ceramic which has been used as bone filler in 
orthopedic applications [48]. Brushite and monetite have been evaluated for fracture 
treatment and bone augmentation respectively. Mostly ceramic materials are used as 
reinforcing materials in polymer matrices to develop biocomposite scaffolds for bone tissue 
engineering.  
Hydroxyapatite: HA (chemical formula: Ca10(PO4)6(OH)2) is the most widely used 
ceramic for bone regeneration owing to its similar composition to that of bone mineral. It 
is highly biocompatible, osteoconductive, osteoinductive, and bonds chemically with the 
host tissue. These advantages make HA a suitable candidate for different applications such 
as bone repair and augmentation, bone fillers, hard tissue replacement implants, and coating 
of implants. Further, nano-hydroxyapatite (nHA) has been found to have improved 
mechanical properties and bioactivity [49]. However, its brittle nature, difficulty in shaping 
as a scaffold and low mechanical properties restrict its use as a scaffold material for load 
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bearing sites. Hence, to meet the requirements of tissue engineering, nHA reinforced 
polymer composites are developed with improved biological and mechanical properties. 
Other ceramic materials: The biocompatibility, osteoconductivity and chemical 
similarity to the inorganic phase of natural bone make TCP an attractive biomaterial for 
bone tissue engineering applications. It exists in two phases, α and β, both of which possess 
similar chemistry but different crystal structures [50]. The Ca/P ratio of the stoichiometric 
TCP (Ca3(PO4)2) is 1.5, and it is more soluble in aqueous environment owing to the 
instability of its phases in comparison to the HA. On the other hand, BCP, consisting of 
different concentrations of a stable phase (HA) and a soluble phase (β-TCP), has 
advantages of controlled bioactivity and biodegradation properties. By varying the 
concentration of HA and β-TCP, BCP with desired degradation time is developed for bone 
implant applications. Along with its ability to induce stem cell differentiation, BCP is 
attracting researchers as it can be easily tailored to different sizes and shapes. Nevertheless, 
the use of these ceramic materials is associated with few drawbacks including brittleness 
and poor mechanical properties. This shows that the additional efforts are required to 
further advance the applications of ceramics in bone tissue engineering.   
1.6.3. Metals  
A variety of biocompatible metallic materials have been used as a bone implant or a fixation 
device. Frequently used metallic bone implant materials include titanium alloys, stainless 
steel, cobalt-chromium alloys, tantalum, and magnesium. Metallic implants have extensive 
mechanical properties like high strength, fracture toughness and corrosion resistance 
making them suitable as implants for load bearing sites [51]. The major drawback of 
metallic implants is that it lacks biological recognition on its surface. To improve their 
surface biocompatibility several treatments and coating have been successfully used. 
Titanium is an inert and biocompatible materials which has osseointegration capability. 
Titanium alloys have shown superior biocompatibility and mechanical properties as 
compared to stainless steel and cobalt alloys [51]. They also have capability to carry growth 
factors which induce bone repair and regeneration. Titanium foams were developed and 
used as porous implant for total hip replacement and knee arthroplasty [52]. With the 
similar modulus of elasticity to that of bone, highly porous tantalum has shown its potential 
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for total knee arthroplasty. Recently, magnesium is gaining attention of researchers for its 
applications as scaffolds, screws and plates. Unlike other metallic scaffolds, it is a 
biodegradable material hence there is no need to remove it after repair and regeneration of 
bone. Magnesium and its alloys have good mechanical properties and their corrosion 
products can be easily removed from body by normal metabolic pathways [53]. However, 
more in-vivo studies are required to check the potential of magnesium and its alloys as a 
biomaterial for bone tissue engineering. 
1.6.4. Carbon based materials 
Carbon based materials like diamond, graphite, carbon fibers, activated carbon, nanotubes, 
nanowires and nanoribbons are being used from years for various electronics, optics, and 
sensor applications [54]. In recent years, carbon and its allotropes have attracted increased 
interests as reinforcing materials. Further, the developments in the field of nanotechnology 
have paved the way for the use of carbon nanomaterials as reinforcements in the polymer 
matrix. These nanomaterials have unique nanoscale dimensions, large surface area, 
biocompatibility with living tissues, and exceptionally good mechanical properties which 
make them promising material for orthopedic applications. Three types of carbon 
biomaterials widely being used in the field of bone tissue engineering are carbon nanotubes 
(CNTs), graphene nanoplatelets (GNPs) and activated carbon (AC). 
Carbon nanotubes: Amongst various carbon based biomaterials, CNTs (1D) have drawn 
a great attention of researchers. Owing to their exceptional mechanical and biological 
properties, CNTs have been reinforced in different polymer matrices to develop composite 
scaffolds with improved properties. In addition, multi-walled CNTs (MWCNTs) have been 
found to accelerate the bone formation [55]. Nevertheless, owing to their intrinsic van der 
Waal interactions, pristine CNTs have the tendency to aggregate, resulting in the reduced 
dispersion and hence, cytotoxicity to human cells [56]. To overcome this problem, 
researchers have functionalized CNTs using different functional groups like hydroxyl, 
carboxylic acid, poly amino benzoic sulfonic acid, and poly(vinyl alcohol) etc. [57]. The 
functionalization increases CNTs dispersion and eliminate them easily from the body via 
renal excretion route. These functional groups also improve the bioactivity of the scaffolds 
by attracting calcium cations [58].  
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Graphene nanoplatelets: Graphene, a 2D sp2 hybridized carbon sheet, is emerging as a 
potential biomaterial for bone tissue engineering. Its aromatic structure, strong bonding 
between carbon atoms, and active sites on the surface make graphene a unique material 
with exceptional physicochemical, thermal, electrical and mechanical properties. Graphene 
nanoplatelets (GNPs) are also gaining attention of researchers owing to their structural 
similarity to idealized graphene. GNPs provides an ameliorative substitute to CNTs as it 
contains no metallic impurities and its production is cost effective. Due to its high aspect 
ratio and sheet like structure, GNPs form percolated networks when reinforced in the 
polymer matrix. The large interfacial interaction between GNPs and polymer matrix helps 
in effective load transfer and improved mechanical properties of the composite. The defects 
present on the edges of GNPs promote the oxidative reaction with surrounding environment 
yielding hydrophilic structure due to oxygen containing functional groups [59]. Therefore, 
GNPs are less prone to agglomeration as compared to single layer graphene [60]. 
Functionalization of GNPs with different functional groups increases their water 
dispersibility. Moreover, GNPs have shown non-toxic behavior towards human osteoblast 
and mesenchymal stromal cells. In recent in-vitro cell culture studies, GNPs were found to 
stimulate the osteoblast cell attachment, growth, and differentiation. 
Activated carbon: Activated carbon (AC), a quasi-graphitic form of carbon, is a highly 
porous biomaterial with large surface area to volume ratio. Due to its irreversible 
adsorption of toxic metabolites it is widely used to enhance cell growth and development 
in plant tissue culture [61]. The large surface area and powerful adsorption properties of 
AC fulfill the space requirement and help living cells to attach onto its surface. The 
adsorption of inflammatory cytokines by porous carbon decreases the inflammation. 
Owing to these properties AC is expected to encourage osteoblast cells growth and 
differentiation. 
1.7. Summary 
This chapter has provided essential basic information about the bone tissue engineering. 
The limitations of the existing bone repair and regeneration techniques along with the need 
of bone tissue engineering have been discussed. The requirements and fabrication 
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techniques for an ideal scaffold were described. Finally, various biomaterials and their 
advantages for better repair and replacement of the injured bone tissues were briefed. 
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Chapter 2  
Literature review 
This chapter provides a comprehensive literature review of the research field. A brief but 
informative review on tissue engineering and its application for bone tissue repair and 
regeneration will be presented. Following that, various biomaterials used for bone tissue 
engineering are described. The current research using hydroxyapatite and carbon materials 
as reinforcements in polymer matrices are also discussed in this chapter. Lastly, the scope, 
objectives of the present work and the outline of various chapters are also mentioned. 
2.1. Tissue engineering 
Many other instances of the vision of regenerative medicine and tissue engineering have 
been reported in ancient times. The Sanskrit texts like Sushruta Samhita have described the 
skin transplantation done by Koomas caste members in ancient India, during 2500-3000 
BC [62]. Later, a famous painting named as “Healing of Justinian” from 278 AD depicted 
the homograft limb transplantation to a soldier [63]. In the 18th century, transplantation of 
teeth and skin proved to be a milestone in the modern tissue engineering. In the mid-1980s, 
tissue engineering term came into existence to represent the surgical manipulations of 
tissues. Y. C. Fung, a researcher working in the field of biomechanics submitted a proposal 
entitling “Center for the Engineering of Living Tissues” to NSF (in 1985) from which the 
term “tissue engineering” originated [64]. Dr. Eugene Bell further explained the tissue 
engineering by focusing on its applications [65]: 
 providing cellular prostheses or replacement parts for the human body; 
 providing formed acellular replacement parts capable of inducing regeneration; 
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 providing tissue or organ-like model systems populated with cells for basic research 
and for many applied uses such as the study of disease states using aberrant cells; 
 providing vehicles for delivering engineered cells to the organism; and 
 surfacing non-biological devices 
The most frequently referred definition of  tissue engineering was reported in a review 
paper by Robert Langer and Joseph P. Vacanti as [6]: 
“Tissue engineering is an interdisciplinary field that applies the principles of 
engineering and the life sciences toward the development of biological substitutes 
that restore, maintain, or improve tissue function”. 
Over the past 30 years, the field of tissue engineering has evolved significantly. It has been 
applied to regenerate a wide variety of organs and tissues. Tissue engineered skin, the first 
successful cell-based product, was marketed under the name of Epicel. As this product did 
not have a dermis, another product was developed consisting of collagen and chondroitin 
sulfate along with a silicone sheet as a temporary epidermis [66]. Even the advanced tissue 
engineered skin products have several limitations such as lack of cells, glands etc. High 
occurrence of joint diseases has increased the cartilage regeneration and repair demand. 
Currently, three different techniques are used for cartilage repair: osteochondral 
transplantation, marrow simulation, and cell based techniques. In 1994, the first 
commercially available cell based technique for cartilage repair, named as Carticel was 
developed [67]. Later, various engineered tissues have been or being developed throughout 
the world including skin, bone, cartilage, liver, blood vessels, kidney, heart valves, 
pancreas, breast, and lung [68]. Some of the commercial tissue engineering products and 
their uses have been summarized in Table 2.1. With increasing demand for tissue 
engineered products, several approaches are adopted to tailor its needs.  
2.2. Bone tissue engineering (BTE)  
Worldwide, millions of people suffer from bone disorders and injuries due to various 
reasons. Yearly, almost 8.9 million fractures occur only due to osteoporosis, and more than 
26 million people suffer from bone disorders in India [69, 70]. It is estimated that by the 
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year 2050, 50% of global hip fractures will occur in Asia [71]. About, 2.2 million bone 
grafting surgeries are performed every year worldwide making the bone as most frequently 
transplanted tissue [72].   
Table 2.1 Commercially available tissue engineering products [73, 74]. 
Tissue Products Company Application 
Skin Integra Dermal Template Integra 
Lifesciences 
Burns 
TransCyte Advanced 
Biohealing 
Burns 
Apligraf Organogenesis Diabetic foot ulcers 
and venous leg ulcers 
Dermagraft Organogenesis Foot ulcer of diabetic 
patients 
Integra Flowable Wound 
Matrix 
Integra 
Lifesciences 
Ulcers 
Oasis Wound Matrix Healthpoint Ulcer and other types 
of wounds 
Xelma Molnlycke Leg ulcers 
Bone OP-1 Stryker Bone injury 
INFUSE Bone Graft Medtronic Spinal fusion 
Vitoss Scaffold FOAM Orthovita Bone injury 
FortrOss Pioneer surgical Bone injury 
Bioset IC Pioneer surgical Bone injury 
GEM 21S BioMimetic 
Therapeutics 
Dental defects (bone 
and gum) 
BCT001 Bioceramic 
Therapeutics 
Bone defects 
Cartilage Synvisc Genzyme Synovial fluid 
replacement 
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CaReS Arthro Kinetics Articular cartilage 
injury 
Menaflex Regenbiologics Meniscus cartilage 
injury 
Bioseed-C Biotissue 
Technologies 
Articular cartilage 
injury 
MACI Genzyme Articular cartilage 
injury 
Tendon and 
ligaments 
GraftJacket  Wright Medical 
Technology 
Tendon and ligament 
repair 
X-Repair Synthasome Tendon and ligament 
repair 
Heart valve CryoValve SG 
pulmonary human heart 
valve 
CryoLife Heart valve 
replacement 
Clearlink valve Baxter Healthcare 
Corporation 
Heart valve 
replacement 
Carbomedics standard 
aortic valve 
CarboMedics Heart valve 
replacement 
On-X heart valve CryoLife Aortic and mitral 
prosthetic valve 
replacement 
Medtronic Open Pivot 
mechanical heart valves 
Medtronic Valve replacement 
with mechanical 
valve 
CryoValve Aortic valve CryoLife Aortic valve 
replacement 
Liver Bioartificial liver system ExcorpMedical Liver replacement 
ELAD Artificial liver Vital therapies Liver replacement 
Pancreas Islet sheet  Cerci Medical Diabetes mellitus 
Amcyte  ReNeuron Diabetes mellitus 
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Current treatments for bone defects include autologous and allogenic bone grafts. 
Autografts are the gold standard for bone grafts owing to their osteoconductive, 
osteoinductive and non-immunogenic properties. These grafts are the second most 
commonly transplanted tissues. However, bone grafts have limitations such as high cost, 
donor site injury, scarring, inflammation, and infection. Additionally, high demand and less 
supply of bone grafts stimulated researchers to go for substitutes such as metal implants. 
After the failure of stainless steel and cobalt alloys implants, titanium was used as implant 
material back in 1930s. Although metallic implants provide mechanical support, they have 
certain disadvantages such as stiffness, stress shielding, poor integration with biological 
tissues, and risk of infection [1]. It has been reported that 13% of people are sensitive to 
different metals such as nickel, cobalt and chromium [75]. Given the limitations associated 
with the grafts and metallic implants, there is a need for a tissue engineered bone. Bone 
tissue engineering initiated almost three decades ago and it has progressed very fast over 
the years. It is an excellent option for full recovery of patients suffering from bone injuries 
by using engineered bone substitute that mimick the natural bone. 
2.3. Biomaterials for bone tissue engineering 
An ideal material for bone tissue engineering should be biocompatible and biodegradable 
with good mechanical strength. A number of natural and synthetic materials have been 
explored for bone applications. Based on the BTE requirements, biomaterials can be 
divided into various categories. Properties of these biomaterials used for bone repair and 
regeneration are mentioned in Table 2.2.  
2.3.1. Biodegradable polymers 
The use of biodegradable biomaterials for BTE has progressed in years to avoid the use of 
second surgery to remove implant material after bone recovery. The three types of 
biodegradable materials are polymers, ceramics, and metals. Natural biomaterials such as 
chitosan, alginate, hydroxyapatite, agarose, etc. have low mechanical properties making 
them unsuitable for bone tissue engineering [76-78]. To overcome these problems, 
synthetic biomaterials came into existence, but these materials lack adequate tissue 
interactions.   
  
Chapter 2                                                                                                   Literature review 
22 
 
Table 2.2 Properties of different biomaterials used for bone repair and regeneration. 
Materials Origin Properties Applications Ref. 
Polymers 
Collagen 
 
 
 
 
 
Chitosan 
 
 
 
 
Hyaluronic acid 
 
 
 
 
PGA 
 
 
 
 
 
PLA 
 
 
 
Natural 
 
 
 
 
 
Natural 
 
 
 
 
Natural 
 
 
 
 
Synthetic 
 
 
 
 
 
Synthetic 
 
 
 
Biodegradable, 
biocompatible, 
porous, hydrophilic, 
weak mechanical  
strength 
 
Osteoconductive, 
biodegradable 
 
 
 
Biodegradable, 
injectable, 
weak mechanical 
properties 
 
Tunable degradation 
behaviour and 
mechanical properties 
 
 
 
Good mechanical 
strength 
 
Scaffold, composite, 
drug delivery, guided 
bone regeneration 
 
 
 
Scaffolds, 
microgranules, 
vertical bone 
augmentation 
 
Synthetic bone grafts, 
wound dressing 
 
 
 
Bone grafts, 
scaffolds, bone 
internal fixation 
devices, synthetic 
suture 
 
Fracture fixation, 
screws, scaffolds 
 
[79] 
 
 
 
 
 
[1, 46] 
 
 
 
 
[19, 80] 
 
 
 
 
[81, 82] 
 
 
 
 
 
[83, 84] 
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PLGA 
 
 
 
 
 
PCL 
 
 
 
PVA 
 
 
Polydioxanone 
 
Synthetic 
 
 
 
 
 
Synthetic 
 
 
 
Synthetic 
 
 
Synthetic 
Fast degradation, high 
mechanical strength, 
biocompatible, 
hydrophobic 
 
 
Biocompatible 
 
 
 
Biocompatible, 
hydrophilic,  
 
Biodegradable 
properties 
Scaffolds, coating, 
microspheres, drug 
delivery system, 
monofilament suture, 
carrier for BMP 
 
Scaffolds, 
composites, 
coating 
 
Bone scaffolds, 
composites 
 
Fixation screws 
 
[19, 46, 
85] 
 
 
 
 
[86] 
 
 
 
[30] 
 
 
[19] 
Ceramics 
Corals 
 
 
 
Hydroxyapatite 
(HA) 
 
 
 
Brushite 
 
 
 
Alumina 
Natural 
 
 
 
Synthetic 
 
 
 
 
Synthetic 
 
 
 
Synthetic 
Biocompatible, 
porous, high 
dissolution rate 
 
Biodegradable, 
tunable degradation 
rate, brittle, high 
mechanical strength 
 
Biodegradable, high 
strength 
 
 
Good strength 
Repair of distal 
phalanx of the thumb 
 
 
Bone regeneration 
scaffolds, composites, 
coatings, bone defect 
filler 
 
Controlled drug 
delivery system for 
bone healing 
 
Joint replacement 
[7] 
 
 
 
[27, 87] 
 
 
 
 
[88] 
 
 
 
[89] 
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Tri-calcium 
phosphate 
Synthetic 
 
Biodegradable 
 
Bone filler, bone 
cement 
[46] 
Metals 
Titanium and its 
alloys 
 
 
 
 
Stainless steel 
 
 
Magnesium 
Synthetic 
 
 
 
 
 
Synthetic 
 
 
Synthetic 
Non-biodegradable, 
resistant to corrosion 
and fatigue 
 
 
 
Non-biodegradable, 
corrosive 
 
Degradable, corrosive 
Implant for load 
bearing site, screws, 
plates, fracture 
treatment, BMP 
carrier 
 
Implant for load 
bearing site, screws 
 
Implant for load 
bearing site, 
osteosynthesis device, 
screws, wires 
[89, 90] 
 
 
 
 
 
[91] 
 
 
[92, 93] 
Carbon based biomaterials 
Carbon 
nanotubes 
 
 
 
Graphene 
nanoplatelets 
 
 
Activated 
charcoal 
Synthetic 
 
 
 
 
Synthetic 
 
 
 
Synthetic 
High mechanical 
strength, excellent 
electrical properties 
 
 
Large surface area, 
high mechanical 
strength 
 
Highly porous, large 
surface area to 
volume ratio 
Biomaterial 
reinforcement, cell 
and tissue labelling, 
drug delivery system 
 
Biomaterial 
reinforcement, cell 
and tissue labelling 
 
Adsorption of toxic 
metabolites, plant 
tissue culture 
[54] 
 
 
 
 
[54] 
 
 
 
[94] 
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Poly(glycolic acid): Owing to its biodegradability, biocompatibility and good mechanical 
properties, PGA has attracted the attention of researchers worldwide. Its applications 
include tissue engineered scaffolds, drug delivery systems, and orthopedic implants [95]. 
Conversely, a decrease in strength, an increase in localized pH and fibrous capsule 
formation after implantation of PGA, limit its suitability as scaffold material [96]. To 
improve the biocompatibility, various treatments have been performed on the PGA based 
scaffolds. Boland et al. have reported that the pretreatment of PGA scaffolds with 
concentrated hydrochloric acid (HCl) improves its cellular responses [37]. The acid 
pretreatment of PGA degrades the amorphous region present on its surface and releases the 
monomers prior to implantation. This results in a reduction of the localized pH decrease 
and improves the in-vivo responses. In another study, PGA grafted chitosan films were 
prepared to counteract the acidic degradation products of the PGA and to improve the 
degradation of chitosan [95]. After the degradation of chitosan, the released glucosamine 
neutralizes the acidic products and prevents the inflammatory tissue reactions. By taking 
advantage of the formability of PGA, β-TCP reinforced composite scaffolds, possessing 
improved biological properties, were also developed [97]. The presence of β-TCP in PGA 
matrix stabilized the physiological pH near the implant, increased the biocompatibility and 
encouraged the bone formation after implantation.  
Poly(lactic acid): PLA has been widely used to provide the architectural cues for the repair 
and regeneration of large bone defects. The in-vivo implanted PLLA degrades itself by 
hydrolysis without the use of any enzyme and makes the surgical removal of implant 
unnecessary [98]. The low molecular weight PLLA was found to degrade at an adequate 
rate while maintaining its mechanical properties until the bone defect was healed properly 
[99]. The self-reinforced PLLA rods were also used as a scaffold for bone regeneration in 
muscle by free tibial periosteal grafts. After 6 weeks of implantation, new bone was 
generated in a predesigned cylindrical form [100]. In an attempt to design PLLA based 
scaffolds for load bearing applications, ceramic materials such as β-TCP and HA have been 
reinforced into the polymer matrix to improve its mechanical properties [101]. The 
reinforcement of β-TCP strengthens the PLLA composite along with the improvement in 
cell viability [102]. Similarly, silane modified HA has also increased the mechanical 
properties of the resulting composite scaffold [103]. The PLLA based microspheres and 
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microcapsules have shown their potential as drug delivery systems for prolonged 
administration of a wide range of drugs [104]. 
Poly(lactic-co-glycolic acid): PLGA, a copolymer of PLA and PGA, is preferred for BTE 
as it satisfies most of the requirements of scaffold fabrication. The PLGA microspheres 
with calcium phosphate cement have shown improved biological response after loading of 
bone morphogenetic protein (BMP-2) [105]. It has shown carbonated apatite growth when 
kept in simulated body fluid for 16 days [106]. It has also been explored as nanofibers, 
hydrogels, films and 3D scaffolds [107]. However, hydrophobicity, weak mechanical 
strength and poor bioactivity of PLGA are the critical issues of concern that often limit its 
applications [45]. Blending PLGA with other hydrophilic polymers (e.g. poly(vinyl 
alcohol)) or ceramics along with the surface treatments have shown improved biological 
properties [43, 108, 109]. The graphene oxide reinforced PLGA nanocomposites have 
enhanced surface chemical and mechanical properties. Coating PLGA with hydrophilic 
polymers have been found to slightly improve the cell adhesion on its surface [110]. 
However, the results obtained from these studies are non-satisfactory. Thus, reinforcing 
PLGA with a suitable biomaterial is required to potentially improve its biological and 
mechanical properties. 
Poly(vinyl alcohol): Owing to its biodegradable and biocompatible nature PVA has been 
used as a scaffold material for BTE [30]. Most of the biodegradable polymers (PLA, PCL, 
PLGA) are hydrophobic nature, whereas PVA showed excellent hydrophilic nature. 
Furthermore, its semi-permeable nature allows transport of nutrients and oxygen to the 
cells inside the scaffolds [36].  Porous PVA scaffolds have been developed by using 
porogens like sodium chloride, sucrose and polyethylene glycol [111]. Selective laser 
sintering technique has also been used to develop PVA based porous scaffolds with 
improved osteoblast cell adhesion [112]. However, weak cellular affinity and mechanical 
properties limit its application as a scaffold material for bone tissue engineering. Research 
is being carried out to improve the cellular affinity and mechanical properties of PVA as a 
scaffold. The coating of bioactive glass was found to improve the tensile strength of PVA 
but reduced the elongation to failure value [113]. Thus, the composites of PVA with 
suitable reinforcements are required to potentially improve the biological and mechanical 
properties of scaffolds. 
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2.3.2. Ceramics 
The compositional similarity of various calcium phosphate bioceramics to the bone mineral 
makes these materials an appropriate option for bone scaffold material. The commonly 
used calcium phosphate ceramics for bone tissue repair and regeneration are TCP, BCP 
and HA. Porous β-TCP scaffolds with 3D orthogonal periodic architecture were fabricated 
via selective laser sintering by using epoxy resin and nylon as adhesive [114].  The 
fabricated scaffolds with 55% porosity exhibited good mesenchymal stem cell attachment 
and growth on their surface. Tarafder et al. have reported the manufacturing of microwave 
sintered 3D printed TCP scaffolds with controlled interconnected macroporous architecture 
for bone tissue engineering [115]. The efficient densification obtained by microwave 
sintering increased the compression strength of the scaffolds many folds in comparison to 
the conventional sintering technique. The presence of both micro and macropores 
expedited the osteoid like bone formation in femoral defects of rats. In another study, the 
addition of strontium oxide and magnesium oxide in TCP improved the mechanical and 
biological properties of the scaffolds for BTE [116]. An increased bone formation and 
mineralization of the newly formed bone was observed in the strontium oxide and 
magnesium oxide doped 3D printed TCP scaffolds. In another study, the effect of an 
increasing amount of BCP granules (50-250 mg) on viability, morphology, adhesion, and 
differentiation of the total bone marrow cells was studied [117]. A decrease in cell viability, 
attachment and differentiation was observed with the increasing amount of BCP.  These 
declined cellular responses could be explicated by calcium phosphate precipitation 
resulting to a reduction in calcium concentration with increasing BCP amount. A 
biomimetic BCP-collagen-apatite composite scaffold with improved biological properties 
was fabricated [118]. The BCP facilitated the formation of collagen matrix and 
strengthened the scaffold, whereas, collagen and apatite improved the cellular interactions. 
Amongst the bioactive inorganic materials, nHA has gained a widespread application 
because of its biocompatibility, bioactivity, osteoconductivity, and osteoproductivity [87]. 
The nHA that mimics the stoichiometry of bone composition easily bonds with the living 
bone tissue by forming a new apatite layer. From decades nHA is being used in 
maxillofacial surgery as bone defect filler. The 3D scaffolds made up of nHA have shown 
migration of cells inside the porous scaffolds [119]. However, owing to its poor mechanical 
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properties like brittleness, low plasticity and fatigue strength, nHA is difficult to use as a 
monolithic in load-bearing applications. Therefore, HA has been used as a reinforcing 
material to the polymer matrices to develop composites with the improved mechanical and 
biological properties. The HA reinforced porous PVA bioactive composite scaffolds, when 
seeded with SaOS-2 cells, were found to encourage the cell penetration into pores and 
enhanced their proliferation [87]. In another study, PVA-nHA composites were developed 
by varying the concentration of nHA in PVA matrix [27]. It was observed that above a 
certain concentration (3% w/v), HA started agglomerating which deteriorated the 
properties (biological and mechanical) of the composites. The incorporation of nHA into 
polyamide (poly hexamethylene adipamide) was found to increase both, bioactivity and 
mechanical properties of the scaffold material [120]. The nHA coatings on polymeric, 
metallic and carbonaceous materials have always attracted the researchers. The coating of 
nHA on carbon matrix has shown positive effects on biological responses by up-regulating 
the corneal cell growth [121].  
2.3.3. Carbon based materials 
The unique properties of carbon based materials make them a suitable candidate for 
scaffold development and present new opportunities in the field of tissue engineering. The 
carbon nanomaterials provide a microenvironment similar to the biological ECM which 
improves the cellular responses. Different dimensional structures of various carbon 
materials play an important role in their application. Carbon based materials with 1D, 2D, 
and 3D structures are extensively being used in the field of bone tissue engineering. 
Carbon nanotubes: In the year 1991, Sumio Iijima first reported the preparation of CNTs 
which fuelled research on CNTs [122]. Since then, CNTs are effectively being used in 
various fields of chemistry, electronics, physics, and material science. The unique 
electrical, biological and mechanical properties of CNTs have also attracted attention in the 
medical field. The CNTs have also been reinforced in different polymer matrices for 
potential use in various biomedical applications. However, in few studies, the 
agglomeration of pristine CNTs have shown toxic effects. To avoid this problem, CNTs 
are being functionalized with various functional groups to achieve better dispersion in 
polymer matrices. Polymer composites reinforced with CNTs have shown better growth of 
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various cell types such as osteoblast, fibroblast, skeletal myoblast, and stem cells. 
Researchers have shown that the reinforcement of functionalized CNTs in PCL matrix 
improves both, the stem cell osteogenesis and mechanical properties of the composite 
[123]. Lahiri et al. showed that the addition of CNTs in polylactide-caprolactone enhanced 
the osteoblast cell viability and mechanical properties of the composites [124]. Studies have 
also proven that the functionalized MWCNTs impart osteoinductive properties to the PCL 
composite with increased wettability. This increase in wettability of the matrix improves 
the protein and cell adhesion on the surface. Further, the incorporation of the carboxylated 
MWCNTs into PLGA films induced the mesenchymal stem cells to differentiate into 
osteoblast cells [44]. Polyethyleneimine functionalized single-walled CNTs (SWCNTs) 
promoted the neurite growth and branching due to the positive charge on their surface 
[125]. PVA matrix reinforced with 1 wt% carboxylic acid functionalized CNTs has shown 
an up-regulated osteoblast cell adhesion, proliferation, and differentiation [30]. Further, 
increase in concentration up to 1.5 wt% lead to agglomeration of CNTs which caused toxic 
effects. In-vitro studies have exposed the toxic effects of CNTs on the various types of 
cells. Different structures of CNTs are expected to play an important role in their toxicology 
towards osteoblast cells. Zhang et al. investigated the effect of SWCNTs, DWCNTs 
(double-walled CNTs) and MWCNTs on the various cellular responses of primary 
osteoblasts [126]. A time and dose-dependent reduction in cell proliferation and 
differentiation was observed in the order SWCNTs>DWCNTs>MWCNTs. They have also 
reported that the SWCNTs with the smaller diameter are intended to aggregate more due 
to their high surface energy in comparison to the MWCNTs [127]. Hence, more 
aggregation could be the reason for high toxicity of SWCNTs. At a concentration of 50 
µg/ml, CNTs significantly inhibited the mineralization and expression of Runx-2 and Col-
I proteins in osteoblasts. However, the ALP activity of the cells was found to be dependent 
on the time of interaction of the cell with CNTs instead of the CNTs dose.  Another reason 
for cytotoxicity of CNTs is their ability to induce reactive oxygen species (ROS) and 
oxidative stress due to the presence of metallic impurities. In another study, authors have 
demonstrated the aggregation of MWCNTs in mouse embryonic stem cells leading to DNA 
damage through ROS generation [128]. This interaction with MWCNTs induced the 
apoptosis in cells and doubled the frequency of mutations. Few other studies have also 
shown cytotoxicity of CNTs depending on the concentration used. As both, positive and 
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negative effects of CNTs have been reported in the literature, in-depth study of cytotoxic 
effects of CNTs are required. 
Graphene nanoplatelets: Graphene is considered as the basic building block of all other 
carbon allotropes. Graphene family nanomaterials like graphene, GNP, graphene oxide 
(GO), and reduced graphene oxide (rGO) have been used for various biomedical 
applications since their first application as a drug delivery system by Dai et al. [129]. 
Several studies have shown that graphene supports the adhesion and proliferation of 
osteoblast, mesenchymal stem cells, and fibroblast cells.  Literature has reported an 
accelerated differentiation of human mesenchymal stem cells towards osteoblast lineages 
when cultured on graphene substrate [130]. Improved expression of osteocalcin and 
calcium deposition was observed due to the improved protein adsorption via π−π 
interactions. The surface morphology and chemistry also affected the osteogenic 
differentiation of cells on graphene. Kalbacova et al. demonstrated the osteoconductive 
behavior of graphene without any toxicity [131]. It was found biocompatible to both human 
osteoblast and mesenchymal stromal cells. The graphene oxide reinforced PLGA 
nanocomposites have enhanced surface chemical and mechanical properties [132]. 
Graphene hydrogels showed biocompatible nature by forming monolayers due to increased 
osteoblast cells adhesions and proliferation [133]. When GO was reinforced in chitosan 
matrix, increased swelling properties and hydrophilicity lead to better osteoblast cellular 
response [134]. However, the mechanical properties of the developed scaffolds are not 
suitable for bone tissue engineering applications. Mehrali et al. have reported that GNPs 
are less prone to agglomeration as compared to single layer graphene [60]. Further, GNPs 
have also shown positive effects on various biological and mechanical characteristics of 
composites when incorporated in poly(lactic acid) matrices.  Pinto et al. showed that 
reinforcement of small amount of GO and GNPs (0.4 wt%) in PLA matrix significantly 
enhances Young’s modulus and tensile strength of the composite [135]. In another study, 
Zhang et al. had reported improved mechanical and biological properties when 
hydroxyapatite was reinforced with GNPs [136].  A few studies have also testified the 
contradictory results showing toxicity of graphene depending on its concentration [137]. 
Studies are being performed to investigate the cytotoxic effects of graphene and its 
derivatives on mammalian cells. It has shown toxic effects to fibroblasts, epithelial cells, 
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osteoblasts, and blood cells. The graphene has been found to cause ROS generation and 
hindrance in nutrient uptake [134]. Similarly to CNTs, graphene has also shown size-
dependent cytotoxicity. Smaller GO particles showed higher toxicity towards the cells by 
ROS generation [138]. They also led to increased hemolysis of erythrocytes with the 
decrease in GO size. The dose-dependent toxicity of GO decreased the fibroblasts cell 
adhesion and viability at a concentration above than 20 µg/ml [139]. The GO enters the 
cell cytoplasm and disturbs the cell energy metabolism, gene transcription and translation 
resulting into cell apoptosis. However, Zhang et al. have reported that at a concentration of 
10 µg/ml, graphene induces mitochondrial injury and neuronal cell apoptosis due to the 
activation of caspase 3 [140]. Like CNTs, the aggregation of graphene also leads to 
enhanced toxic effects. On interaction with blood cells, GO exhibited higher hemolysis 
than the graphene sheets, whereas, on interaction with fibroblasts, graphene sheets caused 
more damages than the GO [141]. The GNPs induced the ROS generation and disruption 
of cell membranes at a dose of 5 µg/cm2 [142]. The use of low concentration or 
functionalized carbon nanomaterials is expected to reduce their cytotoxic effects. Thus, 
more detailed research efforts are required to study the mechanical and biological effects 
of GNPs.  
Activated carbon: Owing to its fine network of pores and large surface area, AC provides 
more surface for adsorption. It has been used in plant tissue culture to enhance the growth 
by adsorbing toxic compounds from culture medium [61]. As reported by Sandman et al., 
the adsorption of inflammatory cytokines by porous carbon matrix, suppressed the 
inflammation and increased the corneal cell growth on hydroxyapatite-coated porous 
carbon matrix [121]. They showed the adsorption of inflammatory cytokines by porous 
carbon matrix, hence, suppressing the inflammation and increasing cellular growth. Further 
in another recent study AC-ECM composite scaffolds facilitated the regeneration of 
damaged neural tissues by promoting neuronal differentiation [94]. The AC composite 
helped in concentrating the growth factors and cell adhesion proteins. The differentiation 
of stem cells in the presence of AC lead to more matured neuron- like cells. The AC has 
advantages like low cost and economical synthesis in comparison to other carbon based 
materials. However, in spite possessing better properties and low cost, AC has not been 
explored much in the field of tissue engineering. 
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2.4. Scope 
It has been observed that most of the current biomaterials fail to fulfill all the requirements 
for an ideal bone scaffold. The mechanical properties of scaffolds are significantly low than 
those of natural bone. Therefore, there is need to combine two or more biomaterials to 
develop a composite scaffold material with improved properties. Different composites such 
as polymer-polymer, polymer-ceramics, polymer-metal, and ceramics-metal combinations 
have been developed and evaluated for bone tissue engineering. Inert biomaterials can be 
reinforced with osteoinductive and osteoconductive materials to encourage bone repair and 
regeneration. Similarly, osteoinductive brittle materials can be reinforced with a 
mechanically strong material. Owing to their biocompatibility and biodegradation 
properties, PVA and PLGA have been widely used in the field of tissue engineering. 
However, weak mechanical strength and inert nature of PVA, and hydrophobicity and poor 
bioactivity of PLGA are the critical issues of concern that often limit their applications. 
Amongst the bioactive inorganic materials, nHA has gained a widespread application 
because of its biocompatibility, bioactivity, osteoconductivity, and osteoproductivity. On 
the other hand, carbon based materials are fascinating due to their size, large surface area 
and well acceptance by the biological environment. Along with the favorable biological 
properties, the mechanical properties of these materials are also comparable to that of 
natural bone. All these verdicts establish the feasibility of using hydroxyapatite and carbon 
allotropes (CNTs, GNPs and AC) with different structures as ideal reinforcement materials 
in PVA and PLGA matrices for bone tissue engineering.  The cytotoxic effects of carbon 
materials are also necessary to be studied further to evaluate their biocompatibility. 
Therefore, in the present study, optimized concentrations of nHA and carbon materials, 
with improved cellular responses and no toxicity, were obtained. These threshold 
concentrations were further used to develop carbonaceous polymer-ceramic composite 
materials with required biological and mechanical properties for better bone regeneration. 
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2.5. Objectives 
From the literature review, the broad objectives of the thesis are: 
 To develop polymer composite scaffolds by reinforcing hydroxyapatite and 
various carbon allotropes with different dimensional structures in PVA and 
PLGA matrices. 
 To characterize the composite scaffolds for their physicochemical and 
mechanical properties. 
 To perform in-vitro bioactivity and evaluate the biological properties of the 
composite scaffolds. 
2.6. Outline of the chapters 
 Chapter 1 provides an introduction to the field of bone tissue engineering, 
scaffold preparation techniques and various biomaterials used for scaffold 
preparation. 
 Chapter 2 provides an overview of literature reported for bone tissue engineering 
applications using hydroxyapatite and various carbon based materials as 
reinforcements in polymer matrices. 
 Chapter 3 reports the materials and methodology followed for development of 
carbon reinforced PVA/PLGA based composites with and without nHA. The 
techniques used to characterize and evaluate the mechanical and biological 
properties of the developed composites are provided.   
 Chapter 4 delineates the results and discussion of the present research work. 
Results obtained from various characterizations of PVA based composites 
reinforced with varying concentrations of carbon materials and nHA are 
reported. The optimum concentrations obtained and their effects of these 
optimum concentrations on various properties of PVA and PLGA based 
composites are also reported.  
 Chapter 5 discusses the final conclusions drawn from the present research work 
and recommendations for future research are also reported in this chapter.  
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2.7. Summary 
This chapter provided an overview of the current research in the field of bone tissue 
engineering. Ongoing research on the development of various scaffolds for improved bone 
repair and regeneration has been discussed. Advantages and disadvantages of different 
biomaterials as reinforcements have been mentioned. From the literature survey it can be 
summarized that hydroxyapatite and carbon based materials have extensive potential for 
bone tissue engineering applications. Different shapes and aspect ratio of these biomaterials 
are expected to trigger diverse biological and mechanical effects. The effect of different 
dimensional structures of carbon reinforcements on PVA/PLGA matrices has not been 
explored much. Finally, the scope of the present work, objectives, and outlines of the 
chapters of the thesis have been reported. 
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Chapter 3 
Materials and methods 
This chapter describes various materials required and methods followed to perform the 
present research. The preparation and characterization of PVA based composite scaffolds 
using varying concentrations of different materials (nHA, CNTs, GNPs, AC) will be 
described to find the threshold (optimum) concentration of each reinforcement material, 
above which it deteriorates the composite properties. Further, the preparation of 
PVA/PLGA based composites using optimized reinforcement concentrations and their 
characterizations are explained to study the effects of different carbon structures. 
3.1. Materials 
PVA (hot water soluble), AC powder, antibiotic-antimycotic solution, phosphate buffer 
saline (PBS), Bradford reagent, bovine serum albumin (BSA) and 3-(4,5-dimethyl-2-yl)-
2,5-diphenyltetrazolium bromide (MTT) assay kit from HiMedia Laboratories Pvt. Ltd., 
India; PLGA (lactide:glycolide = 75:25), carboxylic acid functionalized CNTs (multi-
walled; diameter: 9.5 nm; length: 1.5 µm), Dulbecco’s Modified Eagle’s medium 
(DMEM), trypsin-EDTA solution, alkaline phosphatase (ALP) assay kit, alizarin red stain 
based (ARS) assay kit, TRITC-phalloidin stain, Hoechst stain and fetal bovine serum (FBS) 
were procured from Sigma-Aldrich, India; carboxylic acid functionalized GNPs (average 
thickness 6-8 nm, surface area 150 m2g-1) from Cheap tubes, USA, nano-hydroxyapatite 
(nHA) from Acros Organics, USA, calcein-AM from Thermo Fisher Scientific India Pvt. 
Ltd., India and the human osteoblast-like MG-63 cells (human osteosarcoma cell line) from 
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the National Centre for Cell Science (NCCS, Pune) India, were procured and used in this 
research work. All reagents used in this research work were of analytical grade. 
3.2. Preparation of composite scaffolds 
The present work is divided into two phases as shown in Fig.3.1. In the first phase, varying 
concentrations of four different materials (nHA, CNTs, GNPs and AC) were reinforced 
into PVA matrix to develop various composites. The developed composites were 
characterized for their physicochemical, biological and mechanical properties to find the 
optimum concentration of each reinforcement. In the second phase, the obtained optimum 
concentrations of different materials were further reinforced into polymer (PVA and 
PLGA) matrices to study the effect of different structures (1D, 2D, and 3D) of carbon.  
3.2.1. PVA-nHA scaffolds 
The PVA-nHA scaffolds were prepared by solvent evaporation method as a preliminary 
work to find optimum concentration of nHA. Five different PVA-nHA composite scaffolds 
were prepared by dissolving 10% w/v of PVA in distilled water, followed by addition of 
nHA by varying its concentration (1%, 2%, 3%, 4% and 5% w/v). The homogenous 
dispersion was achieved by sonication and continuous stirring (90°C), and the solution was 
poured into a glass mold and kept in a vacuum oven at 60°C for 24 h. The five resultant 
PVA-nHA composite scaffolds were designated as PHA 1, PHA 2, PHA 3, PHA 4 and 
PHA 5 respectively. Pure PVA scaffold was also prepared and coded as PVA. These 
composites were characterized, and their mechanical, and in-vitro biological properties 
were studied. 
3.2.2. PVA-CNTs scaffolds 
The PVA-CNTs nanocomposite scaffolds were prepared by freeze drying technique. To 
reduce the tendency of agglomeration, carboxylic acid functionalized CNTs were used. 
PVA (10% w/v) in distilled water was dissolved and stirred at 90°C for 3 h in a magnetic 
hot plate. Different concentrations of CNTs (0, 0.5, 1 and 1.5 wt% with respect to PVA) 
were added to the solution and stirred. The obtained solutions were frozen at -20°C for 24 
h and then lyophilized in vacuum for 48 h to obtain porous PVA-CNTs nanocomposite 
  
Chapter 3                                                                                          Materials and methods 
 
37 
 
scaffolds. The obtained scaffolds by varying the CNTs (0, 0.5, 1 and 1.5 wt%) composition 
were coded as PCN 0, PCN 0.5, PCN 1 and PCN 1.5 respectively. 
 
 
Fig. 3.1 Schematic representation of the sample preparation and characterization. 
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3.2.3. PVA-GNPs scaffolds 
To prepare PVA-GNPs nanocomposite scaffolds by freeze drying technique, PVA (10% 
w/v) was dissolved in distilled water and stirred at 90°C for 3 h in a magnetic hot plate. 
Different concentrations of functionalized GNPs (0, 0.5, 1 and 1.5 wt% with respect to 
PVA) were dispersed in the prepared PVA solution. To obtain porous PVA-GNPs 
nanocomposite scaffolds the solutions were frozen at -20°C for 24 h and then lyophilized 
in vacuum for 48 h. The developed scaffolds by varying the GNPs (0, 0.5, 1 and 1.5 wt%) 
composition were coded as PGN 0, PGN 0.5, PGN 1 and PGN 1.5 respectively. 
3.2.4. PVA-AC scaffolds 
The porous PVA-AC scaffolds were prepared by freeze drying method. PVA (10% w/v) 
was dissolved in distilled water and stirred at 90°C for 3 h in a magnetic hot plate. Different 
concentrations of AC powder (0, 0.5, 1, 1.5, 2 and 2.5 wt% with respect to PVA) were 
added to the solution and stirred. The obtained PVA-AC composite solutions were frozen 
at -20°C for 24 h and lyophilized in vacuum for 48 h to obtain dry, porous PVA-AC 
composite scaffolds. The six scaffolds with different concentrations of AC powder were 
prepared and coded as PC 0, PC 0.5, PC 1, PC 1.5, PC 2 and PC 2.5 respectively. 
3.2.5. Carbonaceous PVA-nHA composite scaffolds 
The carbon reinforced PVA-nHA scaffolds were prepared by reinforcing PVA with 
optimized concentrations of nHA and carbon materials using freeze drying method. PVA 
(10% w/v) was dissolved in distilled water and stirred at 90°C (3 h) followed by addition 
of nHA (3% w/v).  After proper dispersion of nHA, optimized concentration of respective 
carbon (1 wt% CNTs, 1 wt% GNPs, and 2.5 wt% AC) material was added and stirred. The 
obtained carbonaceous PVA-nHA composite solutions were frozen at -20°C for 24 h and 
lyophilized in vacuum for 48 h. Similarly, PVA-nHA composite scaffolds without addition 
of any carbon were also prepared. The four different scaffolds were coded as PH (PVA-
nHA), PHCN (PVA-nHA-CNTs), PHGN (PVA-nHA-GNPs) and PHAC (PVA-nHA-AC). 
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3.2.6. Carbonaceous PLGA composite scaffolds 
The PLGA-CNTs, PLGA-GNPs and PLGA-AC composite scaffolds were prepared by 
solvent casting technique. To obtain proper dispersion, 1 wt% of each of functionalized 
CNTs and GNPs, and 2.5 wt% of AC were sonicated in dichloromethane (DCM) at room 
temperature. The PLGA (7% w/v) polymer was dissolved in DCM separately and added to 
the above solutions. The solutions were then sonicated, poured in glass dish and vacuum 
dried overnight. The dried films were then kept in a vacuum oven at 37°C for 48 h. 
Similarly, pure PLGA film (PL) was also prepared. Thus obtained four different films were 
coded as PL, PLCN (PLGA-CNTs), PLGN (PLGA-GNPs) and PLAC (PLGA-AC) 
respectively. 
3.2.7. Carbonaceous PLGA-nHA composite scaffolds 
The carbon and nHA reinforced PLGA composite scaffolds were prepared by solvent 
casting method. The PLGA (7% w/v) polymer was dissolved in DCM followed by addition 
of respective carbon solutions (1 wt% of CNTs and GNPs, and 2.5 wt% of AC sonicated 
in DCM). While stirring, nHA (3 wt%) was added slowly to the PLGA-carbon composite 
solutions while stirring. The composite solutions were then sonicated, poured in glass dish, 
vacuum dried overnight and kept in oven at 37°C for 48 h. Similarly, PLGA-nHA 
composite (PLH) was also prepared. Thus obtained four different films were coded as PLH, 
PLHCN (PLGA-nHA-CNTs), PLHGN (PLGA-nHA-GNPs) and PLHAC (PLGA-nHA-
AC) respectively.  
3.3. Characterization 
3.3.1. Physicochemical characterization  
The initial structure and size of the nHA and carbon allotropes were studied using 
transmission electron microscopy (TEM). The samples were first sonicated using a probe 
sonicator in ethanol medium until homogenous dispersion.  The dispersed solution is then 
placed on a carbon coated copper grids and then observed in transmission electron 
microscope (TEM-FEI Tecnai F30). The selected area electron diffraction (SAED) patterns 
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were also observed. The surface morphology of all the composite scaffolds was evaluated 
using a field emission scanning electron microscope (FESEM-FEI NovananoSEM 450). 
The samples were gold sputter coated prior to SEM imaging to avoid imaging artifacts 
from electrical charging. The phase and crystallinity of all the composites were studied 
using X-ray diffraction (XRD, RigakuUltima IV Diffractometer, Japan) technique. The 
XRD over a scan range of 15°-60° was performed with a scan speed of 5°/min and step 
size of 0.05° using CuKα radiation. Attenuated total reflectance-Fourier transform infrared 
spectroscopy (ATR-FTIR, AlphaE, Bruker, USA) was performed to characterize the 
functional groups present in composites. Transmittance spectra within the range of 600-
4000 cm-1 were obtained. Further, the FTIR spectra were deconvoluted using Fourier self-
deconvolution. The effect of different reinforcements on the hydrophilicity of composites 
was evaluated by measuring contact angles (DSA25, Kruss, Germany) at room temperature 
with distilled water using sessile drop method. Ten measurements of contact angle were 
measured for each sample.  
3.3.2. In-vitro swelling studies  
All the composite samples (triplicates) were subjected to swelling by immersing them in 
PBS (pH 7.4) at 37°C after measuring the initial weight (Wd). The samples were retrieved 
from PBS after 24 h, and wet weight (Ws) was measured. The swelling percentage was 
calculated from the following equation: 
                                      S (%) = 
𝑊𝑠−𝑊𝑑
𝑊𝑑
x 100                                                      ...(1) 
where Ws and Wd are the wet and dry weights of the samples respectively. 
3.3.3. In-vitro degradation studies  
The in-vitro degradation studies were performed in triplicate to determine the weight loss 
of the composite scaffolds. The initial samples were weighted (Wi) and soaked in PBS for 
4 weeks in a constant temperature environment of 37°C. The PBS was not refreshed during 
the experiment. At regular intervals, the samples were withdrawn, dried at 40°C for 4 days, 
and its final weights (Wf) were measured. The degradation percentage (Dw) of each sample 
was calculated in the form of weight loss as in equation (2): 
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                                              Dw (%) = 
𝑊𝑖−𝑊𝑓
𝑊𝑖
x 100                                               ...(2) 
where Wi and Wf are the initial and final weights of the samples respectively. 
3.3.4. In-vitro mineralization activity studies 
The in-vitro bioactivity study of the composites was carried out in simulated body fluid 
(SBF), an inorganic physiological solution having a similar composition to that of human 
blood plasma. The SBF was prepared following the standard procedure described by 
Kokubo and Takadama [143].  The composite samples were soaked in SBF and kept at 
37°C in a constant temperature water bath for 21 days. The samples were then removed, 
gently rinsed with deionized water and dried. The apatite formation was evaluated by 
performing FESEM and XRD analysis.  
3.3.5. In-vitro hemocompatibility studies 
The hemocompatibility of the composite samples was studied by performing hemolysis 
and anticoagulant assays. To perform hemolysis assay, the samples in triplicates were 
equilibrated with a physiological saline solution for 24 h. The equilibrated samples were 
put into test tubes with fresh physiological saline (10 ml) and incubated for 30 min at 37°C. 
After addition of anticoagulant (potassium citrate), goat blood was diluted (v/v; 4/5) with 
physiological saline. The diluted goat blood (0.2 ml) was added to each tube containing 
samples with saline and incubated for 1 h at 37°C. To prepare positive and negative 
controls, diluted blood was added to distilled water and physiological saline respectively. 
After the incubation time, the samples were centrifuged (1000 rpm for 10 min) and its 
absorbance (OD) was taken from the supernatant liquid at 545 nm (double beam 
spectrometer 2203, Systronics, India). The percentage hemolysis was calculated using 
following equation: 
                             % Hemolysis = 
𝑂𝐷𝑡𝑒𝑠𝑡− 𝑂𝐷𝑛𝑒𝑔
𝑂𝐷𝑝𝑜𝑠− 𝑂𝐷𝑛𝑒𝑔
x 100                                  …(3) 
where ODtest, ODneg, and ODpos are absorbance values for test samples, negative and 
positive controls, respectively.  
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3.3.6. Protein adsorption studies 
To perform protein adsorption study, a calibration curve was drawn for standard BSA 
solution ranging from 200-1000 µg/ml. The Bradford assay was used for the quantification 
of adsorbed protein by composite samples. The samples (triplicates) were immersed in 1 
ml BSA solution (1 mg/ml protein in PBS) for 24 h at 37°C. The samples were retrieved 
from the solution and then centrifuged at 4000 rpm for 10 min. After centrifugation, 100 
µl of supernatant was mixed with 1 ml of Bradford reagent and 2 ml of distilled water 
followed by incubation in the dark for 10 min, and its absorbance was measured at 595 nm 
using a UV-spectrophotometer. The protein concentration was determined using the 
calibration curve. 
3.3.7. Tensile properties 
The tensile properties of the composites were obtained using a universal testing machine 
(ElectroPuls E1000, Instron, UK) with a load cell of 250 N at a strain rate of 2 mm/min. 
The test samples were cut following ASTM D3039 standard, and testing was done in 
triplicates [144].  
3.3.8. In-vitro biocompatibility studies 
MG 63 cell line, an established model for human osteoblasts was used to study the response 
of osteoblast cells on the developed composites. Human osteoblast like MG-63 cells were 
cultured in T-25 tissue culture flasks in a humidified atmosphere containing 5% CO2 at 
37°C in DMEM supplemented with 10% FBS, and 100 U/ml of penicillin-streptomycin. 
Prior to cell seeding, the samples were sterilized using UV and ethanol treatment for 20 
min each. All the tests were performed in triplicates and compared with control i.e. tissue 
culture plate. 
a. Cell viability 
The cell viability of osteoblast cells cultured on the composites was evaluated using MTT 
assay and trypan blue exclusion assay. To perform MTT assay, the MG-63 cells (1 x 104 
cells) were incubated on the samples in a tissue culture plate at 37°C in 5% CO2. After 48 
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h, 20 µl of MTT solution at a concentration of 5 mg/ml was added to each well and 
incubated for 4 h. The removal of the MTT solution from tissue culture plate was followed 
by addition of dimethyl sulfoxide (DMSO) to solubilize the formazan crystals. After 
shaking plate gently for 15 min, its absorbance was measured at 595 nm. For trypan blue 
exclusion assay, cells (1.5 x 104) were seeded on the samples in a 24 well plate. After 48 
h, the cells were trypsinized and stained with a 0.4% trypan blue solution. Live/dead cells 
were counted using a phase contrast microscope (Primo Vert, Carl Zeiss, Germany). 
b. Cell morphology 
The MG-63 cells (1 x 104 cells) were seeded on the sterilized samples into tissue culture 
plate and incubated (at 37°C in 5% CO2). After incubation, the samples were washed gently 
with PBS to remove media.  For fixing the samples, 2.5% glutaraldehyde solution (3 h) 
was used followed by dehydration in a graded series of ethanol solution (30, 50, 70, 90, 95 
and 100%). Then the samples were vacuum dried, gold sputter coated and observed in 
FESEM to study the cell morphology and adhesion.  
c. Alkaline Phosphatase (ALP) activity 
The alkaline phosphatase activity of osteoblast cells cultured on composites was evaluated 
using ALP colorimetric assay. After 7 days of cell seeding, the samples were washed with 
PBS, followed by addition of lysis buffer and then p-nitrophenyl phosphate (pNPP) 
substrate for 1 h at 37°C. The reaction was stopped using 0.5 N NaOH, and the absorbance 
was measured at 405 nm. 
d. Mineralization assay  
The calcium deposition on the samples was measured using alizarin red stain (ARS) based 
colorimetric assay. The osteoblast cells seeded on the composites for 7 days were fixed 
with 70% ethanol for 1 h at 4°C, washed thrice with distilled water and stained with ARS 
for 30 min. After a series of distilled water washes, the stain was eluted with a destaining 
solution consisting of 10% cetylpyridinium chloride (CPC) and incubated for 30 min. The 
absorbance of the eluted dye was measured at 562 nm. A calibration curve was also plotted 
for known concentrations of ARS. 
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e. Confocal microscopy and quantification of cell 
morphology 
To further evaluate the cytoskeletal organization of cells, double staining was performed 
only on the samples reinforced with optimized concentrations of reinforcements 
(carbonaceous composites of PLGA, PVA-nHA and PLGA-nHA). After 48 h of cell 
seeding, the cells were fixed with paraformaldehyde (4%) for 15 min and permeabilized 
with Triton-X 100 (0.25% in PBS) for 10 min. The actin cytoskeleton and nuclei of cells 
were stained with TRITC-phalloidin and Hoechst dyes, respectively. The stained samples 
were washed with PBS and observed under the confocal microscope (TCS-SP8, Leica). 
Further, to quantify the cell spreading on different scaffolds, the cell area was measured 
using ImageJ software. The cells present on five different confocal micrographs were 
evaluated for each sample. 
f. Live cell staining 
Live cell staining was performed by using calcein-AM (acetoxymethyl ester) to determine 
the number of viable cells on samples reinforced with optimized reinforcement 
concentrations. Calcein-AM is a marker of esterase activity of living cells. In live cells, 
esterase’s remove the acetoxymethyl ester group of calcein-AM by hydrolysis converting 
it to calcein which produces green fluorescence. After 7 days of cell seeding, media was 
removed, and samples were washed with PBS. Calcein-AM (1 µl/ml) was added to each 
scaffold and incubated at 37°C for 30 min. The samples were washed with incomplete 
media and visualized under the fluorescence microscope (Olympus IX71, Japan). 
g. Collagen quantification 
The total collagen secreted by osteoblast cells on the scaffolds (with optimized 
reinforcement concentrations) was determined by using Sirius red colorimetric assay. After 
7 days of cell culture, the cells were fixed on the scaffolds with Bouin's fluid. The fixation 
fluid was removed after 1 h, and the samples were washed with distilled water, air dried 
and then stained with Sirius red dye for 1 h. Thereafter, the samples were washed with 0.01 
M HCl, and the bound dye was dissolved in 0.1 M NaOH. The absorbance of the solution 
was measured at 550 nm against 0.1 M NaOH as a blank. 
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3.3.9. Statistical Analysis 
Data are expressed as mean ± standard deviation and one-way analysis of variance 
(ANOVA) was used for comparison. The level of significance was measured and data was 
represented at significant (∗p ≤ 0.05) level. 
3.4. Summary 
This chapter has described the materials used and methods followed to perform the present 
work. Preparation of various samples and their characterization techniques 
(physicochemical, biological and mechanical) to find optimum concentration of 
reinforcement have been explained in detail. The sample preparation using optimum 
reinforcement concentrations and their characterizations have also been mentioned to study 
the role of reinforcement structure.  
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Chapter 4 
Results and discussion 
This chapter provides the results obtained from the present research work. The results are 
divided into two phases. The first phase includes the results and discussion of optimization 
of reinforcement concentration. The optimum (threshold) concentration of each of the 
reinforcement material will be obtained after analyzing physicochemical, mechanical and 
biological properties of the developed composites with varying reinforcement 
concentrations. The second phase results include the effect of different carbon materials 
(1D, 2D, 3D) with and without nHA in the two polymer matrices, i.e. PVA and PLGA.  
4.1. Optimization of reinforcement concentration 
4.1.1. Transmission electron microscopy 
TEM analysis was performed to investigate the initial structure and size of three carbon 
based materials and nHA used in this study to reinforce PVA and PLGA matrices. The 
TEM micrographs (Fig. 4.1) revealed the typical morphology of nHA, CNTs, GNPs and 
AC.  The nHA showed nanorods, CNTs and GNPs showed their respective tubular and 
sheet like (platelets) structure whereas AC exhibited irregular structure. The SAED patterns 
indicated the amorphous nature of CNTs whereas nHA and GNPs displayed crystalline 
nature. The lack of distinct reflections in the SAED pattern indicated the poorly ordered 
structure of AC which is consistent with a turbostratic structure [145]. 
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4.1.2. Scanning electron microscopy analysis 
The surface topography and microstructure are important parameters in designing scaffolds 
for tissue engineering applications. The scaffold morphology significantly influences the 
in-vitro and in-vivo behavior of the composite scaffolds. Microstructural analysis was done 
on all composite scaffolds with varying concentrations of nHA, CNTs, GNPs and AC to 
analyze whether the homogeneous dispersion of different reinforcements in the polymer 
matrix has been achieved.  
The FESEM micrographs of different PVA-nHA composite scaffolds are shown in Fig. 
4.2. Agglomeration of nHA in the polymer matrix might affect composite properties 
whereas, homogeneous dispersion of nHA aids in the improvement of physical, mechanical 
and biological properties of the composite. The SEM micrographs have revealed the 
distribution of nHA in PVA matrix, which plays a major role in surface roughness of these 
composites as the concentration of nHA has been increased. The micrograph of PVA 
scaffold without nHA (Fig. 4.2 (a)) shows the smooth surface owing to the bio-inert nature 
of PVA. The micrographs show that on the addition of nHA in PVA matrix, the surface 
roughness was found to increase. The PHA 1 and PHA 2 samples have shown a 
homogeneous dispersion of uniformly sized clusters of nHA particles (Fig. 4.2 (b-c)). With 
further increase in the concentration of nHA particles, the roughness was found to increase 
as in PHA 3 (Fig. 4.2 (d)). The microstructural analysis also reveals that the agglomeration 
of nHA in PVA matrix increase with the increase in the concentration of nHA. The PHA 3 
sample shows some regions of agglomerated nHA particles; with 3% w/v of nHA, whereas, 
PHA 4 and PHA 5 samples (Fig. 4.2 (e-f)) showed more agglomerated clusters. The 
formation of agglomerated nHA clusters might attribute to the charged inorganic ions that 
were not evenly distributed in PVA matrix and thereby getting agglomerated clusters under 
the effect of van der Waals force and Brownian motion. Brownian motion causes the 
collision of the nHA particles with each other and the van der Waals forces attract these 
particles leading to agglomeration [40]. So from the SEM micrographs, it was observed 
that with the increase in the concentration of nHA above a certain amount (3% w/v), more 
agglomeration was evident, which could affect the mechanical and biological properties of 
composites. 
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Fig. 4.1 (a) TEM micrographs and (b) SAED patterns of nHA, AC, CNTs and GNPs. 
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Fig. 4.2 FESEM micrographs of (a) PVA, (b) PHA 1, (c) PHA 2, (d) PHA 3, (e) PHA 
4 and (f) PHA 5. 
The cross-sectional surfaces of PVA-CNTs nanocomposite scaffolds with varying CNTs 
concentrations were analyzed using FESEM (Fig. 4.3). The micrographs have revealed the 
rough, interconnected and porous structure of the PVA-CNTs scaffolds that allow cells to 
attach, migrate and grow into the scaffold interior. Both micro (<50 µm) and macro (>50 
µm) pores were observed in the nanocomposite scaffolds that increase the surface 
roughness. The pore size was found to decrease slightly with the addition of CNTs in PVA 
matrix.  The pore size obtained in both, PCN 0.5 and PCN 1 (Fig. 4.3 (b-c)) were large 
enough to fulfill the requirements for osteoblast cell proliferation. However, sample PCN 
1.5 (Fig. 4.3 (d)) was observed to have slightly smaller pores. Sample PCN 1 and PCN 1.5 
(Fig. 4.3 (e-f)) were also observed at higher magnification to analyze the CNTs dispersion. 
Sample PCN 1 showed a uniform distribution of CNTs whereas, with further increase in 
concentration, CNTs started agglomerating. PCN 1.5 showed the presence of CNTs 
agglomerates in the PVA matrix. These agglomerates may diminish the mechanical and 
biological properties of the PCN 1.5. 
A representative cross-sectional FESEM micrographs of PVA-GNPs composite scaffolds 
are shown in Fig. 4.4 (a-f). The FESEM micrographs revealed the porous network structure 
of all the scaffolds. Both, macro and micro sized pores were observed in all the samples 
which support the cell adhesion, growth and nutrients supply inside the scaffolds [146]. 
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Fig. 4.3 FESEM micrographs of (a) PCN 0, (b) PCN 0.5, (c) PCN 1 and (d) PCN 1.5. 
Surfaces of (e) PCN 1 and (f) PCN 1.5 observed at higher magnification. (Arrows show 
the agglomeration in PCN 1.5.) 
Lee et al. have reported that microporous scaffolds encouraged the MG-63 cell adhesion 
and proliferation, whereas increasing micropore size resulted in improved cell 
differentiation [147]. With the addition of GNPs in PVA matrix variation in pore 
architecture was obtained. Pore walls of PGN 0 (Fig. 4.4 (a)) scaffold were thin which led 
to crumbling of pores while addition of GNPs in PVA provided stability of pore structure 
by thick pore walls and prevented the pores from collapse, therefore, larger pores were 
observed in composite scaffolds. The large pore size and stable pore architecture play a 
significant role in providing mechanical interlocking with surrounding tissue [148]. The 
FESEM micrographs of PGN 1 and PGN 1.5 scaffolds at higher magnification have also 
been shown in Fig. 4.4 (e-f). The GNPs were homogeneously dispersed throughout in PGN 
1 sample (Fig. 4.4 (e)). The homogeneous dispersion of GNPs is beneficial to enhance the 
mechanical properties of the scaffold. However, with the further increase of GNPs in PGN 
1.5 (Fig. 4.4 (f)), the GNPs started to agglomerate due to van der Waals force [56]. These 
agglomerates in PGN 1.5 may result in the deterioration of the mechanical and biological 
properties.  
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Fig. 4.4 FESEM micrographs of (a) PGN 0, (b) PGN 0.5, (c) PGN 1 and (d) PGN 1.5. 
Scaffolds (e) PGN 1 and (f) PGN 1.5 at higher magnification. (Arrows represent the 
well dispersed GNPs and asterisks represent the agglomeration of GNPs.) 
The FESEM micrographs of the cross-sectional surface of PVA-AC composite scaffolds 
with varying AC concentrations are shown in Fig. 4.5. From these micrographs, it is evident 
that AC is homogenously dispersed, and there is no trace of agglomeration of AC in PVA 
matrix. The well dispersed AC was also observed in high magnification micrograph of PC 
2.5 (Fig. 4.5 (h)). The cross-sectional morphology of all the composite scaffolds showed 
macro and micro pores which are an important requirement for influencing cell attachment 
and growth. Researchers have reported that the pore size plays an important role in 
encouraging cell attachment and differentiation on a surface roughened biomaterial that 
develops mechanical interlocking between the implant and surrounding tissues [149, 150]. 
The cross-section micrographs of PVA (Fig. 4.5 (a) revealed undefined pore shapes. Due 
to the flexible character of PVA polymer, shrinkage and collapse of the pore structure were 
observed in PC 0 scaffold. However, comparatively larger and homogenous pore 
architecture was obtained for PC composite (Fig. 4.5 (b-f)) scaffolds. The AC present in 
PVA matrix enhanced the stability of the structure and prevented the pores from collapse. 
The porosity obtained in the PC scaffolds fulfilled the pore size requirements for osteoblast 
cell to penetrate into the scaffolds. The micrographs of samples have shown the presence 
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of micropores that are essential for regulating cell migration and nutrient supply to the cells, 
thereby permitting cell growth inside the scaffold. The interconnected porosity observed in 
the PC 2.5 sample has been shown in Fig. 4.5 (g). Thus, the developed scaffolds have the 
required morphology and porosity which may help in osteoblast growth and proliferation. 
 
 
Fig. 4.5 FESEM micrographs of (a) PC 0, (b) PC 0.5, (c) PC 1, (d) PC 1.5, (e) PC 2, (f) 
PC 2.5, (g) interconnected pores in PC 2.5 and (h) higher magnification micrograph 
of PC 2.5 scaffolds. 
4.1.3. X-ray diffraction 
The XRD spectra of all four different reinforcements (nHA, CNTs, GNPs, AC) used in the 
present study are shown in Fig. 4.6 (a). The nHA showed characteristic peaks at 25.87°, 
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31.77° 32.1° and 32.90° similar to JCPDS standard for HA (PDF NO. 09-0432) [151]. 
Other peaks for nHA were found at 34.04°, 39.7°, 46.6° and 49.4°. Pure CNTs showed 
peaks at 25.6° and 42.7° corresponding to the (002) and (101) planes of CNTs respectively, 
as mentioned in JCPDS number 75-1621 [152]. For as received GNPs, the characteristic 
peak at 26.5° corresponding to the (002) plane reflection of GNPs was observed, as 
mentioned in JCPDS number 01-0646 [153]. Pure AC showed peaks at 26.5° and 43.5° 
indicating alignment of carbon planes [154]. 
The XRD spectra of PVA-nHA composite scaffolds with different nHA concentrations 
(Fig. 4.6 (b)) were obtained to investigate the formation of any new phase or contamination 
during processing. The broad diffused peak at 19.5° (101) corresponding to the 
characteristic peak of PVA demonstrates that PVA possesses a semi-crystalline structure 
that was observed in all composite scaffolds. No other peaks were found in PVA sample 
indicating that there is no phase contamination. The intensity of nHA peaks was found to 
increase from PHA 1 to PHA 5 samples as nHA concentration increases. No intermediate 
calcium phosphate phases like TCP or BCP were observed in all the processed PHA 
composite scaffolds.  
In the XRD patterns of PVA-CNTs composites no strong CNTs characteristic peak was 
observed (Fig. 4.6 (c)). This might be due to the lower concentration of CNTs as compared 
to PVA in the composites. The broad peaks at 19.5° and 40.5° correspond well to the 
characteristic reflection of the (101) and (220) plane of the pure PVA (PCN 0) indicating 
its semi crystalline structure. These peaks were found in all the PVA-CNTs composite 
samples confirming the presence of PVA in all the samples.  
The effect of GNPs addition to the PVA matrix can be very well seen in the XRD patterns 
of PVA-GNPs nanocomposites as shown in Fig. 4.6 (d). A sharp characteristic peak at 
26.5° (002) corresponding to GNPs was observed, whereas PVA showed a peak at 19.5° 
(101) [155]. The characteristic peaks of PVA and GNPs were found in all the PVA-GNPs 
nanocomposite samples confirming the presence of PVA and GNPs. The intensity of the 
GNPs peak increased with the increase in the amount of the GNPs from PGN 0.5 to PGN 
1.5. 
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A broad diffused characteristic peak at 19.5° (101) was observed in all PVA-AC samples 
corresponding to PVA (Fig. 4.6 (e)). This broad peak indicates that the PVA possesses 
semi-crystalline structure. There was no strong AC characteristic peak observed in PVA-
AC composite scaffolds. This might be due to the lower concentration of AC as compared 
to PVA in the composites. 
 
Fig. 4.6 XRD patterns of (a) different reinforcements, (b) PVA-nHA, (c) PVA-CNTs, 
(d) PVA-GNPs and (e) PVA-AC composites.  
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4.1.4. Fourier transform infrared analysis 
After studying the morphology of the composite scaffolds, it is also important to understand 
the molecular interactions in the composites. In order to investigate the intermolecular 
interactions, ATR-FTIR analysis was carried out for all the composite samples, and their 
spectra are shown in Fig. 4.7. The deconvoluted spectra are also shown in Fig. 4.8. 
The FTIR spectra of nHA, CNTs, GNPs and AC are shown in Fig. 4.7 (a) and the FSD 
spectra are given in Fig. 4.8. The spectra of nHA showed a high intensity peak at 1030 cm-
1 along with the peaks at 1090 cm-1 and 960 cm-1 corresponding to the asymmetric 
stretching of PO4
3- ions. Peak at 871 cm-1 corresponds to the out of plane bending mode of 
CO3
2- ions. Stretching from adsorbed water was shown by a peak at 1642 cm-1. Small 
intensity peaks around 3500 cm-1 and 600 cm-1 were observed due to stretching of O-H 
groups. The spectra of CNTs showed a peak at 3728 cm-1 attributing to the free O-H groups 
while the peak at 2361 cm-1 can be assigned to the O-H groups from strongly hydrogen 
bonded carboxyl groups [156]. Two peaks for C-H stretching were observed at 2922 cm-1 
and 2850 cm-1, whereas, the peaks for C=O stretching were obtained at 1738 cm-1 and 1682 
cm-1. Two peaks for C=C stretching around 1535 cm-1 and a weak peak at 1026 cm-1 
correspond C=C stretching and C-O stretching. A unique peak for MWCNT was observed 
at 1450 cm-1 [157]. The GNPs IR spectra showed characteristic peaks at 3725 cm-1, 1682 
cm-1, and 1513 cm-1 which can be assigned to free O-H groups, C=O and C=C stretching. 
The presence of C=O and O-H groups in FTIR spectra of both CNTs and GNPs confirmed 
their carboxylic acid functionalization. Further, AC showed weak intensity peaks for O-H 
and C=C bond stretching at around 3728 cm-1 and 1527 cm-1 respectively. 
The ATR-FTIR spectra of PVA-nHA composite scaffolds showed the characteristic peaks 
corresponding to standard PVA and nHA (Fig. 4.7 (b)). PVA, a polar polymer having -CH, 
-CH2 and -OH side groups with C-C backbone. On C-C backbone, PVA has O-H pendant 
groups that make PVA capable of physical crosslinking. All these characteristic functional 
groups were observed in the FTIR spectra of PVA. A broad absorption band obtained at 
about 3500 and 3000 cm–1 corresponds to the interaction of absorbed O-H group present in 
both nHA and PVA. The bonding between PVA and nHA became stronger because of the 
increase in number of O-H groups with the addition of nHA in PVA. This is due to the 
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attraction of Ca+ ions onto the OH– group of PVA. The peak at 2920 cm–1 indicates C-H 
stretching. Weak absorbance around 2474 cm–1 represents the interaction of hydrogen 
atoms of PVA with phosphorous atoms of nHA. Poursamar et al. also obtained a peak at 
2430 cm–1 indicating PVA and nHA interactions [87]. The difference in concentration of 
nHA added might be the reason for the peak shift of ~40 cm–1. The absorption band 
associated with the stretching of H2O molecules was observed at 1640 cm
–1. Peaks with 
low intensity observed around 1470 cm–1 correspond to the stretching vibration of -CO3
2- 
ions due to atmospheric -CO2 absorption. Absorption at around 1417 cm
–1 originates from 
C-H bend and C-C stretching. The intensity of this peak was found to decrease with the 
increase in the concentration of nHA. The peak for C-O stretching was observed around 
1083 cm–1. The characteristic peaks for stretching vibration of phosphate ion (PO4
3-) at 
1030 cm–1 were observed at the higher concentration of nHA. This peak was absent in pure 
PVA scaffold. Other characteristic peaks for nHA were present at 960 cm–1 (symmetric P-
O), 560 cm–1, 570 cm–1 and 601 cm–1 (O–P–O bend).The intensity of these bands was very 
low because of less concentration of nHA used in processing from 1% w/v to 5% w/v.  
The investigation of the intermolecular interactions in PVA-CNTs composites was 
performed by ATR-FTIR analysis and the obtained spectra is shown in Fig. 4.7 (c). The 
spectra of PVA (PCN 0) and other developed PVA-CNTs nanocomposites showed all the 
characteristic peaks corresponding to standard PVA. A broad absorption band observed 
between 3550 cm-1 and 3044 cm-1 indicates the stretching of free and hydrogen bonded 
hydroxyl groups in both, alcohol and carboxylic acid. The vibrational peaks at 2920 cm-1 
and 2850 cm-1 refer to the stretching of C-H bond.  The stretching vibration of C=O and C-
O bonds in acetate groups was observed at 1654 cm-1 and 1081 cm-1. The presence of C=O 
bonds in both CNTs and PVA confirms that the PVA can interact strongly with CNTs. 
Hence, the intensity of C=O peak (1654 cm-1) was found to increase with the addition of 
CNTs in PVA. The absorptions at 1428 cm-1, 1320 cm-1 and 837 cm–1 originate from the 
bending of C-H bond. The broadening of C-O peak (1081 cm–1) occurred due to the 
formation of a new absorption peak at 1022 cm–1 in PCN 1 and PCN 1.5 samples attributed 
to the interfacial covalent reaction between PVA and CNTs [158]. Both, PCN 1 and PCN 
1.5 samples showed O-H peak at 3728 cm-1 confirming the presence of functionalized 
CNTs in PVA matrix.  
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The spectra of pure PVA (PGN 0) and PVA-GNPs nanocomposites showed all the 
characteristic peaks corresponding to standard PVA (Fig. 4.7 (d)). A broad absorption band 
around 3272 cm-1 indicates the O-H stretching vibrations and the vibrational peak at 2920 
cm-1 refers to the aliphatic stretching of C-H bond.  The peaks at 1718 cm-1 and 1652 cm-1 
are assigned to the stretching vibration of C=O whereas peak at 1082 cm-1 is assigned to 
the stretching vibration of C-O bond. With the increase in concentration of GNPs, the 
intensity of peaks at 1718 cm-1 and 1652 cm-1 was found to increase confirming the 
presence of carboxylated GNPs in nanocomposites. Further the absorptions at 1427 cm-1, 
1321 cm-1 and 837 cm-1 indicate the bending of C-H bond.  
The ATR-FTIR analysis of the developed PVA-AC composite scaffolds was carried out to 
investigate the intermolecular interactions between the AC and PVA (Fig. 4.7 (e)). The 
spectra showed the characteristic peaks corresponding to standard PVA, a polar polymer 
having -CH, -CH2 and O-H groups with C-C backbone. All these functional groups were 
observed in the FTIR spectra of PC 0 and all the PVA-AC composite scaffolds. A broad 
absorption band obtained at 3596-3024 cm-1 indicates the existence of free and 
intermolecular bonded hydroxyl groups of PVA and AC. The intensity of this band was 
found to decrease in PVA-AC composites as a result of carbonization of AC. The peaks at 
2925 cm-1 and 2855 cm-1 correspond to the aliphatic stretching of C-H,  which is a polar 
bond present in most of the polymers [159, 160]. The absorption bands associated with 
C=O and C-O stretching were observed around at 1726 cm–1 and 1651 cm–1. The low 
intensity peak observed around 1527 cm–1 corresponds to C=C bond vibrations [161]. The 
absorption peak at 1416 cm–1 and 1320 cm–1 originate from C-H aliphatic bending [159]. 
However, in PVA-AC composites, the peak at 1320 cm–1 was not observed which might be 
due to the alteration of molecular arrangements as a result of AC addition. A strong peak 
for C-O stretching in alcohols was observed around 1084 cm–1. The broadening of this C-
O peak (1084 cm–1) occurred with the formation of a new absorption peak at 1026 cm–1 in 
composite samples attributing to the interfacial covalent reaction between PVA and AC. 
The peak at 837 cm–1 for C-H bending in all the PVA-AC samples shifted to 816 cm–1 with 
AC addition. The absence and shifting of C-H bending peaks indicate that the addition of 
AC has obvious effects on the structure of PVA molecules. 
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Fig. 4.7 FTIR spectra of (a) different reinforcements, (b) PVA-nHA, (c) PVA-CNTs, 
(d) PVA-GNPs and (e) PVA-AC composites. 
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Fig. 4.8 Fourier self-deconvolution of FTIR spectra of various samples. 
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4.1.5. Contact angle measurements 
Wettability is one of the key factors affecting the cell attachment and growth on the scaffold 
materials. To evaluate the effect of different reinforcements on the surface hydrophilicity, 
the water contact angles of composites were measured. The water contact angles of all the 
prepared composites are shown in Table 4.1.  
The contact angles of all PVA-nHA composites were found to be less than 80°, indicating 
the hydrophilic behavior of the scaffolds. Pure PVA without nHA showed the lowest 
contact angle of 43.2°. The contact angles of PVA-nHA composites gradually increased 
with the increasing concentration of nHA. The increase in contact angles and the decrease 
in the hydrophilicity of the composite scaffolds correspond to the addition of hydrophobic 
nHA which made the developed composite comparatively hydrophobic.  
With the reinforcement of CNTs into PVA, the contact angle of PVA-CNTs nanocomposite 
was found to increase. However, the increase in contact angles was not much significant 
due to the presence of hydrophilic carboxyl groups on the surface of CNTs and increase in 
surface roughness with the addition of CNTs. All the nanocomposites showed hydrophilic 
nature (contact angle less than 90°) that makes them suitable for osteoblast cell adhesion 
and growth. 
Similarly, the contact angles of the PVA-GNPs samples were also found to increase 
comparing to the pure PVA, showing a small hydrophobic effect. As observed in above 
case, the increase in contact angles was not much significant due to the increase in surface 
roughness with the addition of nanofillers and the presence of hydrophilic functional 
groups on the surface of GNP.  
In the case of PVA-AC composites, pure PVA (PC 0) sample showed the highest contact 
angle of 49.02°. The contact angle of the PVA-AC composite samples was found to 
decrease with an increase in AC compositions. This is due to the water absorbing properties 
of AC, which is homogenously embedded in PVA matrix.  
The contact angle measurement results showed that all the composite samples have 
hydrophilic nature making them suitable for protein and cell attachment.   
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Table 4.1 Average contact angles of different composites. 
Samples 
Average contact 
angle  (degree) 
Samples 
Average contact 
angle  (degree) 
PVA-nHA composites PVA-AC composites 
PVA 43.2±3.42 PC 0 49.02±1.92 
PHA 1 50.4±2.96 PC 0.5 47.28±1.34 
PHA 2 51.8±4.78 PC 1 45.34±5.27 
PHA 3 60.7±3.34 PC 1.5 45.06±0.56 
PHA 4 67.3±6.10 PC 2 44.8±1.64 
PHA 5 71.5±3.56 PC 2.5 43.56±1.63 
PVA-CNTs composites PVA-GNPs composites 
PCN 0 47.04±2.5 PGN 0 44.56±2.45 
PCN 0.5 48.28±1.3 PGN 0.5 50.46±3.52 
PCN 1 52.34±4.6 PGN 1 52.35±1.6 
PCN 1.5 55.86±2.4 PGN 1.5 56.5±5.4 
4.1.6. In-vitro swelling studies 
Scaffolds are destined to swell when coming in contact with body fluids, but it should 
preserve its shape and mechanical stability for the extended time. The increase in pore size 
of the scaffold after swelling enhances the cell attachment and growth. However, 
undesirable swelling of the scaffold reduces its mechanical strength making it unsuitable 
for bone tissue engineering applications. The degree of swelling of the composite scaffolds 
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is dependent on their composition and hydrophilic nature. The influence of the different 
reinforcements on swelling behavior of composites in PBS is shown in Fig. 4.9 (a-d).  
 
 
Fig. 4.9 Swelling studies of (a) PVA-nHA, (b) PVA-CNTs, (c) PVA-GNPs and (d) 
PVA-AC composites. 
Reinforcement of nHA into the PVA matrix brings about a significant change in swelling 
behavior of PVA-nHA composite scaffolds (Fig. 4.9 (a)). PVA without nHA showed the 
highest degree of swelling equal to 271% after 24 h of soaking in PBS. With the increase 
in the concentration of nHA, the degree of swelling was found to decrease which is due to 
the lower hydrophilicity of nHA in comparison to the PVA, which is a hydrophilic polymer. 
The increase in crystallinity with an increase in nHA has led to the decrease in swelling.  
Reinforcement of nHA in PVA matrix made the composite stiffer which decreases the 
swelling of the composites in PBS. Researchers have reported that the addition of ceramic 
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material like HA into PVA matrix leads to the reduction in swelling behavior of composites 
[8]. 
The swelling percentages of various PVA-CNTs scaffolds are illustrated in Fig. 4.9 (b). As 
observed, PVA scaffolds showed the highest swelling percentage. With increase in CNTs 
content in the PVA matrix, the swelling percentage was found to decrease up to PCN 1 
scaffold. This can be attributed to the increase in hydrophobicity and rigidity of the 
nanocomposites with the addition of CNTs [162]. In PCN 1.5, a slight increase in swelling 
was observed. Agglomeration of CNTs in PCN 1.5 might have increased the free volume 
by decreasing compactness of polymer matrix, and hence, resulted in more swelling of the 
scaffold as compared to PCN 1 scaffold. Similar results were also reported  by Shirazi et 
al. for PVA nanocomposite membranes reinforced with CNTs [163]. The swelling was first 
found to decrease with the addition of CNTs in PVA matrix and then increased due to the 
aggregation of CNTs. 
The swelling study results of the PVA-GNPs scaffolds are shown in Fig. 4.9 (c). Pure PVA 
(PGN 0) scaffolds showed highest swelling percentage as compared to PVA-GNPs 
composites. With addition of GNPs up to PGN 1, the swelling percentage was found to 
decrease. This decrease is due to the hydrophobic nature of the GNPs. Also, the 
reinforcement of GNPs in PVA matrix lowers the free volume of fluid uptake sites, hence 
reducing the swelling percentage. With further increase in GNPs (1.5 wt%), a slight 
increase in swelling was observed, which might be due to the agglomeration of 
nanoplatelets. The agglomeration increased the free volume of fluid uptake site which leads 
to increase in PBS uptake in PGN 1.5 scaffolds.  
The incorporation of AC into PVA matrix brings about a significant change in swelling 
behavior of the composite scaffolds (Fig. 4.9 (d)). PVA without AC showed the lowest 
degree of swelling equal to 310% after 24 h of soaking in PBS. The swelling percentage 
increased with increase in AC content in the composites. This is due to the excellent 
absorption properties of AC. Also, the hydrophilic functional groups present in AC tends 
to absorb more fluid on its surface, thus increasing the swelling ratio. 
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4.1.7. In-vitro degradation studies 
Biodegradability is an essential factor that has to be considered while developing a 
composite scaffold. Degradation rate influences the mechanical properties and 
inflammatory responses of the scaffold. It has been reported that biodegradable polymers 
provoke more intense inflammatory responses as compared to non-degradable polymers. 
Further degradation is influenced by many other factors like molecular weight, chemical 
structure, presence of reinforcement and its dispersion. The in-vitro degradation studies of 
PVA based composites scaffolds reinforced with nHA, AC, CNTs and GNPs are shown in 
Fig. 4.10 (a-d). In addition to the degradation percentage, the rate of degradation was also 
modeled and the degradation kinetics was evaluated using power law: 
- 
𝑑𝑀
𝑑𝑡
 = kdM
n 
where M is the mass of the sample, t is the time, kd is the coefficient of the degradation rate 
and n is the order of the reaction. The linear plots (inset of the Fig. 4.10 (a-d)) confirm the 
first order kinetics and the kd values are given in Table 4.2 when the intercept was taken as 
zero.  
Fig. 4.10 (a) shows the weight loss of the developed PVA-nHA composites in PBS over a 
period of 4 weeks. It was observed that the weight loss of PVA-nHA composites initially 
increased rapidly. The PVA scaffold without the addition of nHA showed higher 
degradation rate. With the addition of nHA, the degradation rate was found to decline due 
to the decrease in porosity in the PVA matrix.  The degradation rate of PHA 1, PHA 2, 
PHA 3, PHA 4 and PHA 5 was 1.07, 1.15, 1.37, 1.47 and 1.27 times slower than the pure 
PVA. In the pure PVA scaffold, voids were reported through which fluid can diffuse and 
degrade the matrix [164]. With the reinforcement of nHA, the voids in PVA matrix were 
occupied by these nHA particles, thereby increasing the hydrophobic nature of the 
composites eventually decreasing the degradation rate of PHA samples as compared to 
pure PVA. On the contrary, the composite scaffold PHA 5 (kd = 0.635) shows higher 
degradation rate than PHA 3 (kd = 0.591) and PHA 4 (kd = 0.548). This might be due to 
more agglomeration and improper dispersion of nHA in addition to the voids in PVA 
matrix. Due to this PBS must have penetrated to the matrix more easily and breaking the 
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bond between the agglomerated nHA and degrading the matrix in PHA 5 owing to higher 
degradation as compared to PHA 4 and PHA 3. Amongst all the composite scaffolds, PHA 
3 showed nominal degradation rate due to uniform distribution of nHA in PVA matrix.  
 
 
Fig. 4.10 Degradation studies of (a) PVA-nHA, (b) PVA-CNTs, (c) PVA-GNPs and (d) 
PVA-AC composites. 
The weight loss curves observed in PVA-CNTs scaffolds are shown in Fig. 4.10 (b). The 
pure PVA (PCN 0) scaffold showed highest degradation percentage. The degradation of 
PVA was 1.17, 1.8 and 1.44 times faster than the PCN 0.5, PCN 1 and PCN 1.5, 
respectively. The reinforcement of CNTs in PVA matrix reduced the degradation rate of 
PVA-CNTs nanocomposite scaffolds. This can be attributed to the strong binding between 
CNTs and PVA matrix. The degradation results are also supported by results of contact 
angle measurements and swelling studies. The decrease in hydrophilicity and swelling rate 
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with the reinforcement of CNTs reduced the PBS uptake and hence retarded the 
degradation of the polymer backbone in nanocomposites. However, PCN 1.5 showed 
slightly higher degradation rate when compared to PCN 1 which might be due to the 
agglomeration of CNTs in PCN 1.5.  
Table 4.2 Degradation rate coefficient for the developed composites. 
Sample kd (h-1) (x10-3) Adj. R-
Square 
 Sample kd (h-1) (x10-3) Adj. R-
Square 
PVA-nHA composites  PVA-AC composites 
PVA 0.811 0.999  PC 0 0.752 0.994 
PHA 1 0.753 0.999  PC 0.5 0.848 0.995 
PHA 2 0.700 0.999  PC 1 0.973 0.997 
PHA 3 0.591 0.999  PC 1.5 1.077 0.995 
PHA 4 0.548 0.998  PC 2 1.136 0.997 
PHA 5 0.635 0.999  PC 2.5 1.305 0.999 
PVA-CNTs composites  PVA-GNPs composites 
PCN 0 0.671 0.992  PGN 0 0.690 0.995 
PCN 0.5 0.569 0.995  PGN 0.5 0.520 0.991 
PCN 1 0.372 0.994  PGN 1 0.407 0.995 
PCN 1.5 0.464 0.994  PGN 1.5 0.447 0.999 
 
Similarly, in case of PVA-GNPs scaffolds also, the degradation rate was found to decrease 
with the addition of GNPs in PVA matrix (Fig. 4.10 (c). The PGN 0 sample with highest 
degradation rate coefficient degraded 1.32, 1.69 and 1.54 times faster than the PGN 0.5, 
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PGN 1 and PGN 1.5, respectively. The hydrophobic nature of GNPs in comparison to PVA 
matrix lead to low adsorption of PBS, resulting in reduced degradation rate. Both, PGN 1 
and PGN 1.5 showed almost same degradation percentage till first 2 weeks. However, after 
3 weeks higher degradation was observed in PGN 1.5 indicating the formation of voids due 
to agglomeration of GNPs. 
The percentage degradation curves of PVA-AC composite scaffolds are shown in Fig. 4.10 
(d). The PC 0 sample showed the slowest rate of degradation with kd equals to 0.752 x 10
-
3 h-1, whereas the samples containing AC showed increased degradation. The degradation 
of PC 0.5, PC 1, PC 1.5, PC 2 and PC 2.5 was 1.12, 1.29, 1.43, 1.51 and 1.73 times faster 
than the PC 0 sample. As observed in swelling studies, addition of AC lead to more 
adsorption of PBS due to its excellent absorption properties. Also, the hydrophilic 
functional groups present in AC tends to absorb more fluid on its surface. This increased 
absorption of PBS makes the scaffolds degrading faster. Hence, PC 2.5, with the highest 
degradation rate coefficient, is the fastest degrading PC composite. 
4.1.8. In-vitro hemocompatibility studies 
Blood compatibility is one of the most important properties that has to be tested on the 
scaffold material, as this scaffold on implantation in microenvironment has to be in contact 
with body fluids for a long period of time. During this time period, their interaction may 
lead to cell damage and blood clotting (thrombus). The damage in blood cells’ membrane 
will release hemoglobin which in turn induces acute renal failure. So it is essential to study 
the interaction of blood components with scaffold material. Hemolysis test was performed 
to estimate the blood compatibility of the composite scaffolds. The hemocompatibility of 
scaffold material was estimated by quantifying the amounts of hemoglobin released from 
erythrocytes in whole blood when comes in contact with scaffolds. The percent hemolysis 
values of scaffolds were summarized in Table 4.3. Positive and negative control has shown 
100% and 0% hemolysis respectively.  
It can be observed from data that with increase in amount of nHA above 3% w/v, hemolysis 
has increased to 2% and 1.05% in PVA 4 and PVA 5 composite scaffolds, respectively. 
These data revealed that with the addition of nHA, blood compatibility decreases. This is 
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due to the interaction of ionic groups of nHA with blood leading to high hemolysis. As 
observed in XRD pattern, PHA 4 and PHA 5 samples were more crystalline and hence less 
distorted structure had a higher hemolysis rate when compared to less crystalline (PHA 1, 
PHA 2 and PHA 3) and semi-crystalline PVA.  
Table 4.3 Percentage (%) hemolysis of different composites. 
Samples Hemolysis (%) Samples Hemolysis (%) 
+ve control 100 
-ve control 0 
PVA-nHA composites PVA-AC composites 
PVA 0.20±0.03 PC 0 0.26±0.15 
PHA 1 0.96±0.05 PC 0.5 0.14±0.10 
PHA 2 0.29±0.01 PC 1 0.29±0.10 
PHA 3 0.92±0.04 PC 1.5 0.18±0.05 
PHA 4 2.00±0.16 PC 2 0.11±0.05 
PHA 5 1.05±0.08 PC 2.5 0.22±0.10 
PVA-CNTs composites PVA-GNPs composites 
PCN 0 0.12±0.05 PGN 0 0.15±0.06 
PCN 0.5 0.78±0.12 PGN 0.5 0.58±0.15 
PCN 1 1.01±0.40 PGN 1 1.12±0.45 
PCN 1.5 1.04±0.43 PGN 1.5 1.14±0.35 
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The PVA-CNTs scaffolds have shown hemolysis in the range of 0.12-1.04% with an 
increase in CNTs concentration. The increase in hemolysis percentage is due to the 
roughness induced by the addition of CNTs in PVA matrix. However, the increase in 
hemolysis percent did not significantly differ in PCN 1 and PCN 1.5 samples.  
The percentage hemolysis values for PVA-GNP nanocomposites varied from 0.15% to 
1.14%. This minimal increase in hemolysis (%) is due to roughness induced by addition of 
GNP in PVA matrix. Also, the hydrophobic GNP adhere to the hydrophobic cell membrane 
and cause cell lysis. 
From the hemolysis study it was observed that all the PVA-AC composite scaffold samples 
have negligible percent hemolysis indicating highly hemocompatible nature. The percent 
hemolysis values for PVA-AC scaffolds were found to vary from 0.11% to 0.29%.  
The results have also confirmed the anti-hemolytic activity of the AC in the composite 
scaffold. All the hemolysis results were within the permissible limit. Therefore, from the 
hemolysis study, it can be concluded that the developed scaffolds are highly 
hemocompatible. 
4.1.9. In-vitro mineralization activity studies 
The in-vivo bioactivity is the ability of a scaffold material to bond to a living bone by the 
formation of bonelike apatite on its surface when implanted in the living body. It can be 
predicted by evaluating the apatite formation on the scaffold in in-vitro when immersed in 
SBF. The formation of apatite on composite scaffolds was confirmed by FESEM. Both, 
PVA and PLGA being bioinert materials do not support proper bone integration on its own. 
The addition of different biomaterials can make them bioactive and aid the bone to integrate 
with them.  
The FESEM micrographs were taken to confirm the apatite formation on the PVA-nHA 
scaffolds (Fig. 4.11 (a)). The SEM result has shown enhanced bioactivity of PHA 
composite scaffolds than PVA. Reinforcement of nHA in PVA matrix has enhanced the 
apatite formation as PVA alone does not support it. It has been reported that an increase in 
crystallinity also increases the apatite formation. The XRD data has shown an increase in 
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crystallinity with the increase in the concentration of nHA. Micrograph of PHA 3 
composite scaffold showed dense and homogeneous apatite formation when immersed in 
SBF. This is due to proper dispersion of nHA in PVA matrix leading to this apatite growth 
in SBF. The XRD analysis (Fig. 4.11 (b)) of the composite scaffolds after immersion in SBF 
showed the characteristic peaks of hydroxyapatite at 2θ = 26°, 32° and 46° confirming the 
presence of apatite. Thus, results show that the good dispersion of nHA in a polymer matrix 
influence the homogeneous distribution of apatite when soaked in SBF.  
 
 
Fig. 4.11 (a) FESEM micrographs and (b) XRD spectra of PVA-nHA composite 
scaffolds after immersion in SBF for 21 days. 
The PVA-CNTs composites showed dense apatite formation when compared to pure PVA 
after immersion in SBF for 21 days (Fig. 4.12 (a)). This increase is due to the presence of 
oxygen functionalities on the surface of carboxyl functionalized CNTs.  
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Fig. 4.12 (a) FESEM micrographs and (b) XRD spectra of PVA-CNTs composite 
scaffolds after immersion in SBF for 21 days. 
The carboxyl groups having negative charge act as nucleation points for ionic clusters. The 
positively charged calcium ions (Ca2+) get deposited on the negatively charged carboxyl 
groups, followed by phosphate ions (PO4-), thus forming apatite layer. The PCN 1 sample 
showed homogeneous and dense apatite formation due to the proper dispersion of CNTs 
whereas PCN 1.5 showed less apatite as compared to PCN 1 sample. The agglomeration 
of CNTs in PCN 1.5 sample resulted in uneven apatite formation when soaked in SBF. The 
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XRD spectra (Fig. 4.12 (b)) of all the samples showed a peak at 2θ = 32° confirming the 
presence of apatite. Other characteristic peak for apatite was observed at 46°. 
The apatite formation on PVA-GNPs scaffolds was confirmed by FESEM and results are 
shown in Fig. 4.13 (a). The PGN 0 sample showed the least formation of apatite, whereas 
a thick layer of apatite was observed in all PVA-GNPs composites. This apatite formation 
is due to the presence of carboxyl functional groups on the GNPs surface acting as a 
nucleation point for ionic clusters [60].  
 
 
Fig. 4.13 (a) FESEM micrographs and (b) XRD spectra of PVA-GNPs composite 
scaffolds after immersion in SBF for 21 days. 
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The apatite layer grows by deposition of Ca2+ and PO4- ions from the SBF on negatively 
charged functional groups of GNPs. The PGN 1 sample showed dense and well-formed 
apatite layer suggesting proper dispersion of GNPs in PVA matrix as compared to PGN 
0.5 and PGN 1.5 samples. The apatite granules were homogeneously distributed all over 
the surface of PGN 1 which implies a strong bone-bonding ability between the scaffold and 
surrounding tissue. In contrast, uneven apatite deposition on PGN 1.5 scaffold was 
observed which is due to agglomeration of GNPs. The XRD peaks (Fig. 4.13 (b)) at 2θ = 
26°, 32° and 46° confirmed the apatite formation on all the samples. 
The PVA-AC composite scaffolds showed dense and homogenous apatite formation on the 
surface when immersed in SBF (Fig. 4.14 (a)).  This is due to the presence of oxygen groups 
available on the surface of AC, which provides a favorable site for apatite nucleation. The 
negatively charged groups (carboxyl and carbonyl) electrostatically interact with positively 
charged calcium ions in SBF, which further attracts phosphate ions, thus forming calcium 
phosphate. The morphology of the apatite was found to be globular, but its size varied with 
AC concentration. With the addition of AC, the size of apatite particles was found to 
increase. The PC 0 sample also showed apatite formation, but the size of the apatite 
particles was smaller as compared to PVA-AC samples for the same time period. Further, 
the apatite formation was also confirmed by performing XRD analysis (Fig. 4.14 (b)) which 
showed sharp peaks at 32° and 46°.  
4.1.10. Protein adsorption studies 
The adsorption of proteins on the surface of an implant is among the leading events that 
occur immediately after implantation. When a scaffold is implanted in the human body a 
variety of cytoplasmic, transmembranal and extracellular proteins get adsorbed onto its 
surface when comes in contact with physiological fluids. These proteins facilitate the cell 
attachment and encourage tissue repair (cell responses). Protein adsorption is intensely 
influenced by the surface chemistry, surface charge, and hydrophobicity of the scaffold 
material. Bovine serum albumin (BSA) is a glycoprotein representing 50% of all the plasma 
proteins. Its molecular structure and functions are similar to those of human serum albumin 
[165]. Therefore, in the present study, the adsorption of BSA protein on composite 
scaffolds was evaluated by Bradford assay (Table 4.4).  
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Fig. 4.14 (a) FESEM micrographs and (b) XRD spectra of PVA-AC composite 
scaffolds after immersion in SBF for 21 days. 
In the PVA-nHA scaffolds, pure PVA showed least protein adsorption which was found to 
increase with the addition of nHA in PVA matrix. It is evident that hydrophobic surfaces 
tend to adsorb more proteins than hydrophilic surfaces [166].  The addition of nHA made 
the composite surface less hydrophilic as observed in contact angle measurement results. 
Therefore, more protein was absorbed on the surface of composite samples. However, 
sample PHA 4 and PHA 5 showed slightly less protein adsorption when compared to PHA 
3 sample. The agglomerated nHA in these two samples led to decrease in BSA adsorption. 
Amongst the PVA-CNTs composites, PCN 0 scaffold showed least protein adsorption, and 
it was increased with the addition of CNT. The hydrophilic functional groups (carboxylic 
and hydroxyl) present on the surface of functionalized CNTs adsorb proteins by interacting 
with the functional groups of protein molecules via electrostatic and van der Waals forces. 
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Hence, PVA-CNTs nanocomposites have shown enhanced protein adsorption making them 
biologically recognizable materials suitable for cell attachment. 
Table 4.4 Protein adsorption on different composites. 
Samples 
Protein adsorbed 
(µg/ml) 
Samples 
Protein adsorbed 
(µg/ml) 
PVA-nHA composites PVA-AC composites 
PVA 250±13.51 PC 0 340.25±3.04 
PHA 1 269.56±13.23 PC 0.5 376.90±1.55 
PHA 2 286.43±15.30 PC 1 380.70±3.81 
PHA 3 302.72±6.43 PC 1.5 399.10±5.37 
PHA 4 295.09±10.16 PC 2 401.85±12.23 
PHA 5 291.05±12.45 PC 2.5 405.68±2.26 
PVA-CNTs composites PVA-GNPs composites 
PCN 0 316.31±10.5 PGN 0 233.91±9.13 
PCN 0.5 345.32±13.74 PGN 0.5 248.24±13.76 
PCN 1 396.13±12.67 PGN 1 297.46±13.00 
PCN 1.5 455.02±15.32 PGN 1.5 250.95±25.24 
 
With the addition of GNPs, the hydrophilicity of the samples was decreased as shown by 
contact angle results of the as-cast nanocomposite, which has played an important role in 
enhancing protein adsorption on PVA-GNPs composites. The π electron cloud in graphene 
interacts with the inner hydrophobic cores of protein leading to increase in protein 
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adsorption. However, there was a slight decrease in amount of protein adsorbed for PGN 
1.5 scaffolds which might be due to agglomeration which decreased the exposed surface 
of GNPs for protein adsorption. Hence, PGN samples have shown augmented protein 
adsorption making them suitable for cell attachment, proliferation, and mineralization. 
The PC 0 scaffold showed least protein adsorption and was found to increase with the 
addition of AC. The hydrophilic functional groups present in AC interact with the 
functional groups of BSA molecules via electrostatic and van der Waals forces which 
induce the adsorption of protein molecules on the composite scaffolds. Further, an increase 
in the amount of AC provides more porosity, which means more surface area available for 
higher AC concentrations, thus paving more protein adsorption. 
4.1.11. Tensile properties 
To evaluate the effects of reinforcements on the mechanical properties of composite 
scaffolds, tensile testing was carried out. The tensile strength, Young’s modulus and energy 
at break are tabulated in Table 4.5.  
The tensile strength of the PVA-nHA composite scaffolds was found to increase initially 
with the increase in nHA concentration from PVA to PHA 3; 33.5% from PVA to PHA 3 
composites. Later, it has been observed that the strength decreased for composite scaffolds 
PHA 4 and PHA 5 (higher concentration of nHA) with respect to PHA 3. The decrease in 
the tensile strength is due to agglomeration of nHA in PHA 4 and PHA 5 samples that 
hinder the effective stress transfer and deteriorates the tensile strength of the composite 
scaffolds [167]. The Young’s modulus of the composites was found to increase with the 
increase in nHA concentration. This increase in Young’s modulus is due to the improved 
rigidity of PVA-nHA composites on the addition of nHA; hence increasing the capability 
of the scaffolds to resist external forces.  The lack of interfacial adhesion in PHA 4 and 
PHA 5 resulted in an early failure at the interface, leading to weak mechanical properties. 
The mechanical test results have revealed that the composite scaffold with 3% w/v nHA 
(PHA 3) has shown the best mechanical properties in comparison with the composite 
scaffolds PHA 4 and PHA 5.         
  
Chapter 4                                                                                          Results and discussion 
77 
 
In case of PVA-CNTs composites, PCN 0 sample showed lowest values for tensile strength, 
Young’s modulus and energy at break. Increasing CNTs concentration in PVA matrix 
significantly improved the tensile properties of the nanocomposite scaffolds. The results 
showed that the tensile strength initially increased with increasing CNTs concentration up 
to 1 wt% (i.e., from 0.73±0.07 MPa for PCN 0 to 19.38±1.03 MPa for PCN 1 scaffold).  
This might be due the homogeneous dispersion of CNTs and strong interaction between 
CNTs and PVA matrix, which led to the effective stress transfer in the composite scaffolds 
leading to high tensile strength. With further increase in CNTs concentration (1.5 wt%), 
the tensile strength was found to decrease slightly (17.08±0.74 MPa) as compared to PCN 
1 sample, which may be due to agglomeration of CNTs. The Young’s modulus of the 
nanocomposites also showed a significant increase of 815% from PCN 0 to PCN 1 
scaffolds. A substantial improvement in energy at break was also observed in 
nanocomposites as compared to PCN 0. Similarly, to tensile strength results, the energy at 
break also increased up to PCN 1 indicating more toughness of nanocomposites. This is 
due to the homogenous dispersion of CNTs up to 1 wt% concentration, resulting large 
interfacial area and hence increases the energy required to break the sample. A slight 
reduction in toughness was observed in PCN 1.5 which suggests that the further increase 
in CNTs concentration deteriorates the mechanical properties of the scaffold. Therefore, it 
can be concluded that PCN 1 scaffold showed overall good mechanical properties and 
further increasing the CNTs concentration has detrimental effect on PVA-CNTs 
nanocomposites. 
As expected, the addition of GNPs into PVA matrix has a significant effect on the 
mechanical properties of the developed nanocomposites. The results have shown that the 
PGN 0 has least mechanical strength. The tensile strength of the nanocomposites increased 
with the addition of GNPs from 0 to 1 wt% and then diminished as the GNPs concentration 
reached 1.5 wt%. At 0.5 wt% of GNPs, the reinforcement effect is limited due to its less 
density in the matrix. However, a further increase in GNPs concentration (1 wt%, i.e. PGN 
1) improved the tensile strength by 2068% when compared with pure PVA (PGN 0) 
scaffold. Similarly, the Young’s modulus (stiffness) initially increased with the increase in 
GNPs concentration from 0 to 1 wt%, followed by a decrease in PGN 1.5 with 1.5 wt% of 
GNPs. 
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Table 4.5 Mechanical properties of different composites. 
Samples 
Tensile strength 
(MPa) 
Young’s modulus 
(MPa) 
Energy at break 
(mJ) 
PVA-nHA composites 
PVA 
23.31±8.96 500.02±99.57 25.98±1.39 
PHA 1 
24.12±5.94 520.23±30.34 46.66±3.46 
PHA 2 
24.34±5.69 1000.34±80.45 156.94±6.38 
PHA 3 
31.15±8.33 1100.45±80.65 571.30±13.68 
PHA 4 
22.12±3.42 1700.00±40.36 29.26±1.52 
PHA 5 
26.13±3.62 1900.00±47.97 24.23±1.02 
PVA-CNTs composites 
PCN 0 
0.73±0.07 23.5±1.07 17.11±1.14 
PCN 0.5 
7.12±0.57 95.60±5.53 49.25±4.36 
PCN 1 
19.38±1.03 215.00±9.20 730.86±60.28 
PCN 1.5 
17.08±0.74 211.91±10.74 640.22±42.12 
PVA-GNPs composites 
PGN 0 
0.76±0.08 23.85±1.11 15.03±2.56 
PGN 0.5 
1.92±0.28 78.47±14.42 19.96±7.83 
PGN 1 
16.48±0.50 248.49±16.85 1106.85±67.56 
PGN 1.5 
10.53±1.62 10.61±1.35 202.78±64.93 
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PVA-AC composites 
PC 0 
0.72±0.09 24.85±1.13 17.31±1.07 
PC 0.5 
1.00±0.15 29.32±6.105 24.80±2.00 
PC 1 
1.39±0.26 42.71±2.12 50.21±4.76 
PC 1.5 
1.45±0.11 43.04±6.00 51.90±5.29 
PC 2 
1.68±0.19 52.57±10.52 40.84±2.65 
PC 2.5 
2.21±0.25 111.57±15.91 44.64±2.45 
 
The increase in mechanical strength can be ascribed to the homogeneous dispersion of 
GNPs in the polymer matrix which led to the effective stress transfer in the 
nanocomposites. At higher concentrations (>1 wt%), GNPs stack together forming layers 
due to strong van der Waals forces. This decreases the interaction between GNPs and 
matrix, generating a weak interface which prevents the effective stress transfer, 
deteriorating the mechanical properties of nanocomposites (PGN 1.5). Similar results have 
already been reported in the literature where the agglomeration of GNPs in polymer matrix 
decreases the mechanical strength of composites [168]. The critical concentration of GNPs, 
above which it starts agglomerating varies with the different matrices used. In the present 
work, a significant improvement in energy at break was also observed in all the 
nanocomposites as compared to PGN 0 making the nanocomposites tougher. Therefore, it 
can be concluded that the reinforcement of 1 wt% GNPs improves the overall mechanical 
properties of PGN 1 nanocomposite scaffolds.  
The tensile strength of the scaffolds was found to increase (up to 207%) with an increase 
in AC concentration (i.e., from 0.72±0.09 MPa for PC 0 to 2.21±0.25 MPa for PC 2.5 
sample). The same trend was also observed in the Young’s modulus of the scaffolds that 
showed an increase of 349% from PC 0 to PC 2.5 sample. The increase in strength with 
AC concentration is attributed to the homogenous dispersion of AC in PVA matrix, which 
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helps the effective stress transfer in the composite scaffolds leading to high tensile strength. 
The PVA-AC composites showed a higher value of energy at break (toughness) as 
compared to PC 0 sample. This is due to the homogenous dispersion of AC, resulting large 
interfacial area and hence, increases the energy required to break the sample. A slight 
reduction in toughness was observed in PC 2 and PC 2.5 which suggests that the further 
increase in AC concentration may deteriorate the mechanical properties of the scaffold. 
From results it can be concluded that PC 2.5 scaffold showed overall good strength, 
toughness, and Young’s modulus when compared to other composites.  
4.1.12. Cell viability 
Through preceding studies, it has been found that reinforcement of various carbon materials 
into polymer matrices (PVA) improves its biological and mechanical properties. 
Furthermore, it is also of interest to study in detail the effect of these reinforcements on the 
in-vitro cellular response like cell viability, proliferation, morphology, and differentiation. 
The ability of the scaffold material to encourage cell attachment and proliferation is a 
critical factor for osseointegration. The cell attachment and proliferation, controlled by the 
scaffold properties, further influence the cell differentiation [166]. The viability of MG-63 
cells cultured on scaffolds was measured by MTT assay and trypan blue exclusion assay, 
and the results are shown in Fig. 4.15 and 4.16. The cell viability (%) of the cells cultured 
on the control was normalized to 100%. 
At 48 h post cell seeding, the PVA-nHA scaffolds (Fig. 4.15 (a)) showed significantly 
higher cell proliferation as compared to the control (tissue culture plate). The MTT results 
showed that the addition of nHA encouraged the cell proliferation. This is due to the higher 
surface area to volume ratio of nHA which provides more space for the cells to proliferate. 
The cell viability and proliferation increased up to 3% nHA (PHA 3). With further increase 
in nHA concentration (PHA 4 and PHA 5), there was a slight decrease in the number of 
viable cells. Similar results were found by trypan blue exclusion assay (Fig. 4.16 (a-b). The 
PHA 3 sample exhibited highest total cell count, whereas, PHA 4 and PHA 5 showed a 
decrease in cell count and live/total cells ratio. This decrease is due to increase in 
crystallinity and contact angle of PHA 4, and PHA 5 might have inhibited the osteoblast 
cell proliferation.  
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It is evident from the results shown in Fig. 4.15 (b) and 4.16 (c-d) that the PVA-CNTs 
porous scaffold structures facilitate cell proliferation as compared to the control (tissue 
culture plate). The cell viability of the PVA-CNTs nanocomposite scaffolds was higher 
than that of pure PVA (PCN 0) scaffolds, suggesting that the CNTs encourage the MG-63 
cell proliferation. The number of cells grown on the PCN 1 scaffold showed the highest 
cell proliferation when compared to other compositions and was found to be almost twice 
as compared to the control. The hydrophilic functional groups (carboxylic and hydroxyl) 
present on CNTs surface boosted the protein adsorption by nanocomposite scaffolds that 
further promoted the cell attachment. With further increase in CNTs concentration in 
sample PCN 1.5 (1.5 wt%), the cell viability was found to decrease. As shown in Fig. 4.16, 
PCN 1 sample showed highest cell count and all the scaffolds exhibited less number of 
dead cells than the control. In comparison to control, both PCN 0.5 and PCN 1 showed 
significantly higher live cell to total cell ratio. Hence, the results suggest that 1 wt% might 
be the threshold concentration of CNTs in PVA matrix, which potentially encourage the 
cell attachment and growth.  Beyond that concentration (1 wt%), CNTs might have toxic 
effects on the osteoblast cells. 
The results of osteoblast cell viability on the PGN scaffolds by MTT assay and trypan blue 
exclusion assay are shown in Fig. 4. 15 (c) and 4.16 (e-f). In MTT assay results, all the 
scaffolds showed significantly higher cell viability when compared to control, indicating 
that the porous scaffold structure facilitates cell proliferation. Among all the scaffolds, pure 
PVA showed the least cell viability. The addition of GNPs in polymer matrix promoted the 
cell attachment and proliferation which might be due to the high protein adsorption and 
surface roughness of the composite scaffolds. Also, the sheet like structure of GNPs 
contains more number of functional groups (when compared to functionalized CNTs) to 
interact with proteins and osteoblast cells. The nanocomposite scaffold with 1 wt% GNPs 
(PGN 1) exhibited the highest cell proliferation by facilitating its attachment. However, the 
cell proliferation on PGN 1.5 was significantly lesser than PGN 1 scaffold which might be 
due to the toxic effects of agglomerated GNPs. The concentration dependent toxicity of the 
graphene and its derivatives has already been reported in the literature [141, 166]. Mehrali 
et al. showed that the addition of 1 wt% GNPs into ceramics has positive effects on the 
proliferation of human osteoblast cells, whereas the further increase in GNPs concentration 
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lead to considerably lower cell viability [60].  Significantly higher total cell count and live 
cells to total cells ratio of PGN 1 than the control supported the MTT assay results. Hence, 
the results suggest that 1 wt% of GNPs potentially encourage the osteoblast cell attachment 
and growth.   
 
 
Fig. 4.15 MTT assay results of (a) PVA-nHA, (b) PVA-CNTs, (c) PVA-GNPs and (d) 
PVA-AC composites. 
The MTT assay and trypan blue exclusion assay results of PVA-AC composite scaffolds 
are shown in Fig. 4.15 (d) and 4.16 (g-h), respectively. All the PVA-AC scaffolds showed 
higher cell proliferation than the control plate. It was observed from the MTT assay results 
that the addition of AC encouraged the cell proliferation. The hydrophilic functional groups 
present on AC enhanced the protein adsorption by composite scaffolds which further 
promoted the cell attachment. The PC 1 scaffold showed highest cell proliferation (230%) 
as compared to other compositions.  
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Fig. 4.16 Trypan blue exclusion assay results showing total cell count (a, c, e and g) 
and live to total cells ratio (b, d, f and h) for various scaffolds. 
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With further increase in the AC, the cell viability was found to decrease. This might be due 
to the differentiation of cells in scaffolds with higher concentrations of AC. However, in 
the trypan blue assay results PC 2.5 sample presented the highest cell count with the lowest 
number of dead cells. Briefly, the obtained results confirmed that PVA-AC composite 
scaffolds supported cell proliferation without inducing any cytotoxic effects. 
Thus, the MTT and trypan blue assay results suggested that the carbon reinforcements in 
polymer matrix potentially increase the cell viability on composite samples.  
4.1.13. Cell morphology 
The ability of the scaffold material to encourage cell adhesion and proliferation is an 
important factor in determining the potential of scaffold for bone tissue engineering. The 
adhesion of osteoblast cells plays an important role in the expression of cell functions such 
as cell proliferation and differentiation [169]. It depends on different factors like surface 
charge, hydrophilicity and roughness of the material. The cells can sense surface 
topography and accordingly regulate their shape and cytoskeletal organizations. The 
FESEM analysis was performed to evaluate the effect of reinforcements on cell attachment, 
morphology and mineral production on different composite scaffolds. 
Fig. 4.17 shows the FESEM micrographs of the human osteoblast-like MG-63 cells seeded 
on PVA-nHA scaffolds. The growth of the osteoblast cells on all the PHA composite 
scaffolds confirmed the biocompatibility of these scaffolds. The PVA scaffold showed 
globular shaped cells attached to its surface. The addition of nHA in PVA matrix enhanced 
the cell spreading and cell density on composite scaffolds. This might be due to a higher 
surface area to volume ratio of nHA that provides more space for cells to adhere and 
proliferate. The cells formed large groups on the scaffold surfaces. Nodule formation and 
mineralization were also observed in nHA containing scaffolds (PHA 2 and PHA 3). With 
further increase in nHA concentration (PHA 4 and PHA 5) the number of adhered cells and 
mineralization was decreased. This is due to the combined effect of an increase in 
crystallinity and contact angle of PHA 4 and PHA 5.  
The growth of the osteoblast cells on all the PVA-CNTs nanocomposite scaffolds 
confirmed the biocompatibility of these scaffolds (Fig. 4.18). A less number of cells were 
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found in the PCN 0 samples, whereas more cells were attached to the nanocomposite 
scaffolds. The cells on PCN 0 scaffolds were localized and less spread indicating less 
favored interactions of osteoblast cells with pure PVA.  
 
 
Fig. 4.17 FESEM micrographs of PVA-nHA composite samples cultured with MG-63 
cells. 
In contrast to PCN 0, MG 63 cells cultured on PVA-CNTs nanocomposite scaffolds were 
well spread and showed characteristic osteoblast cell morphology. The reinforcement of 
PVA with CNTs improved both, the cell density and growth on the nanocomposite scaffold 
samples. This might be due to the large surface area provided by CNTs to attach more cells 
and promote cell spreading and proliferation [170]. The increase in nanoroughness and 
protein adsorption with CNTs addition also mediated the osteoblast attachment on 
nanocomposite scaffolds [123]. Keselowsky et al. have also reported the improved 
osteoblast cell attachment on the surfaces having carboxyl functional groups [171]. In the 
case of PCN 1, cellular extensions were observed from the edges of cells. With further 
increase in CNTs concentration up to 1.5 wt% (PCN 1.5), reduced cell attachment and 
spreading was observed. The FESEM results of cell attachment support the MTT assay 
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results, suggesting 1 wt% concentration of CNTs as the threshold concentration of CNTs 
in PVA matrix for cell attachment and growth.   
 
 
Fig. 4.18 FESEM micrographs of PVA-CNT composites cultured with MG-63 cells. 
The FESEM micrographs of osteoblast cells (MG-63) attached to different PVA-GNPs 
scaffolds are shown in (Fig. 4.19). The results revealed that MG-63 cells were successfully 
attached to the scaffold surface. The growth of cells on all the PVA-GNPs scaffolds 
confirmed the biocompatibility of these scaffolds as supported by the MTT assay results. 
The cells on pure PVA (PGN 0) sample were localized and globular indicating less favored 
interactions of osteoblast cells. In contrast, more number of adhered and well-spread cells 
were observed on the surface of nanocomposites. The adjacent osteoblast cells were 
connected to each other through cytoplasmic extensions as shown in FESEM micrographs 
for PGN 1 scaffolds which are important for cell-cell communication required during cell 
differentiation. The mineralized nodules and elongated filopodia were also observed in the 
nanocomposite scaffolds. In the case of PGN 1, spherical cells were also found suggesting 
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that the few cells might be in dividing stage. The enhanced cell attachment on 
nanocomposites can be attributed to the large surface area and nanoscale surface roughness 
provided by GNPs for cells to attach on the nanocomposite scaffolds. Furthermore, high 
protein adsorption on nanocomposites makes more adhesion molecules available for cell 
adhesion [166]. Aryaei et al. have also shown the non-cytotoxic behavior of graphene 
towards the osteoblast cells [172]. A layer of graphene on bone implants was suggested for 
better osteoblast cell attachment and proliferation. However, in our study, a higher 
concentration of GNPs (1.5 wt%) was found to exert adverse effects on the cellular 
behavior. This might be due to the agglomeration of GNPs.  Thus, the above results 
indicated that 1 wt% is the threshold concentration of GNPs in PVA matrix. 
 
     
Fig. 4.19 FESEM micrographs of PVA-GNPs composites cultured with MG-63 cells. 
In PVA-AC scaffolds (Fig. 4.20), the PC 0 scaffold showed round-shaped cells attached to 
its surface, whereas, MG-63 cells cultured on composite scaffolds started to spread and 
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showed characteristic morphology. The decrease in contact angle with AC addition 
increased the cell adhesion on the composite scaffolds surfaces. The cells formed groups 
on the surfaces and within pores of the scaffolds. Nodule formation was also observed in 
composite scaffolds as AC encouraged the formation of mineralized bone nodules and 
more number of mineralized bone nodules were observed in PC 2.5 sample. Clusters of 
matrix appeared inside the pores and on the surface of PC 2 and PC 2.5 scaffolds. Lee et 
al. have reported that the increasing pore size inhibits the cell proliferation but enhance the 
cell differentiation [173]. Similar results were also found in this study. With the addition 
of AC, the pore size was found to be larger as observed in FESEM (Fig. 4.5), which resulted 
in cell differentiation and matrix secretion in PC 2 and PC 2.5. This feature is very 
imperative for scaffold materials used in bone regeneration. Biomaterials often require 
growth factors and mineralization agents for improved cell responses [174]. The present 
study showed that the developed PVA-AC composites formed mineralized nodules without 
the addition of any extra agents. 
 
 
Fig. 4.20 FESEM micrographs of PVA-AC composites cultured with MG-63 cells. 
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4.1.14. Alkaline Phosphatase (ALP) activity 
Alkaline phosphatase, an early and quantitative osteoblastic differentiation marker, is a key 
factor in the formation of hard tissue. The osteoblast cells mineralize bone matrix during 
their differentiation. The ALP helps in decreasing the concentration of extracellular 
pyrophosphate which is an inhibitor of mineralization, and it increases the inorganic 
phosphate concentration to promote mineral formation. Osteogenic differentiation of cells 
cultured on composites was estimated by quantifying ALP activity, and the results with 
respect to control (tissue culture plate) are shown in Fig. 4.21 (a-d). 
As shown in Fig. 4.21 (a), the control showed the least ALP activity as compared to the 
PVA-nHA scaffolds. The ALP activity of cells grown on PVA-nHA composite scaffolds 
was higher than the PVA scaffold. With the addition of nHA, the ALP activity increases 
up to PHA 3 as the hydroxyapatite acts as a chelating agent for mineralization of osteoblast. 
There was a slight decrease in ALP activity with the further increase in nHA concentration 
which might be due to the less number of adhered cells on higher concentrations of nHA 
(PHA 4 and PHA 5) as demonstrated by cell viability study.  
The addition of CNTs in polymer matrix resulted in significant up regulation of ALP 
activity in PVA-CNTs nanocomposites as compared to the PVA scaffold (Fig. 4.21 (b)). 
This increase might be attributed to the increase in surface roughness, hydrophobicity and 
hence, protein adsorption on the nanocomposite scaffolds. Watari et al. have also reported 
that the high protein adsorption with CNTs addition is responsible for improved osteoblast 
adhesion, growth and ALP activity [175]. With an addition of CNTs, the ALP activity 
increased up to PCN 1, whereas with further increase there was a slight decrease in ALP 
activity in PCN 1.5 due to the less number of adhered cells on higher concentrations of 
CNTs (PCN 1.5) as showed by MTT assay and FESEM results. 
The ALP activity of the cells cultured on PGN scaffolds is shown in Fig. 4.21 (c). As 
expected, control (tissue culture plate) showed least ALP activity after 7 days of culturing. 
With the addition of GNPs, the ALP activity significantly improved in comparison to both 
control and pure PVA which suggested an osteogenic induction. Improved cell attachment 
and growth on the nanocomposite scaffolds as evidenced by MTT assay and cell 
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morphology results, exhibited an up-regulation of ALP activity. Better electric properties 
and surface topography of GNPs augment cell attachment and differentiation. A less 
number of not so well spread cells were observed on PGN 1.5 scaffold which led to less 
ALP activity on its surface.  
 
 
Fig. 4.21 ALP activity results of (a) PVA-nHA, (b) PVA-CNTs, (c) PVA-GNPs and (d) 
PVA-AC composites. 
Fig. 4.21 (d) shows the ALP activity of PVA-AC samples with respect to the control (tissue 
culture plate). The control demonstrated the least ALP activity. The addition of AC in PVA 
matrix resulted in significant increase in ALP activity. The PC 2.5 sample showed highest 
ALP activity among all other composites. This increase might be due to the increase in 
surface roughness, protein adsorption and hence, cell adhesion with reinforcement of AC 
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in PVA matrix. Also, the hydrophilic nature of AC plays an important role in up-regulation 
of ALP activity of PC composites. 
4.1.15. Mineralization assay 
The calcium deposition on the samples cultured with cells indicates the matrix 
mineralization by osteogenic cell differentiation. The ARS based assay was performed to 
evaluate the matrix mineralization by quantifying calcium content on the developed 
composite samples, and the results are shown in Fig. 4.22 (a-d).  
An increase in the concentration of ARS staining in PVA-nHA composites (Fig. 4.22 (a)) 
indicated a significant increase in calcium deposition and hence mineralization when 
compared to control. The results are consistent with SEM and ALP results. The control 
showed the least mineralization after staining. The mineralization was found to increase 
with an increase in nHA concentration up to PHA 3 composite scaffolds when compared 
to pure PVA scaffolds. The Ca2+ in HA might have contributed to this increase in osteoblast 
differentiation. The PHA 4 and PHA 5 samples showed a slight decrease in ARS staining 
indicating a reduction in mineralization. This might be due to direct contact of 
agglomerated HA particles with cells causing cell membrane damage in-vitro. Also, the 
crystalline nature and increase in hydrophobicity of PHA 4 and PHA 5 decreased the 
osteogenic differentiation, and hence less mineralization was observed.  
As observed in PVA-CNTs scaffolds (Fig. 4.22 (b)), a significant increase in calcium 
deposition on nanocomposite scaffolds was observed after 7 days. The nanocomposite 
scaffold containing 1 wt% CNTs showed the highest amount of calcium deposition 
compared to other scaffolds. The researchers have reported the increased osteoblast 
attachment and differentiation on the surfaces containing hydroxyl and carboxyl groups 
[176]. These hydrophilic functional groups (-COOH, -OH) present on CNTs up regulated 
the ALP activity and matrix mineralization. However, the PCN 1.5 sample showed a slight 
decrease in ARS staining indicating the reduction in mineralization. The agglomeration of 
CNTs may expose a much less surface area for cells to interact, hence decreasing cell 
differentiation on PCN 1.5 scaffold. 
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Fig. 4.22 Alizarin red stain assay results for (a) PVA-nHA, (b) PVA-CNTs, (c) PVA-
GNPs and (d) PVA-AC composites. 
A significant increase in calcium deposition was observed on PVA-GNPs scaffolds while 
control showed minimum deposition (Fig. 4.22 (c)). In particular, the scaffold containing 
1 wt% GNPs exhibited the highest amount of calcium deposition. As serum proteins are 
known to directly mediate cellular proliferation and differentiation, this increase in matrix 
mineralization can be attributed to the ability of GNPs to adsorb more protein via π−π 
stacking. Graphene has an ability to pre-concentrate osteogenic inducers such as 
dexamethasone and β-glycerophosphate due to π−π stacking between the aromatic rings in 
the proteins and the basal plane of graphene [177]. The electrical conductivity of the GNPs 
could also be one of the reasons for improved mineralization. The agglomeration of 
abundant GNPs in PGN 1.5 scaffold adversely effected the cell proliferation and 
differentiation on scaffolds. Hence, the ALP activity and relative mineralization studies 
confirm that PGN 1 scaffold has osteogenesis promoting properties. 
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The Fig. 4.22 (d) shows the relative calcium deposition normalized to the control in PVA-
AC scaffolds. These results were consistent with ALP results. As expected the control 
showed least calcium deposition after 7 days, and a significant increase in calcium 
deposition on PC composite scaffolds was observed. This increase in calcium deposition 
indicated the increase in encapsulated osteoblast mineralization. PC 0 and PC 0.5 showed 
almost same matrix mineralization, whereas a high mineral deposition was observed in all 
the other composites. Sample PC 2.5 showed highest cell differentiation as evidenced by 
ALP and mineralization assay results. Hence, the results showed that the addition of AC in 
polymer matrix makes the composites suitable as a scaffold material for bone tissue 
engineering. 
4.2. Effect of 1D/2D/3D carbon structures 
4.2.1. Scanning electron microscopy analysis 
The cross-sectional surfaces of the PVA and PLGA based composites developed using 
threshold reinforcement concentration were also examined to investigate their cross-
sectional morphology.   
The FESEM micrographs of the cross-sectional surfaces of PLGA-carbon composite 
samples are shown in Fig. 4.23 (a-d). The PL (Fig. 4.23 (a)) surface was found to be smooth 
and flat, whereas, the addition of reinforcements in PLGA matrix made the composite 
surfaces relatively rough. This roughness is expected to improve the biological responses 
on composites. Nanomaterials like CNTs and GNPs tend to agglomerate in polymer 
matrices due to van der Waals forces. In the present study, carboxylic acid functionalized 
CNTs and GNPs were used; therefore, reinforcements were well dispersed in PLCN and 
PLGN samples and no agglomeration was observed (Fig. 4.23 (b-c)). Further, owing to the 
presence of oxygen containing groups, no agglomeration of AC in PLAC confirmed their 
well distribution throughout the matrix (Fig. 4.23 (d)). Hence, the FESEM results 
confirmed the successful reinforcement of carbon biomaterials in PLGA matrix. 
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Fig. 4.23 FESEM micrographs of (a) PL, (b) PLCN, (c) PLGN and (d) PLAC 
composites. 
The cross-sectional surfaces of various three component PVA-nHA-carbon composite 
scaffolds are shown in Fig. 4.24. The micrographs displayed the highly porous structure of 
all the composite scaffolds.   However, all the scaffolds exhibited different pore size and 
shape. The PH scaffold showed larger but undefined pore structure, and the pore walls were 
crumbled in this sample. In contrast, the pore structure of carbon containing scaffolds was 
stable. The thick pore walls of PHCN and PHGN led to pore size of >100 µm which is 
highly suitable for osteoblast cells to migrate inside the scaffolds. Further, no 
agglomeration was observed in any of the scaffold. Hence, the obtained micrographs show 
that the developed scaffold structures are appropriate for osteoblast growth and 
proliferation.  
The cross-sectional micrographs of PLGA-nHA based three component composites with 
and without carbon are shown in Fig. 4.25. The FESEM micrographs showed that the PLH 
sample has smooth surface. On the other hand, all the carbon containing samples were 
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comparatively rougher. This increased surface roughness is predicted to play an important 
role in enhancing the biological responses of these three component systems. In PLHCN 
and PLHGN composites, all the reinforced particles were wrapped in polymer matrix, 
whereas in PLHAC few particles were observed on the surface. 
 
 
Fig. 4.24 FESEM micrographs of (a) PH, (b) PHCN, (c) PHGN and (d) PHAC 
composite scaffolds. 
4.2.2. X-ray diffraction 
The XRD patterns of all the composites developed after adding optimized concentrations 
of various reinforcements in both, PVA and PLGA composites are shown in Fig. 4.24 (a-
c). As observed in the XRD patterns of PL and PLGA composites Fig 4.24 (a), PL showed 
a broad peak around 21° which confirmed the amorphous structure of PLGA. All the 
composite samples showed this characteristic peak of PLGA. However, the XRD pattern 
of PLCN composite did not reveal any characteristic peak for CNTs. This might be due to 
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its amorphous nature, less concentration and absence of CNTs at the surface of the 
composite. In contrast, both PLGN and PLAC composites displayed characteristic peaks 
for GNPs and AC, respectively. 
 
 
Fig. 4.25 FESEM micrographs of (a) PLH, (b) PLHCN, (c) PLHGN and (d) PLHAC 
composite scaffolds. 
The XRD pattern of carbonaceous PVA-nHA composites are shown in Fig 4.26 (b).  The 
PH composite showed all the characteristic peaks of both PVA (19.5°) and nHA (25.87°, 
31.77° 32.1°, 32.90°, 34.04°, 39.7°, 46.6° and 49.4°). The reinforcement of CNTs and AC 
has not shown any change in the XRD pattern of PHCN and PHAC samples. This might 
be due to the amorphous nature (Fig. 4.6 (a)) and less amount of CNTs and AC as compared 
to the other two components (PVA and nHA) of the system. Further, in PHGN sample, a 
peak at 26.5° corresponding to the GNPs was observed along with the characteristic peaks 
for PVA and nHA.  
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The XRD pattern of PLGA-nHA composites with and without carbon reinforcements are 
shown in Fig. 4.26 (c). All the samples have shown a broad hump around 21° for PLGA 
and characteristic peaks for nHA. As described above, CNTs and AC have not shown any 
peak, whereas, GNPs have shown its characteristic peak at 26.5° corresponding to (002) 
plane. 
 
 
Fig. 4.26 XRD patterns of (a) PLGA-carbon, (b) PVA-nHA-carbon and (c) PLGA-
nHA-carbon composites.  
4.2.3. Fourier transform infrared spectroscopy 
In order to investigate the intermolecular interactions in the composites FTIR analysis was 
carried out. The FTIR spectra and their respective FSD spectra are shown in Fig. 4.27 (a-
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c) and Fig. 4.28. The chemical composition and intermolecular interactions in PLGA 
composites are shown in Fig. 4.27 (a). The pure PLGA (PL) sample showed sharp peaks at 
1742 cm-1, 1451 cm-1, 1188 cm-1 and 1087 cm-1 attributing to C=O, C-H, C-O-C and C-O 
stretching, respectively. The above mentioned characteristic peaks for PLGA were also 
found in all PLGA composites. Additionally, PLCN and PLGN showed a sharp peak for 
C=O stretching at around 1682 cm-1 confirming the presence of carboxylic acid 
functionalized reinforcements in PLGA matrix. The O-H groups (3728 cm-1) were also 
found in all the composites. 
The FTIR spectra of PVA reinforced with optimized concentration of nHA and different 
carbon allotropes are shown in Fig. 4.27 (b). All the samples showed characteristic peaks 
for PVA and nHA, but the intensity of these peaks was slightly reduced with the addition 
of carbon in PHCN, PHGN and PHAC composites due to the strong interaction between 
PVA, nHA and carbon materials. In case of carbon reinforced composites, small peaks 
around 3728 cm-1 confirmed the presence of CNTs, GNPs and AC in PVA-nHA 
composites. The PH sample showed two peaks at 1083 cm-1 and 1030 cm-1 for C-O 
stretching and stretching vibration of PO4
3- ions respectively. On the other hand, with the 
addition of carbon materials, one sharp peak at 1030 cm-1 was observed in carbonaceous 
composites along with a small peak at 1083 cm-1.  
The FTIR spectra of PLGA reinforced with optimized concentration of nHA and different 
carbon materials such as CNTs, GNPs and AC are shown in Fig. 4.27 (c). The PLH and 
carbon reinforced PLH samples showed characteristic peaks for pure PLGA and nHA as 
described earlier. Further, small peaks around 3728 cm-1 indicated the presence of O-H 
groups in the carbon reinforced composites, especially in PLHCN and PLHGN samples 
due to the carboxylic acid functionalized CNTs and GNPs. 
4.2.4. Contact angle measurements 
The wettability of the composite samples with the optimized reinforcement concentration 
was examined by performing contact angle measurements (Table 4.6). The PL sample 
showed a high water contact angle indicating its highly hydrophobic nature. This 
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hydrophobic nature of PLGA is a major concern as this could lead to its unfriendly behavior 
to cells and proteins [178]. 
 
 
Fig. 4.27 FTIR spectra of (a) PLGA-carbon, (b) PVA-nHA-carbon and (c) PLGA-
nHA-carbon composites. 
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Fig. 4.28 FSD of the FTIR spectra of various composites. 
A significant decrease in contact angle was obtained with the addition of carbon based 
reinforcements. The decrease may be owing to the comparative hydrophilic nature of 
carbon reinforcements exposed onto the composite surfaces. The oxygen containing 
functional groups in CNTs, GNPs and AC have hydrogen bond interactions with the water 
leading to decrease in contact angle and thus increase the hydrophilicity of the composites. 
Both, PLCN and PLGN showed almost similar contact angles i.e. 70° and 68° respectively, 
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whereas PLAC showed slightly higher contact angle (81°). This is due to the presence of 
more carboxyl acid groups on functionalized CNTs and GNPs than on AC used in this 
study.  
Table 4.6 Average contact angles of different composites with threshold 
reinforcement concentrations. 
Samples Average contact angle  (degree) 
PLGA-carbon 
PL 94.97±6.50 
PLCN 70.50±2.76 
PLGN 68.87±3.12 
PLAC 81.00±5.28 
PVA-nHA-carbon 
PH 55.89±1.36 
PHCN 61.24±2.87 
PHGN 57.86±1.56 
PHAC 63.01±2.78 
PLGA-nHA-carbon 
PLH 85.53±3.23 
PLHCN 67.14±2.45 
PLHGN 62.34±2.98 
PLHAC 70.47±2.89 
  
Chapter 4                                                                                          Results and discussion 
102 
 
In PVA-HA-carbon composites, carbon containing samples showed a slight increase in 
contact angle. This increase was not much significant due to the presence of less 
concentration of carbon materials. Furthermore, the concentration of nHA was same in all 
the composites, therefore, all the composites showed contact angle in the range of 55-63°. 
In PLGA-nHA-carbon composites, the addition of carbon materials led to decrease in 
contact angle in all the composites making them hydrophilic in nature. The sample PLHGN 
showed the highest hydrophilicity with lowest contact angle values. As mentioned above, 
the oxygen containing functional groups in CNTs, GNPs and AC interact with the water 
leading to decrease in contact angle and thus increase the hydrophilicity of the composites. 
It can be seen that PLGA composites with nHA and carbon reinforcements showed higher 
hydrophilicity than the PLGA composites only with carbon. Therefore, the addition of nHA 
in PLGA matrix resulted in hydrophilicity. 
Thus, the contact angle results suggest that all the developed composites have improved 
hydrophilicity which makes them suitable for proteins and cells attachment.   
4.2.5. In-vitro swelling studies 
The swelling behavior determines the infusion of nutrients and cellular products in the 
scaffold. It further affects the porosity, degradation and mechanical properties of scaffolds 
when implanted in the body. The swelling percentages of the developed composite samples 
are shown in Fig. 4.29 (a-c).  
The in-vitro swelling degrees of the PLGA composite samples after 24 h of incubation in 
PBS are shown in Fig. 4.29 (a). As expected, pure PLGA showed least swelling percentage 
indicating its hydrophobic nature. The reinforcement of carbon biomaterials in PLGA 
matrix lead to increase in swelling percentage. This significantly improved swelling of all 
the composite samples is due to the oxygen containing functional groups on the surfaces 
of carbon reinforcements, which tends to absorbed more PBS increasing its swelling 
percentage. The PLGN composite showed highest swelling percentage (~40%) owing to 
the presence of more hydrophilic groups exposed on its larger surface area (due to sheet 
like structure of GNPs) when compared to PLCN and PLAC samples. 
  
Chapter 4                                                                                          Results and discussion 
103 
 
The effect of reinforcement of carbon biomaterials on swelling behavior of PVA-nHA 
composite scaffolds has been shown in Fig. 4.29 (b). The swelling results are in accordance 
with the contact angle results of PVA-nHA-carbon composites. The composite without 
carbon showed highest swelling degree. The addition of carbon biomaterials led to decrease 
in hydrophilicity of the composites resulting in decreased swelling percentage. Also, the 
less free volume for fluid uptake might have played a role in reducing the swelling 
percentage of the composites. 
 
 
Fig. 4.29 Swelling studies of (a) PLGA-carbon, (b) PVA-nHA-carbon and (c) PLGA-
nHA-carbon composites.  
The swelling percentage of carbon reinforced PLGA-nHA composites after 24 h incubation 
in PBS is shown in Fig. 4.29 (c). The presence of hydrophilic functional groups on the 
carbon biomaterials resulted in increased swelling percentage of carbon reinforced 
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composites (PLHCN, PLHGN, PLHAC) when compared to PLH sample. These results are 
also supported by contact angle measurement values as the sample with lowest contact 
angle has shown highest swelling percentage value and vice versa. The PLHCN and 
PLHAC showed less swelling whereas, PLHGN composite showed highest swelling 
percentage (~60%) due to the presence of more hydrophilic groups on GNPs surface. 
4.2.6. In-vitro degradation studies 
The degradation rate of scaffold plays a significant role in engineering new tissue after 
implantation. Along with the percentage degradation (Fig. 4.30) of the developed 
composite samples, the rate of degradation was also modeled and their degradation kinetics 
was evaluated using power law: 
- 
𝑑𝑀
𝑑𝑡
 = kdM
n 
where M is the mass of the sample, t is the time, kd is the coefficient of the degradation rate 
and n denotes the order of the reaction. The plots are shown in the inset of the Fig. 4.30 
and kd values are given in Table 4.7 when the intercept was taken as zero.  
The in-vitro degradation of the PLGA composites was evaluated and the results are shown 
in Fig. 4.30 (a). Initially, all samples showed slight reduction of weight for first few days. 
Similar to swelling studies, pure PLGA sample showed lowest degradation percentage. 
However, with the incorporation of carbon reinforcements in PLGA matrix, the 
degradation rate was accelerated. The kd values showed that PLCN, PLGN and PLAC 
samples degraded almost 1.5, 1.7 and 1.3 times faster than the pure PLGA sample. All the 
samples showed first order kinetics as the plot of -ln (Mt/Mo) fitted linearly with respect to 
time. Until three weeks, all the composites showed almost same weight loss. After three 
weeks a dramatic increase in weight loss was observed in PLGN sample. The fast 
degradation process of the composite samples may be due to a higher interaction of carbon 
biomaterials with the PLGA matrix and the PBS. Also, the functionalized CNTs and GNPs 
create hydrophilic pockets in the composites which could fasten the hydrolytic degradation 
of PLGA. Further, the better interaction of sheet like structure of GNPs with PLGA matrix 
accelerated the degradation of PLGN composites. The degradation results are also 
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supported by results of swelling studies and contact angle. The increase in hydrophilicity 
of the composites speed up the degradation process leading to increased weight loss of 
composite samples.  
 
 
Fig. 4.30 Degradation studies of (a) PLGA-carbon, (b) PVA-nHA-carbon and (c) 
PLGA-nHA-carbon composites.  
The results obtained from degradation studies of carbon reinforced PVA-nHA composites 
are shown in Fig. 4.30 (b) and the linear plot in inset shows that all the samples follow first 
order kinetics. The PVA-nHA (PH) composite without any carbon reinforcement showed 
highest degradation rate, whereas the carbon reinforced composites had comparatively 
lower degradation. As shown by the kd values (Table 4.7), PHCN, PHGN and PHAC 
showed 1.88, 1.5 and 1.37 times lower degradation rate than the PH sample. The decrease 
in hydrophilic nature of the composites with the reinforcement of carbon materials reduced 
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the PBS uptake and hence delayed the degradation of the polymer backbone in composites. 
Among carbon reinforced PVA-nHA composites, PHCN showed lowest and PHAC 
showed the highest percentage of degradation. This is due to the high adsorption properties 
of the reinforced AC when compared to GNPs and CNTs. 
Table 4.7 Degradation rate coefficient for the developed composites. 
Sample kd (h-1) (x10-3) Adj. R-
Square 
 Sample kd (h-1) (x10-3) Adj. R-
Square 
PLGA-carbon composites  PVA-nHA-carbon composites 
PL 0.204 0.975  PH 0.618 0.999 
PLCN 0.313 0.995  PHCN 0.328 0.998 
PLGN 0.348 0.972  PHGN 0.411 0.993 
PLAC 0.276 0.997  PHAC 0.450 0.991 
PLGA-nHA-carbon composites  
PLH 0.210 0.978  
PLHCN 0.333 0.968  
PLHGN 0.404 0.972  
PLHAC 0.366 0.983  
 
Further, the degradation studies of carbon reinforced PLGA-nHA composites were 
performed (Fig. 4.30 (c)). As expected the PLH sample showed lowest percentage 
degradation due to hydrophobic nature of both PLGA and nHA. The addition of carbon 
materials increased the degradation rate of the composites due to the improved 
hydrophilicity and water absorption. For all the samples, the degradation rate coefficients 
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were consistent with the degradation trend and the samples showed first order kinetics. The 
samples PLHCN, PLHGN and PLHAC exhibited 1.6, 1.9 and 1.7 times faster degradation 
than the PLH sample. The highest degradation rate of PLHGN shows that GNPs have 
hydrophilic groups which created hydrophilic pockets in the composites to absorb fluids 
and degrade the sample faster than other samples. 
4.2.7. In-vitro hemocompatibility studies 
Hemocompatibility is one of the most important properties to be evaluated for a scaffold 
material as they interact with blood and may cause cell damage. The hemolysis study was 
performed for all the samples and the results are shown in Table 4.8.  
The percentage hemolysis values for PLGA-carbon, PVA-nHA-carbon and PLGA-nHA-
carbon composites varied in the range of 0.90-1.32%, 0.82-1.09% and 1.06-1.44% (Table 
4.8). The PL, PH and PLH samples showed least hemolysis, and found to increase for the 
carbon reinforced composites. This increase in hemolysis percentage is due to the 
roughness induced by carbon reinforcements. Further, it has been observed that CNTs 
reinforced PLGA, PLGA-nHA and PVA-nHA composites have shown higher hemolysis 
values when compared to AC and GNPs reinforced composites. This might be due to the 
toxic impurities retained during CNTs synthesis. However, the increase was not much 
significant, and the results for all the samples were in the permissible limit (<5%). 
According to the ISO 10993-4 standard, hemocompatible biomaterial having up to 5% 
hemolysis is permissible [179]. The percentage hemolysis values for all the samples were 
less than 5% showing the hemocompatible nature of the prepared composite scaffolds.  
4.2.8. In-vitro mineralization activity studies 
To mimic the in-vivo bond bonding ability of the developed scaffolds, in-vitro bioactivity 
studies were performed by soaking samples in SBF for 21 days. As confirmed by FESEM 
results (Fig. 4.31 (a)), the PL sample showed very less amount of apatite formed. On the 
contrary, a thick layer of apatite was observed on all the composite samples after 21 days. 
The presence of oxygen functionalities on the surface of different carbon reinforcements 
improved the bioactivity of the composites.  
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Table 4.8 Percentage (%) hemolysis of different composites. 
Samples Hemolysis (%) 
+ve control 100 
-ve control 0 
PLGA-carbon 
PL 0.90±0.01 
PLCN 1.32±0.09 
PLGN 1.02±0.11 
PLAC 1.12±0.04 
PVA-nHA-carbon 
PH 0.82±0.06 
PHCN 1.09±0.11 
PHGN 1.02±0.08 
PHAC 1.08±0.03 
PLGA-nHA-carbon 
PLH 1.06±0.02 
PLHCN 1.44±0.05 
PLHGN 1.11±.06 
PLHAC 1.41±0.06 
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The carboxyl groups present on the functionalized CNTs and GNPs trigger the apatite 
formation, leading to more bioactivity of PLCN and PLGN. Similarly, PLAC also showed 
good bioactivity. The characteristic XRD peaks (Fig. 4.31 (b)) for hydroxyapatite were 
obtained at 26° and 32°. The homogeneous layer of apatite on all the composites also 
confirmed the proper dispersion of reinforcements in the PLGA matrix demonstrating that 
the presence of carbon based biomaterials triggers the self-assembly of apatite.  
 
Fig. 4.31 (a) FESEM micrographs and (b) XRD spectra of carbon reinforced PLGA 
composite scaffolds after immersion in SBF for 21 days. 
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The FESEM micrographs of PVA-nHA-carbon composites after immersion in SBF for 21 
days are shown in Fig. 4.32 (a) and it was observed that all the samples showed formation 
of apatite layer. Reinforcement of nHA in PVA supports the apatite formation as PVA 
alone does not support it much. The crystalline nHA increases the apatite formation. 
Further, the addition of carbon reinforcements makes the scaffold surface more suitable for 
apatite formation. The functional groups on the reinforcement’s surface act as a nucleation 
point for ionic clusters and deposit Ca2+ and PO4- ions from the SBF. Micrograph of PVA-
nHA-GNPs (PHGN) scaffold showed dense and homogeneous apatite formation when 
immersed in SBF which is due to proper dispersion of nHA and GNPs in PVA matrix 
leading to more apatite growth in SBF. The sharp peaks at 26°, 32° and 46° in the XRD 
spectra (Fig. 4.32 (b)) of all the samples confirmed the apatite formation. 
It has been shown already that pure PLGA has poor bioactivity. However, to enhance its 
bioactivity various bioactive materials can be reinforced in the PLGA matrix. The FESEM 
micrographs of nHA and carbon reinforced PLGA composites after immersion in SBF are 
shown in Fig. 4.33 (a). It has been observed that all the samples showed apatite formation, 
but PLH showed very less apatite deposition. On the other hand, the apatite formation on 
carbon containing samples was more and homogeneous which might be due to the 
synergistic effect of nHA and carbon reinforcements. A thick layer of apatite was observed 
on both PLHCN and PLHGN samples. The presence of negatively charged functional 
groups in nHA and carbon reinforcements trigger the apatite formation. Fig. 4.33 (b) shows 
the XRD spectra of the samples after incubation in SBF. The spectra displays the 
characteristic peaks of apatite at around 26°, 32° and 46°.  Thus, the results exhibit that the 
presence of nHA and carbon based biomaterials with oxygen functionalities elicits the self-
assembly of apatite. 
4.2.9. Protein adsorption studies 
When implanted, different proteins from physiological fluid get adsorbed on the surface of 
the scaffold and mediate biological responses. These adsorbed proteins further help in cell 
attachment, proliferation and growth on the scaffold surface. The protein adsorption is 
influenced by factors like surface chemistry, wettability, surface roughness and surface 
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charge. The BSA adsorption on composite scaffolds was evaluated by Bradford assay 
(Table 4.9). 
 
 
Fig. 4.32 (a) FESEM micrographs and (b) XRD spectra of carbon reinforced PVA-
nHA composite scaffolds after immersion in SBF for 21 days. 
The PL sample showed least protein adsorption, however an increase was observed on 
PLGA reinforced with carbon materials. The oxygen functionalities present on the surface 
promoted the protein adsorption of composites [170, 180]. This might be due to the 
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interaction of surface hydrophilic groups with the functional groups of BSA via van der 
Waals and electrostatic forces.  
 
 
Fig. 4.33 (a) FESEM micrographs and (b) XRD spectra of carbon reinforced PLGA-
nHA composite scaffolds after immersion in SBF for 21 days. 
Carbon nanomaterials like CNTs and GNPs have induced more protein adsorption on 
PLCN and PLGN composites as the π electron cloud present on these graphite structures 
interact with the hydrophobic part of BSA proteins. Also, the presence of more functional 
groups on the sheet like (2D) structure of GNPs resulted in the highest protein adsorption 
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on PLGN samples. The protein adsorption on PLAC was almost similar to that on PLCN. 
The high adsorption properties of AC played an important role in such results.  
 
Table 4.9 Protein adsorption on different composites. 
Samples Protein adsorbed (µg/ml) 
PLGA-carbon 
PL 256.15±17.02 
PLCN 326.23±10.56 
PLGN 357.40±10.23 
PLAC 325.12±20.25 
PVA-nHA-carbon 
PH 482.52±16.06 
PHCN 535.71±10.18 
PHGN 527.1±20.08 
PHAC 489.73±19.03 
PLGA-nHA-carbon 
PLH 494.39±20.02 
PLHCN 546.18±10.03 
PLHGN 559.75±7.35 
PLHAC 503.30±25.97 
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Further, the addition of nHA in PVA matrix along with different carbon materials 
significantly increased the protein adsorption. Both PH and PHAC showed almost similar 
protein adsorption. The high concentration of nHA might have suppressed the absorption 
properties of the AC in composite. Similarly, the protein adsorption on PHCN and PHGN 
was also not significantly different. The nHA reinforcement in carbonaceous PLGA 
composites significantly improved their protein adsorption. Among all the composites 
PLHGN showed the highest absorption of BSA. This is due to the synergistic effects of 
nHA and GNPs. It has been explained above that the addition of nHA and GNPs make the 
scaffold surface suitable for protein adsorption.  
All the composite scaffolds have shown higher protein adsorption when compared to pure 
polymer matrices (PVA and PLGA). With the addition of fillers in polymer matrix, the 
surface roughness has been introduced to the scaffolds. The rough scaffolds provide a 
larger surface area to interact with the protein molecules. Also, PBS is a high ionic strength 
buffer that enhances these interactions between proteins and scaffold surface. Thus, the 
existence of nHA and carbon biomaterials in polymer matrix improved the protein 
adsorption on composites making them suitable for cell attachment. 
4.2.10. Tensile properties 
The mechanical properties of pure PLGA, PVA-nHA-carbon and PLGA-nHA-carbon 
composites were assessed by tensile strength, Young’s modulus, and energy at break (Table 
4.10). It was noticed that all the carbon reinforced PLGA composites demonstrated a 
significantly higher tensile strength when compared to pure PLGA sample. The addition of 
1 wt% of CNTs, GNPs, and 2.5 wt% of AC in PLGA matrix resulted in 1.6, 2.0 and 1.3 
folds increase in tensile strength of composites, respectively. Similarly, Young’s modulus 
and energy at break were also found to increase making the composites stiffer and tougher 
in comparison to pure PLGA. The PLAC sample showed weaker tensile properties in 
comparison to other two composites. This might be due to the better dispersion of 
functionalized nano sized CNTs and GNPs in PLGA matrix. Also, the functional groups 
present on the surface of CNTs and GNPs form a hydrogen bond with the matrix and 
augment the interfacial adhesion. Further, PLGN composite showed 2.1 and 1.7 folds 
increase in Young’s modulus and energy at break respectively, when compared to PL 
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sample. The 2D platelet structure of GNPs provides larger interface for effective load 
transfer between PLGA matrix and reinforcement in PLGN composites.  
 
Table 4.10 Mechanical properties of different composites. 
Samples 
Tensile strength 
(MPa) 
Young’s modulus 
(MPa) 
Energy at break 
(mJ) 
PLGA composites 
PL 
5.76±0.09 132.95±9.11 154.76±9.30 
PLCN 
9.62±0.8 275.67±19.13 228.43±10.70 
PLGN 
11.56±0.59 289.89±21.27 265.91±15.89 
PLAC 
7.85±1.58 216.28±23.07 202.83±12.86 
PVA-nHA-carbon 
PH 6.78±0.63 197.16±6.83 48.54±3.14 
PHCN 19.44±1.08 279.85±12.84 97.72±3.86 
PHGN 21.49±1.57 285.74±13.95 102.24±5.63 
PHAC 13.86±1.93 40.99±4.72 232.93±89.32 
PLGA-nHA-carbon 
PLH 5.90±0.02 109.20±4.25 27.56±1.73 
PLHCN 10.05±0.63 844.75±35.42 68.73±4.34 
PLHGN 15.72±0.75 936.83±42.86 162.50±82.64 
PLHAC 7.50±0.25 585.07±22.59 123.12±7.83 
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Further, the carbon reinforced PVA-nHA composites were assessed for their mechanical 
properties. The nHA reinforced PVA composite without carbon showed weakest tensile 
properties among all the PVA-nHA-carbon composites. As expected, the addition of 
carbon increased the mechanical properties of the composites many folds. Both tensile 
strength and Young’s modulus were high for PHCN and PHGN as compared to PHAC 
samples. However, PHAC showed the highest energy at break. This shows that PHAC 
sample is soft but tough which makes it unsuitable for bone tissue engineering applications. 
The mechanical properties of PLGA-nHA without and with carbons were assessed. The 
addition of different carbons i.e. CNTs, GNPs and AC in PLGA-nHA composite matrix 
resulted in 1.7, 2.66 and 1.27 folds increase in tensile strength of composites, respectively. 
The improvements in Young’s modulus and energy at break made these composites stiffer 
and tougher in comparison to PLGA-nHA composite without carbons. The high energy at 
break and low tensile strength of PLHAC in comparison to PLHCN showed its 
comparatively soft but tough nature. The superior tensile properties of all the composites 
indicate the better dispersion of reinforcements in PLGA matrix. Though all the carbon 
reinforcements were found to improve the mechanical strength of composites, GNPs 
showed best results owing to its sheet like structure that provides larger interface for 
effective stress transfer between polymer matrix and reinforcement. 
4.2.11. Cell viability 
The MTT assay results of MG-63 cells cultured on PLGA composites are normalized and 
shown in Fig. 4.34 (a). It is evident from the results that all the samples including pure PL 
and PLGA composites, improved the cell metabolic activity when compared to control 
plate. Further, the cell viability of all the carbon reinforced PLGA composites was higher 
than that of pure PLGA samples. The trypan blue assay results are shown in Fig. 4.35 (a-
b). The total cell count was found to be higher on all the carbon reinforced samples (PLCN, 
PLGN and PLAC) than the control plate and pure PL samples. This shows that the 
reinforcement of carbon biomaterials encourage the cell attachment and growth on the 
composite surfaces. The hydrophilic functional groups present on the carbon 
reinforcements improve the protein adsorption which further increases the cell adhesion 
and growth. The cells viability was highest on PLGN composites which might be due to 
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the fast proliferation of the cells on PLGN sample as compared with PLCN and PLAC 
samples.  
 
 
Fig. 4.34 MTT assay results of (a) PLGA-carbon, (b) PVA-nHA-carbon and (c) 
PLGA-nHA-carbon composites. 
The cell viability results of MG-63 cells cultured on carbon reinforced PVA-nHA 
composites are shown in Fig. 4.34 (b) and 4.35 (c-d). Though all the scaffolds showed 
better percentage cell viability in MTT assay results, the PH and PHCN samples showed 
more than double cell viability (%) in comparison to control. The higher surface area to 
volume ratio of nHA and carbon reinforcements offers more space for the proteins and 
hence, cells to attach and proliferate. In the samples PHGN and PHAC, the cell viability 
was found to decrease. This might be due to the differentiation of cells in these scaffolds 
leading to reduced cell proliferation on PHGN and PHAC. Similarly, the total cell count 
was also found to increase in PH and PHCN samples, whereas a reduction was observed in 
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both, PHGN and PHAC samples. However, no significant difference was observed in live 
cells to total cells ratio. 
 
 
Fig. 4.35 Trypan blue exclusion assay results showing the total cell count (a, c, e and 
g) and live to total cells ratio (b, d, f and h) for various scaffolds. 
The MTT assay and trypan blue exclusion assay results for PLGA-nHA-carbon composite 
scaffolds are shown in Fig. 4.34 (c) and Fig. 4.35 (e-f). It is evident from the MTT results 
  
Chapter 4                                                                                          Results and discussion 
119 
 
that all the composite samples facilitated cell proliferation when compared to control plate. 
The PLH, PLHCN, PLHGN and PLHAC samples showed 1.61, 1.68, 1.94 and 1.44 folds 
increase in proliferation than control. This is due to the high surface area to volume ratio 
and hydrophilic functional groups of the reinforcements (nHA, CNTs, GNPs, AC) which 
boosted the protein adsorption on the composite scaffolds. Further, the reinforcement of 
carbon biomaterials such CNTs, GNPs and AC in PLGA-nHA encourage the cell 
attachment and growth on the composite surfaces. As described earlier, the presence of 
more functional groups and high protein adsorption on GNPs encouraged the cell growth 
and cell viability on PLHGN composites as compared with PLHCN and PLHAC. Further, 
the trypna blue assay results showed the highest total cell count in case of PLHGN sample. 
All the composite samples showed improved cell count than the control plate. Amongst all 
the carbon reinforced samples, GNPs reinforced samples showed least number of dead 
cells. 
Thus, the MTT assay and trypan blue exclusion assay results suggested that the nHA and 
carbon reinforcements in polymer matrix potentially increase the cell viability on 
composite samples. 
4.2.12. Cell morphology 
The osteoblast cell attachment and growth mainly depends on the scaffold surface 
properties like wettability, charge and surface roughness. The growth of the osteoblast cells 
on all the composite scaffolds confirmed their biocompatibility. The FESEM analysis was 
performed to evaluate the effect of reinforcements on cell attachment, morphology and 
mineral production on different composite scaffolds. 
The morphology of the osteoblast cells cultured on carbon reinforced PLGA composites 
was evaluated by FESEM as shown in Fig. 4.36. It can be seen from the micrographs that 
the cells were round in shape and less spread on PL sample. However, on PLGA-carbon 
composite samples, cells were more spread and elongated. The propagation of filopodia 
was evident on composite samples. Cells were found to adhere to each other with cellular 
micro extensions. The osteoblast cells cultured on PLCN and PLAC samples showed 
spindle like morphology whereas on PLGN sample cells were fully spread and formed a 
group.  
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Fig. 4.36 FESEM micrographs of (a) PL, (b) PLCN, (c) PLGN and (d) PLAC 
composites cultured with MG-63 cells. 
The SEM micrographs of osteoblast cell attachment and morphology on the PVA-nHA-
carbon composites are shown in Fig.  4.37. Owing to the presence of nHA, all the samples 
have shown elongated morphology of the osteoblast cells. The addition of carbon materials 
along with nHA in PVA matrix enhanced the cell spreading and cell density on composite 
scaffolds. The surface of carbon containing samples was fully covered with well-spread 
cells. This might be due to higher surface area to volume ratio of nHA and carbon materials 
that provided more space for cells to adhere and proliferate.  
The osteoblasts cell attachment and morphology on PLGA-nHA-carbon composite 
scaffolds was evaluated by SEM and the results are shown in Fig. 4.38. The growth of the 
MG-63 cells on all the scaffolds confirmed the biocompatibility of these scaffolds. 
Although cells were observed to be present on all the samples, carbon containing samples 
showed more number of cells attached to their surface. 
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The cells were found to be well spread on these samples compared to that on PLH sample. 
The formation of mineralized nodules was also observed on samples. The reinforcement of 
polymer matrices with carbon improved both, the cell density and growth on the composite 
scaffold samples owing to large surface area and nanoscale surface roughness provided by 
reinforcements. In GNPs containing PLGA-nHA scaffolds, cells were found to fully cover 
the scaffold surface and secreted matrix. Further, being a hydrophobic polymer, PLGA 
does not encourage cell adhesion. However, the addition of hydrophilic groups containing 
carbon materials improved the cell adhesion by lowering the contact angle of the PLGA 
based composite samples. The osteoinductive and osteoconductive properties of the nHA 
also played an important role. Hence, all the scaffolds showed biocompatible nature 
towards osteoblast cells. 
 
 
Fig. 4.37 FESEM micrographs of (a) PH, (b) PHCN, (c) PHGN and (d) PHAC 
composites cultured with MG-63 cells. 
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Fig. 4.38 FESEM micrographs of (a) PLH, (b) PLHCN, (c) PLHGN and (d) PLHAC 
composites cultured with MG-63 cells. 
4.2.13. Alkaline Phosphatase (ALP) activity 
Alkaline phosphatase (ALP) is an early osteogenic differentiation marker. To evaluate the 
bone forming ability of osteoblast cells cultured on various composite scaffolds, the ALP 
activity was examined quantitatively from the amount of p-nitrophenol produced after 
hydrolysis of pNPP and the results with respect to the control are shown in Fig. 4.39.  
In carbonaceous PLGA composites, all the samples revealed up-regulation of ALP activity 
in comparison to control Fig. 4.39 (a). Further, the cells grown on composites displayed 
significantly higher ALP activity than those on pure PLGA sample. Thus, carbon 
reinforced PLGA composites supported higher osteoblast differentiation. Among these 
composites, the PLCN and PLGN samples showed better results than PLAC sample. The 
nanostructured CNTs and GNPs provide better surface topography and electric properties 
which play an imperative role in the promotion of cell differentiation. Consistent with the 
cell viability results, PLGN composite has shown the best ALP expression. This is due to 
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high protein adsorption on 2D structured GNPs with larger area and more functional groups 
to interact. 
 
Fig. 4.39 ALP activity results of (a) PLGA-carbon, (b) PVA-nHA-carbon and (c) 
PLGA-nHA-carbon composites after 7 days of culturing. 
The ALP activity of the carbon reinforced PVA-nHA composites is shown in Fig. 4.39 (b). 
The ALP activity was found to be in order of: control < PH < PHAC < PHCN < PHGN. 
All the carbon containing composite scaffolds showed better ALP activity than the control 
and PH sample. The increase in surface roughness due to the addition of nHA and carbon 
biomaterials led to improved protein adsorption and cell attachment which further resulted 
in the enhanced ALP activity of the composite scaffolds. The 2D structure of GNPs 
supported highest ALP activity of PHGN among all the other scaffolds. However, it was 
observed in MTT assay studies that PHGN showed less cell viability as compared to PH 
and PHCN. This might be due to the differentiation supporting ability of GNPs which 
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stopped the cell proliferation and started differentiation. Such behavior led to slow cell 
proliferation but high differentiation of the cells. 
In the case of carbonaceous PLGA-nHA composite scaffolds, all the samples revealed up-
regulation of ALP activity in comparison to the control plate (Fig. 4.39 (c)). The GNPs, 
CNTs and AC reinforcement supported higher osteoblast differentiation. As shown by 
protein adsorption and MTT assay results, nanostructured CNTs and GNPs might have 
provided better surface topography and electric properties to encourage protein adsorption 
and cellular responses [181-183]. Also, the excellent adsorption properties and hydrophilic 
groups present on AC made PLHAC sample suitable for cell differentiation. Moreover, 
high protein adsorption 2D structured GNPs (thus, larger area and more functional groups 
to interact) lead to adhere more cells on PLGN samples which expressed high ALP activity. 
Thus, the ALP results showed that the carbon materials improve the cell differentiation on 
the scaffold surface in comparison to control plate. The synergistic effect of nHA and 
carbon materials up regulated the ALP activity of the three component composites many 
folds.  
4.2.14. Confocal microscopy and quantification of cell 
morphology 
The actin filaments are cytoskeletal proteins which mediate the cellular movement and 
provide structural support to cells. The cytoskeletal organization of cells cultured on 
different composite samples stained with TRITC-phalloidin (F-actin) and Hoechst (nuclei) 
was evaluated by confocal microscopy. The cell spreading is a crucial stage in cell adhesion 
prior to exponential growth phase. It can have an intense effect on cell adhesion, growth, 
proliferation, and differentiation. Therefore, in the present study, the cell morphology was 
quantified in terms of cell spreading area for each sample.   
Fig. 4.40 (a-d) shows the cytoskeletal organization of cells cultured on PLGA-carbon 
composites after dual staining of nuclei and actin filaments. More number of cells were 
observed on composite samples as compared to PL sample. The reinforcement of carbon 
materials increases the surface roughness (especially with carbon nanomaterials such as 
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CNTs and GNPs) which is believed to improve cell adhesion and growth. This is due to 
the increase in protein adsorption on rough surfaces. It has also been reported that the 
presence of oxygen containing groups shows a positive response towards cell attachment 
and growth [109]. Amongst all the carbon containing composites, cells cultured on PLGN 
displayed better cytoskeleton organization and actin expression. In the PLGN sample, the 
cells were distributed on the entire surface and showed numerous filamentous extensions. 
Many layers of well-spread osteoblast cells with filopodia were observed and actin 
filaments were also clearly visible. Quantitative analysis (Fig. 4.40 (e)) also confirmed the 
better spreading of cells on composite scaffolds in comparison to pure PLGA. The average 
cell area for PL, PLCN, PLGN and PLAC was found to be 817µm2, 886 µm2, 1203 µm2 
and 857 µm2, respectively. Therefore, the 2D structure of GNPs resulted in better adhesion 
and spreading of cells on composite samples.  
The cytoskeleton of osteoblast cells cultured and stained on PVA-nHA and PVA-nHA-
carbon composite scaffolds is shown in Fig. 4.41 (a-d). The cells cultured on PH and PHCN 
samples were observed to have globular morphology and formed clumps. On the other 
hand, the cells cultured on PHGN and PHAC samples were well-spread. Fig. 4.41 (c) shows 
the cytoskeletal organization of well spread cells on PHGN sample. Inset (A) shows many 
well spread cells on PHGN sample at lower magnification and inset (B) shows 3D 
micrograph of PHGN scaffold. It can be seen that the cells have migrated inside the porous 
scaffold. This might be a reason for the presence of less number of cells on the surface of 
all the scaffolds. The cell area quantification exhibited smaller size of cells on PH and 
PHCN samples. As observed from the box chart, most of the cells on these two samples 
(PH and PHCN) presented the same size, whereas, on PHGN and PHAC scaffolds, cells 
had comparatively larger size. The average cell area for PH, PHCN, PHGN and PHAC 
scaffolds was 102 µm2, 205 µm2, 1060 µm2 and 550 µm2, respectively. The GNPs 
reinforced scaffolds showed almost 10 times larger cells in comparison to the cells on PH 
scaffold. The large cell size indicated the suitability of the surfaces for better cell 
attachment and spreading. 
Fig. 4.42 (a-d) shows the dual stained osteoblast cells on PLGA-nHA-carbon composite 
scaffolds. An increased number of cells were found attached to the carbon containing 
composites. The carbon reinforcements impart surface roughness and oxygen 
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functionalities on the scaffold surfaces making them suitable for cell attachment and 
growth. Moreover, the better protein adsorption on these scaffolds promotes interaction 
between cells and sample surface.  
 
Fig. 4.40 Confocal micrographs of MG-63 cells seeded on (a) PL, (b) PLCN, (c) PLGN, 
(d) PLAC and (e) quantification of cell area on different scaffolds. 
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Fig. 4.41 Confocal micrographs of MG-63 cells on (a) PH, (b) PHCN, (c) PHGN, (d) 
PHAC and (e) quantification of cell area. Inset (A) shows well spread cells on PHGN 
sample at lower magnification and (B) shows cells migrated inside the porous scaffold. 
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Fig. 4.42 Confocal micrographs of MG-63 cells seeded on (a) PLH, (b) PLHCN, (c) 
PLHGN, (d) PLHAC and (e) quantification of cell area on different scaffolds. Inset 
shows the 3D micrograph of PLHGN sample confirming the presence of cells 
throughout the sample. 
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The micrographs demonstrated that the cells adopted typical spindle like morphology of 
osteoblast. Further, PLHGN sample showed both improved cell growth and proliferation. 
The 3D micrograph of this sample (inset of Fig. 4.42 (c)) revealed that the cells were 
distributed evenly throughout the sample. Several filamentous extensions were observed 
along with the well-organized actin filaments. This is due to the presence of GNPs which 
provided more surface area for proteins and cells to adhere. Additionally, cell area 
quantification results are shown in Fig. 4.42 (e). The cells on PLHGN sample showed 
highest cell area followed by PLHAC, PLHCN and PLH. The average cell area for PLH, 
PLHCN, PLHGN and PLHAC samples was observed to be 799 µm2, 800 µm2, 1361 µm2 
and 1187 µm2, respectively. This confirms that GNPs provided more surface area for 
proteins adhesion which encouraged the better cell attachment, proliferation and growth. 
From the confocal micrographs, it can be concluded that the reinforcement of carbon 
biomaterials with and without nHA stimulated the cell adhesion and growth. The structure 
of carbon materials played an imperative role in cell attachment. The presence of 2D 
material (GNPs) with more number of functional groups provided better surface for cells 
to attach and grow. 
4.2.15. Live cell staining 
The in-vitro live cell attachment and viability on various scaffolds was studied by staining 
the cells with calcein-AM stain which stains the cytoplasm of living cells. The retention of 
the stain by live cells is detected as green fluorescence.  
Fig. 4.43 shows the live cell micrographs of carbon reinforced PLGA composites. This is 
evident from the micrographs that the cells attached on pure PLGA sample were not so 
well spread and were present in globular shape. On the other hand, the carbon reinforced 
samples exhibited more number of well-spread cells attached to their surface. It was shown 
from the micrographs that the graphene reinforced sample (PLGN) supported the cell 
attachment and growth more in comparison to the other samples.  
Further, the fluorescence staining results of cells cultured on PVA-nHA-carbon composite 
scaffolds are shown in Fig. 4.44. Similar to the FESEM results, the cells on PVA based 
composites were not spread well. The PH sample showed globular cells, whereas carbon 
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reinforced PVA-nHA composites showed the presence of both globular and spread cells. 
The presence of less number of cells on all PVA-nHA-carbon samples might be due the 
penetration of cells into the porous structure of the scaffolds. 
 
 
Fig. 4.43 Live cell staining of MG-63 cells seeded on (a) PL, (b) PLCN, (c) PLGN and 
(d) PLAC composites. 
The live cell staining micrographs of PLGA-nHA-carbon composites are shown in Fig. 
4.45. All the samples have been found to support the cell attachment and growth. The 
sample surfaces were covered with calcein stained cells indicating the presence of a large 
number of viable cells. Amongst all the carbon materials, GNPs reinforced sample 
(PLHGN) exhibited strongly adhered viable cells on the scaffold. Further, the cells were 
found to form cell-cell contact over large distances. Other carbonaceous PLGA-nHA 
composites (PLHCN and PLHAC) also showed firmly attached cells with elongated 
morphology. Multiple layers of cells were observed on the carbon and nHA reinforced 
samples. This is due to the synergistic effect of optimized concentrations of carbon 
materials and nHA that encourage cell adhesion without causing any toxic effects. 
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Hence, the calcein-AM staining results have confirmed the suitability of carbon reinforced 
composite scaffolds for better cell attachment and growth.  
 
 
Fig. 4.44 Live cell staining of MG-63 cells seeded on (a) PH, (b) PHCN, (c) PHGN and 
(d) PHAC composites. 
4.2.16. Collagen quantification 
Collagen is an important component for cell proliferation and tissue formation. The 
collagen production in scaffolds by osteoblast cells indicates the formation of ECM within 
the scaffolds. The collagen content secreted by cells seeded on various scaffolds was 
quantified by staining with Sirius red dye (Fig. 4.46).  
Less amount of collagen was observed in control plate (tissue culture plate), whereas, the 
total collagen content within all the scaffolds was notably higher. In PLGA-carbon 
composite scaffolds (Fig. 4.46 (a)), pure PLGA showed least collagen secretion, that was 
found to increase with the addition of carbon reinforcements. There was no significant 
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difference in the amount of collagen synthesized by cell seeded on both, PLCN and PLGN 
samples; however it was higher than pure PLGA and PLAC samples. This is due to the 
presence of nano sized CNTs and GNPs.  
 
 
Fig. 4.45 Live cell staining of MG-63 cells seeded on (a) PLH, (b) PLHCN, (c) PLHGN 
and (d) PLHAC composites. 
Further, in PVA-nHA-carbon scaffolds (Fig. 4.46 (b)), the addition of all the three carbon 
materials up-regulated their collagen secretion.  Amongst PVA-nHA composites, PHGN 
exhibited the highest amount of collagen production. The cells cultured on carbonaceous 
composites of PLGA-nHA (Fig. 4.46 (c)) revealed many folds increase in the amount of 
collagen secreted in comparison to both, control plate and PLH scaffold. This might be due 
to the synergistic effect of carbon materials and hydroxyapatite added to the PLGA matrix. 
The GNPs reinforced PLGA-nHA composites (PLHGN) secreted significantly higher 
amount collagen in comparison to all other samples. The larger surface area, more 
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functional groups and hence, high protein adsorption values of the 2D structured GNPs 
lead to higher cell adhesion and differentiation.  
The augmented collagen secretion on all the composite scaffolds suggested the positive 
effects of nHA and GNPs on cellular responses. Thus, the results confirmed the 
osteogenesis promoting properties of carbonaceous composites. 
 
 
Fig. 4.46 Quantification of collagen produced by MG-63 cells seeded on (a) PLGA-
carbon, (b) PVA-nHA-carbon and (c) PLGA-nHA-carbon composites. 
4.2.17. Mineralization assay 
The mineralized matrix on the scaffold samples cultured with osteoblast cells is the sign of 
the osteoblast differentiation. The calcium deposition due to matrix mineralization was 
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analyzed using Alizarin Red stain (ARS) based assay and the results were normalized to 
the control (Fig. 4.47 (a-c)). 
Fig. 4.47 (a) shows the relative mineralization results of carbonaceous PLGA composites 
normalized to the control. As expected from other biological results, the calcium deposition 
was lowest on control in comparison to PL and PLGA composites. The carbon reinforced 
samples demonstrated significantly higher calcium depositions than the pure PLGA sample 
after 7 days of cell culturing. Amongst PLGA composites, PLGN showed highest amount 
of bone nodule formation. The functionalized reinforcements impart negative charge to the 
surface of composite. These negative surfaces encourage heterogeneous nucleation and 
growth of hydroxyapatite. It has been reported that the presence of carboxyl groups induce 
calcium deposition even after a short period of cell culturing [180].  
 
Fig. 4.47 Alizarin red stain assay results for (a) PLGA-carbon, (b) PVA-nHA-carbon 
and (c) PLGA-nHA-carbon composites. 
  
Chapter 4                                                                                          Results and discussion 
135 
 
The relative mineralization of the cell cultured on PVA-nHA-carbon composites are shown 
in Fig. 4.47 (b). Though all the scaffolds showed better results, the carbon containing 
scaffolds showed more mineralization as compared to control plate and PH sample. Both 
nHA and carbon biomaterials supported the cell differentiation on the scaffolds. More than 
7 folds increase was observed in calcium deposition on PHGN sample in comparison to the 
control. The electrical conductivity and unique (sheet like, 2D) nanostructure of the GNPs 
encourage the cellular differentiation in PHGN scaffolds. 
In the case of carbonaceous PLGA-nHA composites, PLH sample showed almost double 
mineralization than control plate (Fig. 4.47 (c)). As expected from above results, the carbon 
reinforcements further improved the mineralization deposition on scaffolds. Upon 
implantation, surface chemistry of the material plays an imperative role in regulating the 
cellular responses towards implant. The cellular responses such as cell attachment, 
proliferation, differentiation and matrix formation, depends on the protein adsorption on 
implant. The oxygen containing functional groups present on three carbon reinforcement 
used in this study act as bioactive molecules by providing sites for protein adsorption. Also, 
the interaction of π electrons of graphite structure and the hydrophobic part of protein 
encourage the protein adsorption on carbon nanomaterials (CNTs and GNPs) [177]. These 
interactions specifically adsorb proteins which enhance cell proliferation and 
differentiation, resulting in up regulation of ALP activity and matrix mineralization. 
Among CNTs and GNPs reinforced samples, PLHGN has shown the highest 
mineralization.  
The differences in the morphology of three different carbon materials lead to different 
results. The exceptional electric properties of CNTs and GNPs played an important role in 
improving cellular responses as compared to AC. In spite of having same electric properties 
and graphitic structure, the GNPs showed better responses in comparison to the CNTs. This 
is mainly due to the sheet like structure of GNPs which is different from tubular CNTs. 
The unique 2D nanostructure of GNPs with more number of functional groups was 
available for proteins and cells to attach. Therefore, GNPs displayed stronger enhancement 
in cell proliferation and differentiation. From the results, it can be seen that carbon 
reinforced PLGA-nHA composites not only supported cell attachment and proliferation, 
but it also improved the cell differentiation.  
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4.3. Summary 
In this chapter, the results obtained from the present study have been reported and 
discussed. The optimized concentrations of the various reinforcement materials (such as 
nHA, CNTs, GNPs and AC) have been obtained by characterizing the developed composite 
scaffolds for their physicochemical, biological and mechanical properties.  
Micrograph of PHA 3 composite (3% w/v) showed even and homogenous distribution of 
nHA in PVA matrix. PHA 3 composite scaffold has shown nominal swelling studies and 
degradation studies; as well as dense and homogenous apatite formation on immersion in 
SBF for a duration of 4 weeks. On the other hand, the composite scaffolds PHA 4 and PHA 
5 has shown non-homogenous apatite formation on immersion in SBF due to 
agglomeration of nHA in PVA matrix. The osteoblast adhesion, proliferation, ALP activity, 
and mineralization were significantly higher on composite scaffolds. PHA 3 also showed 
the highest tensile strength, whereas PHA 4 and PHA 5 exhibited less strength and 
undergone brittle failure. Hence, 3% w/v can be concluded to be the optimum composition 
of nHA amongst the other composite scaffolds and can be engineered further for bone 
tissue engineering application.  
The presence of porous AC in the PVA matrix improved the porosity, hydrophilicity, 
bioactivity, hemocompatibility and protein adsorption of the composite scaffolds. The 
efficient load transfer between PVA and AC enhanced the mechanical properties of the 
composites many folds. Further, the hydrophilic nature and high protein adsorption of 
composite scaffolds encouraged the osteoblast cell adhesion and growth. It can be 
concluded that the reinforcing polymer matrix with porous AC (2.5 wt%) improves the 
mechanical as well as biological properties of the composite without compromising with 
the porosity of the scaffolds.  
The physical interactions of carboxylic acid functionalized CNTs and GNPs with PVA 
enabled homogeneous dispersion of them in PVA matrix individually, leading to enhanced 
in-vitro biological and mechanical properties of the nanocomposites. The presence of 
CNTs and GNPs in the PVA matrix improved the surface morphology, bioactivity, protein 
adsorption, and mechanical properties of the nanocomposite scaffolds. The mechanical 
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properties were enhanced many folds with reinforcement of 1 wt% of each of CNTs and 
GNPs in PVA matrix without compromising much with the porosity of the scaffold. 
However, with further increase in reinforcement (1.5 wt%) concentration, mechanical 
properties were found to decrease due to the agglomeration of materials. Among all the 
nanocomposites, both PCN 1 and PGN 1 (1 wt%) provided the most favorable 
microenvironment for cell proliferation and differentiation. Hence, the presented results 
suggest that 1 wt% might be the threshold concentration of CNTs and GNPs in PVA matrix, 
below which they were well dispersed, and the scaffold surface was best suitable for cell 
attachment, proliferation, and differentiation.  
Hence, obtained optimum concentrations of 4 different reinforcements were used to further 
study the effect of different structures of carbon reinforcements. The PLGA, PVA-nHA, 
and PLGA-nHA were reinforced with threshold concentrations of different carbon 
materials. The PVA based composites showed decrease in hydrophilicity, swelling and 
degradation, whereas the PLGA based composites exhibited improvement in these 
properties. The enhanced protein adsorption and bioactivity was obtained in comparison to 
control sample. The tensile strength of all the samples was drastically improved with 
reinforcement of each carbon material. The carbon reinforcement in polymer and polymer-
ceramic matrices stimulated the enhancement in cell biological behavior. Improvement in 
osteoblast cell responses was observed from proliferation, ALP activity, mineralization 
assay and collagen quantification assay.  
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Chapter 5 
Conclusion 
In the present work, different reinforcing materials (nHA, CNTs, GNPs and AC) of 
different concentrations were reinforced in polymer (PVA) matrix. The optimum 
concentrations of the different reinforcements were obtained after conducting systematic 
mechanical and biological studies. The optimum concentrations of carbon materials were 
reinforced into PVA and PLGA along with nHA. The following conclusion was arrived 
from the study. 
a. With the increase in the concentration of reinforcement materials, the mechanical 
and biological properties of the developed composites were improved up to 
threshold (optimum) concentration. At the threshold concentration, the reinforced 
material was homogenously dispersed in the polymer matrix providing a larger 
interface between the matrix and reinforcement for effective stress transfer. The 
well dispersed reinforcement materials also exhibited improvement in the protein 
adsorption, cell adhesion, proliferation, and differentiation in the composite 
samples with optimum reinforcement concentration. The homogenous dispersion 
of reinforcement materials provided suitable surface properties (wettability, 
roughness, surface charge and surface chemistry) to the scaffolds for protein and 
cell adhesion. 
b. It was observed that above the threshold concentrations, the reinforced materials 
start to agglomerate in polymer matrix which results in deterioration of biological 
and mechanical properties of the composite scaffolds. The agglomerated materials 
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at higher concentration reduced the load transfer from polymer to reinforcement 
material weakening the mechanical properties of the composites. Moreover, the 
agglomerated reinforcement materials have also shown cytotoxicity to the 
osteoblast cells. Therefore, 3% w/v of nHA, 1 wt% of CNTs, 1 wt% of GNPs and 
2.5 wt% of AC were considered as the threshold concentration at which 
reinforcements were well dispersed in the polymer matrix. 
c. Further, the effect of different structures of carbon materials (1D, 2D, 3D) was 
studied by reinforcing polymer matrices (PVA and PLGA) with threshold 
concentrations of CNTs, GNPs and AC along with nHA. The synergistic effect of 
nHA and carbon materials improved the protein adsorption, bioactivity and tensile 
properties of the composites. The up regulated ALP activity and mineralization on 
the three component composite scaffolds confirmed the improvement in the bone 
forming ability of osteoblast cells. In spite of having different structures, all three 
carbon materials showed good osteogenic capacity when reinforced along with 
nHA. The different dimensional structures of reinforcements played an important 
role in tailoring the mechanical and biological properties of the composites. Both 
CNTs and GNPs reinforced composites revealed better tensile strength and 
Young’s modulus as compared to AC owing to the good mechanical properties of 
the reinforcements. The improved surface properties i.e. roughness, charge, 
wettability and chemistry showed a positive effect on the biological properties of 
the nanocomposites. The high aspect ratio and exceptional electrical properties of 
the nanomaterials up regulated the proliferation and differentiation of the 
composites.   
d. Although both CNTs and GNPs have similar graphitic structure and electric 
properties, GNPs exhibit greater advantages for reinforcing both polymer and 
polymer-ceramic composites over CNTs. The sheet like 2D structure of GNPs 
provided more number of functional groups for protein adsorption and cell 
attachment in comparison to tubular CNTs (1D). The high ALP activity, collagen 
secretion, and matrix mineralization confirmed that the GNPs reinforced 
composites provide the most favorable microenvironment for osteoblast cell 
  
Chapter 5                                                                                                            Conclusion 
 
140 
 
proliferation and differentiation. Also, their larger interface resulted in the effective 
load transfer between polymer matrix and GNPs. The results from the mechanical 
and biological studies suggested that the structure of reinforcement plays an 
imperative role in developing a suitable composite scaffold. Overall, from the 
above study, it can be concluded that the polymer-ceramic based carbonaceous 
composites possess osteogenesis promoting properties along with the improved 
mechanical properties for bone tissue engineering.  
Scope for future research 
In the present research, carbon reinforced polymer-ceramic composite scaffolds have been 
developed for improved bone tissue regeneration. However, there is a scope for future 
research to further improve the characterization process of the composite scaffolds.   
 Detailed mechanical studies (compression, flexural behavior) can be studied in in-
vitro environmental condition. 
 The interaction of primary osteoblast cells with the developed scaffolds can also be 
studied. 
 In-vivo studies using animal models can be performed to validate the in-vitro 
results. 
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